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MAY RESOLVE INFLAMMATION IN CHRONIC WOUNDS 
ANWAR J AL-MZAIEL 
Abstract 
Hyperbaric oxygen (HBO) therapy is the intermittent inhalation of 100% oxygen at a 
pressure greater than one atmosphere absolute. It is an effective treatment for various 
inflammatory conditions, including chronic wounds which are characterized by an 
excessive influx of neutrophils and their prolonged persistence at the wound site. 
Neutrophil apoptosis and clearance have been shown to be required for resolution of 
inflammation. The mechanisms by which HBO aids wound healing are well documented, 
but its effects on cellular inflammatory response are not well understood particularly with 
respect to neutrophils. The hypothesis presented in this thesis is that increased oxygenation 
via HBO assists chronic wound healing by enhancing non-inflammatory neutrophil 
defences and cell death through apoptosis. 
An investigation was carried out into the effects of HBO on neutrophil antimicrobial 
function and apoptosis using differentiated HL-60 cells as an in vitro neutrophil model. The 
data clearly showed that a single HBO treatment for 90 min caused an increase in the 
oxidative burst activity of neutrophil-like cells as shown by increased NBT staining, 
superoxide (cytochrome c reduction) and H2O2 production (Kruskal-Wallis, P < 0.05), and 
phagocytosis of Staphylococcus aureus. HBO treatment displayed a pro-apoptotic effect, 
enhancing caspase 3/7 activity both in the presence and absence of a TNF-α stimulus 
(Kruskal-Wallis, P < 0.05) and causing morphological changes (observed using Giemsa 
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and SYBR® Safe staining) associated with apoptosis. Although no consistent pattern was 
observed, both hyperoxia and pressure alone seemed to contribute to both the increase in 
antimicrobial activity and the increase in apoptosis induced by HBO in these neutrophil-
like cells (Chapters 4 and 5). 
HBO-enhanced neutrophil clearance by macrophages was investigated using bovine 
neutrophils and monocyte-derived macrophages (MDMФ). A single 90 min HBO exposure 
significantly increased the clearance of fresh and 22 h-aged neutrophils by MDMФ (two-
way ANOVA, P < 0.05), suggesting an increase in phosphatidylserine (PS) exposure in 
apoptotic neutrophils after HBO treatment (Chapter 6). Importantly, a long-term repetitive 
exposure to HBO in patients with chronic wounds caused a significant decrease in the 
antioxidant enzyme defence system (one-way repeated measures ANOVA, P < 0.05), 
plasma TNF-α and IL-1β after 30 HBO sessions, with down regulation of expression of the 
anti-apoptotic factors, NF-B and Bcl-2 (Chapter 7). These findings may go some way 
towards explaining the effectiveness of HBO treatment not only for chronic wounds but 
also for other inflammatory conditions that may be affected by this treatment. 
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GENERAL INTRODUCTION 
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1.1 Introduction 
Chronic wounds such as diabetic foot ulcers and venous or pressure leg ulcers constitute a 
serious health and economic problem. It has been estimated that 15% of diabetic patients 
are likely to develop lower extremity ulcers, while 14-24% of diabetic patients with foot 
ulcers might undergo amputation (James et al., 2008). It is expected that this problem will 
grow rapidly as the population ages, as 85% of chronic wound patients are over 65 years 
old (Menke et al., 2007, Diegelmann, 2003). 
Hyperbaric oxygen (HBO) therapy is a widely-accepted treatment that is used for chronic 
wounds. It involves intermittent inhalation of 100% oxygen at a pressure greater than one 
atmosphere absolute (ATA; Feldmeier, 2003). Hyperbaric oxygen therapy has been 
demonstrated to assist wound healing through increased oxygen delivery to wound tissue 
(Gill and Bell, 2004). This has consequences for the functions of various different cell types 
involved in the wound healing process, including neutrophils, monocytes, fibroblasts and 
keratinocytes. Of particular interest are neutrophils, which play a critical role in the host’s 
defence against infection in normal wound healing, but which contribute to the prolonged 
inflammation which is observed in chronic wounds; increased influx of neutrophils to the 
wound site is associated with increased release of destructive contents (Nwomeh et al., 
1998a). The effects of HBO on wound healing may be attributed in part to altered 
neutrophil recruitment and function and further investigation of these effects could lead to 
the development of treatment protocols and improved wound healing rates. 
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1.2 Normal wound healing 
Wound healing is normally a well-orchestrated, complex process that serves to repair and 
restore tissue structure and function that has been disrupted by physical, chemical, bacterial 
or viral insults  (Diegelmann and Evans, 2004, Singer and Clark, 1999). The general 
sequence of events begins as a response to injury and ends with scar formation. Normal 
(acute) wounds are those that show obvious signs of healing within a reasonable time frame 
after injury, and without any complications. Cellular and biochemical activities including 
phagocytosis, cell proliferation, cell migration, collagen synthesis, angiogenesis and 
cytokine production are well-coordinated in normal wound healing (Fig. 1.1) Those 
activities occur in three major overlapping phases: inflammation, proliferation and 
remodelling (Bonomo et al., 2000). Each phase of wound healing is distinct, although the 
process as a whole is continuous (Singer and Clark, 1999). 
1.2.1 The inflammatory phase 
The sequence of wound healing events begins immediately after injury. Injury induces 
disruption of blood vessels and release of blood constituents into the wound site; this 
facilitates haemostasis, a first step in wound healing to limit blood loss as well as the 
restoration of the integrity of the damaged tissue (Diegelmann and Evans, 2004). 
Haemostasis comprises three main stages: vasoconstriction, platelet plug formation, and 
formation of a clot. Damage to capillaries promotes vasoconstriction which slows blood 
flow, and enhances platelet adhesion and activation to produce a platelet plug (Clark, 2001, 
Lasne et al., 2006). The damaged tissue and activated platelets then produce factors that 
activate a coagulation signalling cascade with the conversion of fibrinogen to fibrin by 
thrombin, a major step in the formation of the fibrin clot that serves as a temporary matrix 
 4 
 
for cellular migration into the site of injury (Grinnell et al., 1981). Activated platelets 
trapped in the clot release several growth factors and cytokines that induce the 
inflammatory phase of wound healing (Schultz et al., 2003, Doughty and Sparks-Defries, 
2007). The inflammatory phase is immediate and lasts 2-4 days. The inflammatory growth 
factors, including platelet-derived growth factor (PDGF), transforming growth factor-β 
(TGF-β), epidermal growth factor (EGF), and insulin-like growth factor-1 (IGF-1) are vital 
for wound healing (Tsirogianni et al., 2006). Within 6 h of injury, these growth factors 
have started to recruit neutrophils to clean the wound site and remove foreign particles; 
cytokines and adhesion molecules give specificity to this attraction (Blakytny and Jude, 
2006). In response to specific chemotactic factors, such as complement factor 5α (C5α), 
and TGF-β, monocytes are attracted to the wound site within 24 h of injury, and later 
differentiate into macrophages during the inflammatory phase. Macrophages phagocytose 
the pathogens and any remaining debris from damaged cells (Lobmann et al., 2005). 
During phagocytosis, neutrophils and macrophages produce reactive oxygen species (ROS) 
or proteases, including collagenase, matrix metalloproteinase and elastase that cause 
extracellular matrix (ECM) degradation. In the latter stages of the inflammatory phase, 
macrophages also release various inflammatory cytokines including TNF-α, IL-1, IL-6 and 
IL-8 which provide powerful stimuli to recruit more inflammatory cells to the wound site 
(Blumenfeld et al., 2000) as well as growth factors which are necessary for initiation of 
granulation tissue formation. In the normal healing process, the late inflammatory phase is 
around three to four days after injury, while granulation tissue formation follows four to 
five days later (Singer and Clark, 1999). After 2-3 days, the number of neutrophils begins 
to decline as they are cleared from the wound site through phagocytosis (Schultz et al., 
2003), while macrophages continue to accumulate at the wound site.
 5 
 
 
Fig. 1.1 The normal wound healing process. The normal wound healing process consists of three overlapping phases; an inflammatory phase, a proliferative phase and a remodelling 
phase, all of which involve the participation of different cell types, cytokines and growth factors. Progression through these phases results in normal wound healing (Singer and 
Clark, 1999). 
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1.2.2. The proliferative phase 
This phase starts at about day three and lasts for about 3-4 weeks after injury. It 
comprises of angiogenesis, collagen synthesis, fibroblasia, granulation tissue formation, 
re-epithelialisation and wound contraction (Midwood et al., 2004). Around two days 
after injury, the macrophages begin to release growth factors (e.g. TGF-β, TGF-α, IL-1, 
IGF-1 and PDGF) as well as both acidic and basic fibroblast growth factors (aFGF and 
bFGF) and vascular endothelial cell growth factor (VEGF, an angiogenic factor), which 
promote cell migration, proliferation, angiogenesis and synthesis of ECM components 
(Diegelmann and Evans, 2004). Therefore, macrophages mediate the transition from the 
inflammatory phase to the phase of granulation tissue formation. 
Angiogenesis, the growth of new blood vessels from pre-existing vessels in order to 
resupply oxygen to ischaemic tissue, is stimulated by macrophage activity (release of 
TGF and TNF-α) and by hypoxia as a consequence of tissue injury (Lamagna et al., 
2006) which, through stabilisation of the transcription factor hypoxia-inducible factor 1-
α (HIF-α), leads to the production of VEGF by macrophages and endothelial cells 
(Lewis et al., 1999). Angiogenesis is modulated by VEGF while cell migration, 
formation of new extracellular matrix, maturation and keratinization of epidermal cells 
are modulated by EGF, keratinocyte growth factor (KGF) and PDGF (Gray et al., 
1993). During fibroplasia and granulation tissue formation, fibroblasts subsequently 
differentiate to myofibroblasts which are responsible for wound contraction, collagen 
production and fibronectin secretion to support cell migration (Schafer and Werner, 
2008, Midwood et al., 2004). 
Re-epithelialization has been shown to start within hours after injury as clotted blood 
and damaged stroma are removed from the wound (Singer and Clark, 1999). Epidermal 
cells migrate across the wound bed and a new basement membrane is formed that 
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separates the epidermis and dermis. Granulation tissue appears during this phase as 
early as the 4
th
 day after injury and consists of endothelial cells, fibroblasts and 
inflammatory cells (Shahzad et al., 2007). 
 
Table 1.1 Cytokines and growth factors that affect wound healing 
 
  
Cytokines 
released 
Type(s)of cell(s) Function in wound healing 
TNF-α Neutrophils, macrophages Inflammation; stimulates angiogenesis 
and collagen synthesis. 
 
IL-1 Neutrophils, macrophages, keratinocytes Inflammation; collagen synthesis; 
enhanced chemotaxis. 
 
IL-6  Neutrophils, macrophages. Inflammation; re-epithelialization. 
 
IL-8 Neutrophils, macrophages Inflammation. 
 
CSF-1 Multiple cells Macrophage activation and granulation 
tissue formation. 
 
TFG-β Platelets, macrophages, 
fibroblasts 
Granulation tissue formation; 
angiogenic activity; matrix formation 
and remodelling. 
 
PDGF Platelets, keratinocytes, macrophages, 
endothelial cells 
Granulation tissue formation; 
angiogenesis stimulation; matrix 
formation and remodelling. 
 
VEGF Platelets, neutrophils, macrophages, 
endothelial cells, smooth muscle cells 
Granulation tissue formation; 
angiogenic activity. 
 
IFN- Lymphocytes Stimulation of macrophages and 
immune cells. 
 
EGF Platelets, macrophages, fibroblasts, 
keratinocytes 
Re-epithelialization; granulation tissue 
formation; angiogenic activity. 
 
FGF-2 Macrophages, mast cells, endothelial cells, 
fibroblasts 
Re-epithelialization; granulation tissue 
formation; matrix formation and 
remodelling. 
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1.2.3 The remodelling phase 
The final stage of the wound repair process is the remodelling phase, which is 
characterized by depletion of metabolic activity, as well as the thickening and 
strengthening of collagen to produce scar tissue. The remodelling process continues for 
months after wound closure, and it involves a balance between synthesis of ECM 
components and their degradation by proteases (Schultz et al., 2003). This phase peaks 
at the third week after the injury, but the contraction of the wound continues in a 
process involving the proliferation of myofibroblasts (Guo and Dipietro, 2010), 
collagen and scar formation (Harding et al., 2002). In the maturation and remodelling 
phase, Type III collagen as the main component is degraded and stronger Type I 
collagen is deposited, increasing the tensile strength of the wound (Stadelmann et al., 
1998, Singer and Clark, 1999). MMPs such as MMP-9 facilitate collagen and 
extracellular matrix degradation (Corbel et al., 2000). Contraction of the wound occurs 
during the second week in a non-infected wound, when new matrix is formed and linked 
together to achieve maximal tensile strength, usually around the 12
th
 week after 
wounding (Doughty and Sparks-Defriese, 2007, Werner and Grose, 2003, Gabriel, 
2009). The scar from a wound can only recover about 80% of the tensile strength of 
non-damaged tissue (Bentley, 2004). The decreased activity at the wound site enhances 
the apoptosis and removal of cells such as endothelial cells, fibroblasts, and other 
inflammatory cells that are no longer needed for the wound healing process 
(Desmouliere et al., 1995). 
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1.3 Chronic wounds 
Chronic wounds are wounds that do not heal in an orderly sequence and/or over the 
expected time frame compared to normal wounds. Such wounds usually fail to heal and 
persist in an inflammatory state. In general, any wound that fails to heal within three 
months is termed a chronic wound (Mustoe, 2004, Schultz et al., 2003). 
There are several conditions which may cause wounds to become chronic and as a 
consequence not follow the normal healing progress. Such conditions include diabetes 
(Marston, 2006), obesity (Wilson, 2003), and age (particularly in patients ≥ 60 years) 
which has a major impact on healing and physiological processes such as the rate of 
blood circulation, reduction in collagen formation and basement membrane 
degeneration (Doughty and Sparks-Defries, 2007). Poor nutrition may prevent wound 
healing by impacting on synthesis of collagen and other proteins needed for the healing 
process. Bacteria in high concentrations at the wound site may cause toxin production, 
and they may also compete with cells in the granulation tissue for available nutrients in 
the wound site (Evans, 2005). 
Chronic wounds include diabetic foot ulcers, pressure ulcers, and venous leg ulcers 
(Marston, 2006). These wounds have a feature in common in that they are all ischaemic. 
The neuropathic impairment of musculoskeletal systems as well as leukocyte 
dysfunction and peripheral vascular disease complications also impairs the healing 
process (Marston, 2006).  
Diabetic foot ulcers (DFU) are the most common complication associated with diabetes, 
and can lead to either neuropathy or vascular disease as a result of damaged 
microcirculation and ischaemia (Lobmann et al., 2005), which results in an increased 
risk of foot ulceration (Jeffcoat and Harding, 2003). Throughout the world, foot lesions 
accompanied by infection are major causes of hospitalization. It has been estimated that 
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15% of diabetic patients (110 million worldwide) will develop DFU and about 85% of 
those patients require lower limb amputations as a result of infection (Jeffcoate et al., 
2004). Only 31% of DFU will heal within 20 weeks (Margolis et al., 1999) and the 
average time for total wound healing of diabetic ulcers is about 89 days (Pecoraro et al., 
1991). Clearly, factors like macroangiopathy, neuropathy and increased susceptibility to 
infection can be responsible for the development of these ulcers. Increased blood 
glucose impairs neutrophils and macrophages that are critical for immune defences of 
patients and their ability to repair wounds (Lobmann et al., 2005). Furthermore, reduced 
blood supply at the wound site may impair wound healing through abnormal expression 
of growth factors and cytokines involved in the healing process. High levels of MMPs 
are present in diabetic foot tissue. These enzymes catalyse the breakdown of 
extracellular matrix proteins and growth factors, impair cell migration (Falanga, 2005) 
and cause poor neovascularisation (Gallagher et al., 2007, Tepper et al., 2002). 
Any ulcer or an area of damaged skin below the knee that takes a long time to heal is 
known as a venous leg ulcer (VLU; Moffatt et al., 1992, Posnett and Franks, 2008). 
VLUs can result from the failure of venous valves in the calf, leading to hypertension 
within veins of the leg, and oedema. Once venous pressure reaches 45 millimetres of 
mercury (mmHg) VLUs are likely to develop. However, other factors that contribute to 
VLU include arterial disease, obesity, trauma, immobility and diabetes (Simon et al., 
2004). About 80-85% of all leg ulcers are VLU and 54% of patients identified have 
venous ulcers for more than one year (Kane, 2007). VLUs are associated with age and 
are therefore less common in people aged < 45 years. 
Pressure ulcers (PU) are the result of tissue damage from excessive or constant long 
term pressure on the tissue. Areas affected by PU are characterised by reduced blood 
supply of oxygen and vital nutrients which result in damage to tissue and ischaemic 
necrosis that can cause ulcers to develop. A secondary problem associated with PU is 
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chronic infection which develops as a result of PU and may lead to death. Despite 
clinical trials on the prevention of PU, the rate of incidence is as high as 66% in 
hospitalised patients (Rygiel, 2009) and it is more common in elderly patients 
(Diegelmann, 2003, Brem et al., 2000). Antibiotics are usually used to treat existing PU 
to resolve infections. However, the existence of microbial biofilms often results in 
wound complications as biofilms are inherently more resistant to antibiotic treatments 
(Wissing, 2009). Biofilms are complex, heterogeneous and integrated community of 
surface-attached microorganisms of either single or multiple microbial species 
(Bjarnsholt et al., 2008). 
1.3.1 Pathological conditions in chronic wounds 
Wound healing is made possible through the restoration of microcirculation and the 
nutrient supply to the tissue (Thackham et al., 2008). The essential nutrient is oxygen, 
which is important for the production of granulation tissue and resistance to infection. 
Hypoxia is the most common feature of chronic wounds, and results from the 
destruction of blood vessels in the wound area and the high oxygen consumption by 
leukocytes and fibrocytes (Tandara and Mustoe, 2004, Gottrup, 2002). These hypoxic 
conditions (5-20 mmHg compared with typical values of 30-50 mmHg in healthy tissue 
(Sheffield, 1998)) affect various aspects of the wound healing process, including 
angiogenesis, collagen synthesis and deposition, and epithelialisation. 
Hypoxic conditions in a wound make the tissue more susceptible to bacterial infection 
due to impaired neutrophil bactericidal activity (Gordillo and Sen, 2003, Hopf and 
Rollins, 2007, Sheffield, 1998). High levels of bacteria can induce degradation of the 
ECM, which impairs cell migration and/or proliferation of leukocytes and fibroblasts, 
and delays the immune response. Consequently, infection occurs as the bacteria can 
easily multiply. Neutrophils at the wound site initiate the inflammatory response to end 
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the bacterial infection. However, bacteria may form biofilms in chronic wounds, and so 
protect themselves against the action of the cells and effectors of the immune system as 
well as antibiotics (Edwards and Harding, 2004). In general, wounds with bacterial 
loads above 10
5 
bacteria/mm
3
 do not heal well (Fonder et al., 2008, Mustoe, 2004). 
Various bacterial species have been identified in chronic wounds; the most common 
species include the Gram-positive species Staphylococcus aureus and Enterococcus 
faecalis, and the Gram-negative species Pseudomonas aeruginosa (Dowd et al., 2008). 
Hypoxic conditions and bacterial contamination in chronic wounds act as stimuli for 
cytokine production from macrophages at the wound site. TNF-α is present in high 
levels in chronic wounds, and is released from monocytes and endothelial cells in 
response to endotoxins produced by bacteria (Wallace and Stacey, 1998). TNF-α 
induces IL-1β production from macrophages. Both cytokines have effects on the 
synthesis of collagen by fibroblasts and up-regulate the expression of MMPs while 
down-regulating tissue inhibitors of MMPs (TIMPs; Mast and Schultz, 1996). Studies 
on fluids from venous ulcers have shown significant increases in TNF-α and IL-1β 
(Trengove et al., 2000) compared with those from healing wounds. This suggests that 
pro-inflammatory cytokines are present at higher levels in wound fluids from non-
healing ulcers than healing ulcers (Harris et al., 1995). 
1.4 Immune cells in wound healing 
The wound healing process involves a sequence of cellular and biochemical events that 
serve to restore tissue integrity after injury. Immune cells are involved in every phase of 
the wound healing process (Clark, 1996). Inflammatory cells, such as neutrophils and 
macrophages are common during the initial stages of healing where the priorities are 
haemostasis and the prevention of infection. Within the inflammatory phase of wound 
healing, neutrophils migrate into the wound site where their function is to prevent or 
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limit infection. Prolonged neutrophil infiltration sustains the inflammatory phase, so 
macrophages enter the area, clearing apoptotic neutrophils and wound debris, and 
resolving inflammation. Therefore the co-ordinated activity of these two cell types is 
essential in wound healing. Although T-lymphocytes may become involved at later 
stages to recognise specific pathogens, they seem to make a less significant contribution 
to wound healing. However, each type of immune cell also has the potential to attract 
other immune cells to the wound site, and their mediators also appear to be essential for 
healing. 
1.4.1 Neutrophils 
Neutrophils are the most abundant white cells in circulation, constituting 40-65% of the 
total white blood cell pool (Nisisako et al., 2002). They originate in the bone marrow 
from myeloid stem cells via a process called myelopoiesis. Neutrophils possess a 
chromatin-dense, lobulated nucleus; hence they are known as polymorphnuclear cells 
(PMNs). Also, because of the presence of multiple granules in their cytoplasm they are 
considered to be a type of granulocyte (Bainton, 1999). The number of neutrophils in 
circulation is normally in the range 3-5 × 10
6
 cells ml
-1
 blood, but this can increase 
during infection. The lifespan of mature neutrophils is quite short, estimated to be 
between 8 and 20 h before they constitutively undergo programmed cell death or 
apoptosis (Savill et al., 2002), but this can be prolonged when neutrophils enter the 
infected or inflamed tissues (Edwards, 1994). Once they are activated by chemical 
stimuli or surface attachment, they undergo a series of morphological changes and 
release cytotoxic components that are important for destroying pathogens (Edwards, 
1993). 
Following transmigration from the circulation into the infected and inflamed site, highly 
coordinated responses aim to kill the invading pathogens. Neutrophils are able to 
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recognize microorganisms and begin the process of killing and phagocytosing these 
particles. Microorganisms may be recognized by neutrophils using surface receptors for 
microbial sugar molecules, but phagocytosis is more efficient if the pathogen is coated 
with antibody or complement fragments. Following ingestion, neutrophils initiate a 
series of components that are able to bind to the Fc receptors (FcγRI, FCγRII and 
FcγRIIIb) and complement receptors (CR1, and CR3), respectively (Smith, 1994). The 
microorganisms ingested by neutrophils are internalized into phagosomes and these fuse 
with granules to form phagolysosomes in which the bacteria are killed. 
Following engulfment of microorganisms into phagocytic vacuoles, the bacteria are 
killed by either oxygen-dependent or oxygen-independent mechanisms (Babior, 1978). 
In the oxygen-dependent mechanism, phagocytosing neutrophils undergo an oxidative 
burst during which the NADPH oxidase complex assembles at the phagosomal 
membrane and produces ROS (Fig. 1.2). These toxic ROS are limited to the 
intracellular environment of the phagocytic vacuole and are rarely released in the 
extracellular environment unless the opsonized particles (particles in which antigen is 
attached to the epitope on the bacteria and consequently can be easily recognized by 
phagocytes) are too large for engulfment, resulting in disturbed phagocytosis. NADPH 
acts as an electron donor and phagosomal oxygen acts as the electron acceptor to 
produce superoxide (Alba-Loureiro et al., 2007), while the oxygen-independent 
mechanisms involve three neutrophil granule subsets: the azurophilic, specific and 
gelatinase granules, which each contain characteristic antimicrobial proteins such as 
defensins, bactericidin, permeability proteins and peptides, and enzymes (Reeves et al., 
2002). Antimicrobial proteins such as defensins predominantly function by disrupting 
anionic bacterial surfaces, whilst proteases, such as neutrophil elastase (NE) and 
cathepsin G (CG), catalyse the degradation of bacterial proteins.  
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Fig. 1.2 Phagocytosis and bacterial killing in neutrophils. Neutrophil phagocytosis is initiated by 
microorganisms. NADPH oxidase activation leads to superoxide (O2
• -
) production which is dismutated to 
hydrogen peroxide (H2O2) by superoxide dismutase (SOD). H2O2 acts as an intermediate that interacts 
with myeloperoxidase (MPO) found in neutrophilic granules to form hypochlorous acid (HOCl) or is 
converted to H2O by catalase activity. Additionally, NO is produced by nitric oxide synthase (NOS) 
activity in response to inflammatory stimuli and reacts with O2
•-
 to form ONOO
-
 (Hampton et al., 1998). 
 
1.4.2 Neutrophils in wound healing 
The first cells that infiltrate the wound site after tissue damage are neutrophils; these 
cells mediate the first line of defence and initiate the inflammatory response during 
wound healing. The main function of neutrophils at the wound site is to remove 
pathogens (Dovi et al., 2004). Foreign materials like bacteria and non-functional host 
cells initiate chemical signals, attracting neutrophils, which ingest bacteria by 
phagocytosis, followed by release of ROS into the phagosome to kill them (Hart, 2002, 
Sylvia, 2003). A rapid and effective response by neutrophils decreases the chance of 
complications caused by infection, while macrophages, which are also essential for 
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wound healing (Leibovich and Ross, 1975), arrive at the wound site after neutrophils 
(up to 48 hours later), whereas other cells of the adaptive immune response do not arrive 
until 7 days post injury. Neutrophils provide a rapid but non-specific immune response 
to injury (Dovi et al., 2004). Neutrophils clean the wound site and are then cleared by 
macrophages (Tsirogianni et al., 2006). 
An additional beneficial role of neutrophils in wound healing is to produce growth 
factors such as GM-CSF (Canturk et al., 2001), VEGF (Mccourt et al., 1999) and IL-8 
(Rennekampff et al., 2000), which can promote revascularization and tissue repair. 
However, most studies suggest there is also a negative role of neutrophils in normal 
wound healing due to the production of bioactive substances that can cause tissue 
damage, in addition to the secreted proteases that themselves cause substantial tissue 
damage (Ashcroft et al., 1999, Ashcroft and Roberts, 2000). 
In chronic wounds the inflammatory response is characterized by a continued influx of 
inflammatory cells, especially neutrophils, into the wound site. Neutrophils produce 
pro-inflammatory cytokines that attract more inflammatory cells, and release further 
toxic mediators causing extensive tissue damage (Nwomeh et al., 1998b). Chronic 
wound conditions such as hypoxia act as stimuli for over-recruitment of neutrophils to 
the wound site via endothelial cells through multi-step adhesion (Sumpio et al., 2002). 
The respiratory burst is impaired as very little oxygen is present and hence NADPH 
oxidase activity is limited. The partial pressure of oxygen (PO2) in chronic wounds is 
often 5-20 mmHg, whereas the Km of NADPH oxidase is 40-80 mmHg (Gordillo and 
Sen, 2003, Sheffield, 1998). It is generally accepted that neutrophils are affected not 
only by hypoxia, but also by the bacteria community and cytokine profile of the wound 
(Yager and Nwomeh, 1999). There are many mechanisms by which neutrophils may 
impair the healing process; activated neutrophils release an abundance of antimicrobial 
substances such as ROS, cationic peptides, eicosanoids, and proteases that harm other 
 17 
 
cells and directly damage any newly-formed structure in the healing wound, and as 
result delay the healing process. For example, neutrophil elastase can catalyse the 
degradation of the components of the extracellular matrix as well as complement, 
immunoglobulin and cytokines (Weiss, 1989). Moreover, neutrophils are responsible 
for exacerbating the hypoxic environment in chronic wounds due to their consumption 
of any available oxygen for respiratory burst activity (Gordillo and Sen, 2003). 
However, some studies suggest a positive effect of neutrophils in wound healing while 
others suggest a negative effect. Studies on PU.1 null mice, which are genetically 
incapable of raising the standard inflammatory response because they lack macrophages 
and functional neutrophils, have reported an ability to heal skin wounds without 
implementation of an inflammatory response. In addition, it has been shown that neither 
neutrophils nor macrophages are needed in these mice for wound healing when there is 
a low risk of infection (Martin et al., 2003). Dovi et al. (2003) reported that neutrophil 
depletion in the mice resulted in increased re-epithelialization and had no effect on 
collagen content or on the wound strength, while a decrease in re-epithelialization and 
vascularisation has been shown in CXCR2 knockout mice with defective neutrophil 
recruitment (Devalaraja et al., 2000). However, neutrophils are a major source of 
inflammatory cytokines, such as IL-1, IL-6 and TNF-α which can stimulate the attracted 
monocytes to differentiate into M1 macrophages (Hübner et al., 1996, Werner and 
Grose, 2003). 
1.4.3 Macrophages in wound healing 
At the wound site, macrophages consist of two populations, both of which originate 
from bone marrow. The first is the resident tissue macrophages that are present in 
tissues at all times. Normal tissue contains resident macrophages at a low density of 1-2 
per mm
2
 (Dipietro et al., 1995), whilst the second is derived from the differentiation of 
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circulating monocytes after recruitment to the injury site. Once the monocytes migrate 
through the vessel wall, they release enzymes that degrade ECM proteins to facilitate 
their migration into the wound site. In response to stimuli such as LPS or IFN-γ present 
in the micro-environment, monocytes differentiate into macrophages (Martin and 
Leibovich, 2005). Macrophages can display different functional phenotypes and 
physiological properties in the wound site (Mantovani et al., 2002). These cells can be 
divided into two groups: the M1 phenotype (classically activated) and the M2 
phenotype (alternatively activated; Schwacha, 2003). In response to mediators such as 
LPS or IFN-γ, macrophages are differentiated into M1 macrophages which have been 
attributed with cytotoxic functions in acute and chronic inflammation (Mosser and 
Edwards, 2008, Gordon, 2003). Macrophages are alternatively activated by IL-4 and IL-
13 into M2 macrophages (Gordon, 2003) that have been attributed with roles in 
proliferation of connective, endothelial and epithelial tissue in wound healing (Martinez 
et al., 2008). The influence of macrophages on each stage of repair varies with the 
specific phenotype. During the inflammatory phase, macrophages exhibit pro-
inflammatory functions such as antigen presentation, phagocytosis, production of 
inflammatory cytokines and growth factors that enhance the wound healing process. 
Fibroblasts, keratinocytes and endothelial cells are stimulated by macrophages to induce 
ECM formation, re-epithelialization, and angiogenesis, while in the remodelling phase, 
macrophages can change the ECM composition by the release of degrading enzymes. 
As such, macrophages play an important role in the transition from the inflammatory 
phase to the proliferative phase in which they are able to switch and sustain wound 
healing events (Singer and Clark, 1999). It seems that the balance between the two 
phenotypes is important in the phases of wound healing and any disturbance in this 
balance results in a poor healing process. The macrophage phenotype in wound healing 
is not fully characterized and it appears to change during the healing process (Daley et 
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al., 2010, Lucas et al., 2010). Furthermore, different macrophage phenotypes produce 
different cytokines and growth factors that stimulate capillary growth, collagen 
synthesis and fibrosis (Mirza et al., 2009). 
Studies on wound healing in which macrophages have been depleted (Table 1.2) show a 
delayed infiltration of fibroblasts and defective fibrosis in guinea pigs (Leibovich and 
Ross, 1975). Furthermore, recent results on wounds in macrophage-depleted mice 
indicate decreased re-epithelization, granulation tissue formation, angiogenesis, wound 
cytokine production, myofibroblast-associated wound contraction, vascularization and 
scar formation in mice depleted before injury or 3 days after injury (Goren et al., 2009, 
Mirza et al., 2009, Lucas et al., 2010). 
 
Table 1.2 The effects of macrophage depletion on wound healing 
Depletion 
stage 
Wound 
closure 
Granulation  
tissue formation, 
angiogenesis 
Collagen/ 
fibrosis 
study 
early decrease ND decrease (Leibovich and Ross, 
1975) 
early decrease decrease decrease (Mirza et al., 2009) 
early decrease decrease decrease (Goren et al., 2009) 
early decrease decrease decrease (Lucas et al., 2010) 
middle decrease decrease ND (Lucas et al., 2010) 
late ND ND ND (Lucas et al., 2010) 
ND: No difference 
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1.4.4 Interactions between neutrophils and macrophages 
Neutrophils have a short life span; 8-20 h in circulation and 1-4 days in tissue (Akgul et 
al., 2001). Macrophages play an important role in the control of cellular events of 
wound healing through their ability to induce apoptosis and phagocytosis of a variety of 
wound cells. Macrophages target neutrophils during the inflammatory phase; the same 
is true of fibroblasts and endothelial cells during the proliferative and remodelling 
phases. Tissue injury is characterised by infiltration of neutrophils and later 
macrophages, with the number of neutrophils decreasing as the macrophages become 
the predominant inflammatory cell. Neutrophils undergo apoptosis in the wound, and 
are then recognised and ingested by macrophages (Meszaros et al., 1999; Fig. 1.3). The 
macrophages recognize apoptotic signals including phosphatidyl serine (PS), and 
throbospondin 1 (TSP1), by several surface receptors such as  integrin αvβ3, and CD36, 
a class B scavenger receptor with a very short C-terminal cytoplasmic domain, has been 
proposed to cooperate with the vitronectin receptor for internalisation of TSP-1-
opsonised apoptotic neutrophils by MDMФ (Meszaros et al., 2000). 
Phagocytosis of human apoptotic neutrophils has been shown to suppress the release of 
the pro-inflammatory mediators GM-CSF, IL-8, MCP-1, eicosanoids and 
chemoattractants from phagocytic cells (Meagher et al., 1992, Hughes et al., 1997). For 
instance, ingestion of apoptotic cells triggers an anti-inflammatory response from 
monocytes/macrophages such as decreased production of TNF-α, IL-1 and IL-12, and 
upregulation of IL-10 (Voll et al., 1997, Fadok et al., 1998). It has been suggested that 
apoptotic neutrophils at wound sites release factors, e.g. low-molecular weight lipid-
soluble factors, that suppress the production of pro-inflammatory mediators from 
macrophages (Daley et al., 2005). Recent studies in CD18 knockout mice as models for 
leukocyte adhesion deficiency syndrome 1, a disorder characterised by infections and 
impaired wound healing in humans, have provided evidence regarding interactions 
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between neutrophils and macrophages in wounds (Peters et al., 2005). In these animals, 
skin wounds failed to recruit neutrophils, assembled a normal complement of 
macrophages, and exhibited retardation of closure by contraction. These changes 
occurred in the context of increased pro-inflammatory cytokine production and 
decreased TGF-β1 and its type II receptor. It was suggested from these findings that the 
lack of apoptotic neutrophils in the wounds of the knockout animals deprived 
macrophages, resulting in a decrease in TGF-β1 production, a main regulator of 
phagocytosis. After resolution of the inflammatory phase of wound healing, 
macrophage numbers decrease in wounds. Some die at the site of the wound, as 
evidenced by the presence of intracellular macrophage molecules such as arginase I in 
the wound extracellular fluids (Albina et al., 1990); others are likely to migrate to 
draining lymph nodes (Brancato and Albina, 2011). 
Cell death can occur via two distinct processes, necrosis and apoptosis. Necrosis 
describes a pathological form of cell death resulting from severe trauma or acute 
cellular injury followed by loss of membrane integrity (Zhivotovsky, 2004), while 
apoptosis is a more controlled form of cell death in which dying cells exhibit distinct 
morphological features that mark them for phagocytosis by neighbouring cells with no 
loss of membrane integrity (Fig. 1.3). Apoptotic cells are characterised by several 
common features that were first described by Kerr and colleagues (1972), such as cell 
shrinkage, condensed chromatin, nuclear fragmentation (pyknosis) and finally 
cytoplasmic budding to form membrane-bound apoptotic bodies. More importantly, 
during apoptosis membrane integrity is maintained and PS, a molecular marker of 
apoptotic cells, appears on the outer leaflet of the plasma membrane, and can be 
measured via the binding of annexin V, a specific phospholipid-binding protein 
(Hongbo and Fabien, 2008). A balance between anti- and pro-apoptotic signals in the 
cell determines whether or not apoptosis will take place. 
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In contrast to necrosis, the cell remains intact (as may be indicated by the exclusion of 
vital dyes), and maintains its contents (Hongbo and Fabien, 2008).  
 
Fig. 1.3 The fate of neutrophils. Neutrophils are removed from tissue in a non-inflammatory process to 
ensure that they do not cause tissue damage through release of their intracellular contents. Neutrophils 
undergo apoptosis followed by recognition and phagocytosis by macrophages, a process associated with 
release of mediators such as TGFβ by macrophages. The apoptotic cells display various signals such as 
phosphatidylserine (PS) and surface-bound thrombospondin (TSP) that are recognized by phagocyte 
receptors CD36 in conjugation with integrin αvβ3. Necrotic cell death results in loss of membrane 
integrity and subsequent release of contents that cause tissue injury and induce further recruitment of 
inflammatory cells (Gregory and Devitt, 2004). 
Neutrophils are terminally differentiated cells which spontaneously undergo apoptosis 
in the absence of cytokines, pro-inflammatory agents, or any other extracellular stimuli 
(Savill et al., 1989). This process is followed by the removal of apoptotic neutrophils by 
macrophages, which prevents them from releasing their cytotoxic contents 
extracellularly, as would occur if the cells died by necrosis (Haslett, 1992). Neutrophils 
undergoing apoptosis lose their abilities to undergo chemotaxis and phagocytosis, and 
to generate a respiratory burst or to degranulate (Wyllie et al., 1980). 
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Cells have two major pathways that lead to apoptosis: the internal and the external 
pathway. The latter is mediated by death receptors while the internal is mitochondria-
dependent; both pathways involve cleavage of and thereby activation of pro-caspase3 
into caspase-3 which in turn affects other components in the apoptotic pathway (Riedl 
and Shi, 2004). Caspases (Cysteine Aspartic-Specific Proteases) are a family of cysteine 
proteases which are central to the neutrophilic apoptotic machinery. The active enzymes 
have a heterotetrameric structure comprised of two large and two small subunits with 
two active sites per molecule (Thornberry and Lazebnik, 1998). Caspases catalyse the 
cleavage of peptide bonds after aspartate residues in their substrate (Nicholson, 1996). 
Depending on the functional and pro-domain lengths which can modulate caspase 
activation, caspases can be divided into initiator or effector caspases; upstream initiator 
caspases have large N-terminal pro-domains, and include caspases -2, -8, -9 and -10, 
while downstream effector caspases possess short apparently non-functional terminal 
pro-domains and include caspases -3, -6 and -7 (Thornberry et al., 1997). 
The extrinsic initiation of apoptosis is originated by death receptors, the tumour necrosis 
factor receptor (TNFR) family and FasR (Degterev et al., 2003). The ligand for TNFR 
is soluble and is secreted during initiation of inflammation, while the ligand for FasR is 
FasL expressed as a trimer during lymphocyte development and homeostasis (Krammer, 
2000); binding of this ligand to its receptor leads to the formation of a cytoplasmic 
death domain that triggers an intracellular signalling cascade and facilitates activation of 
caspases -8 and -3 (Nagata, 1997). The intrinsic pathway of apoptosis is mediated via 
various mechanisms resulting in mitochondrial release of cytochrome c into the cytosol 
in response to cellular damage and stress. Cytochrome c is a key component of the 
apoptosome, a complex that activates caspase-9, which in turn cleaves and activates 
pro-caspase-3 (Riedl and Shi, 2004). Caspase-3 is involved in the inactivation of the 
DNA repair system (Casciola-Rosen et al., 1996). A study by Murphy et al. (2008) has 
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confirmed that although human neutrophils have only small amounts of cytochrome c, 
the apoptotic protease activating factor 1 (Apaf-1) which interacts with cytochrome c, is 
essential in their apoptosis. Release of cytochrome c from mitochondria is regulated by 
the Bcl-2 family of proteins (Akgul et al., 2001; Fig. 1.4). 
 
Fig. 1.4 The extrinsic and intrinsic pathways of apoptosis. The extrinsic pathway engages the cell surface 
death receptors such as TNFR1 and Fas with their specific ligands, which leads to procaspase-8 
activation, which in turn cleaves and activates the effector caspase-3 that degrades essential proteins and 
confers the apoptotic morphological changes. The intrinsic pathway involves mitochondria; it is activated 
following a wide variety of intercellular signals such as DNA damage and oxidative stress. Transduction 
of these signals requires the permeabilization of the mitochondrial outer membrane by proteins of the Bcl-
2 family and results in the release of mitochondrial apoptogenic factors including cytochrome c (Riedl 
and Shi, 2004). 
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1.5 Role of oxygen in wound healing 
In wound healing, oxygen is a basic requirement for the production of adenosine 
triphosphate (ATP). ATP is synthesized by oxidative phosphorylation in mitochondria 
and is essential for intracellular processes such as biosynthesis, movement and 
transport. Therefore, oxygen is required to provide adequate energy for proper cellular 
function (Gordillo and Sen, 2003, Tandara and Mustoe, 2004). However, not all cells 
are oxygen-dependent, for example neutrophils. 
Collagen synthesis and deposition are critical for wound healing in providing the matrix 
for angiogenesis and tissue remodelling. This process is oxygen-dependent. Conversion 
of proline into hydroxyproline is an important step in the formation and stabilisation of 
the pro-collagen triple helix and is catalysed by prolyl hydroxylase, which requires 
oxygen as a substrate as well as α-ketoglutarate. The concentration of oxygen at which 
prolyl hydroxylase displays 50% of its activity has been determined to be in the PO2 
range of 20-25 mmHg (Hopf et al., 2001). Thus depletion of tissue oxygen results in 
production of an immature polypeptide in the rough endoplasmic reticulum which is 
excreted as non-functional gelatinous protein (Gordillo and Sen, 2003). In vivo studies 
have shown that collagen deposition in wound healing is directly related to tissue 
oxygenation, so increasing wound oxygenation results in increased collagen deposition 
and tensile strength (Jonsson et al., 1991). 
At the cellular level, NADPH oxidase is responsible for the respiratory burst that occurs 
in neutrophils during the inflammatory phase of the healing process. This NADPH-
linked enzyme produces oxidants by consuming high amounts of oxygen, which 
contributes to successful wound healing, as these oxidants are required for killing 
bacteria and limiting wound infection (Soneja et al., 2005). Neutrophils and other 
phagocytes use oxygen to produce ROS by respiratory burst activity, including 
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oxidizing species such as superoxide (O2
•-
) and hydrogen peroxide (H2O2). These ROS 
also serve as cellular messengers to promote essential processes in wound healing (Hopf 
and Rollins, 2007), such as cytokine production, angiogenesis, cell motility and 
extracellular matrix formation (Sen, 2003). 
Tissue hypoxia is known to initiate angiogenesis, while increased oxygen levels are 
needed to create the oxygen gradient that promotes and maintains it (Neil, 2007), 
because angiogenesis is an oxygen and growth factor-dependent process (Knighton et 
al., 1981). It has been established that VEGF is the major long term angiogenic stimulus 
at a wound site. It promotes endothelial cell proliferation and migration, inhibits 
apoptosis, and increases vascular permeability (Neufeld et al., 1999). In vitro, VEGF 
has been reported to up regulate endothelial ICAM-1 expression and to promote 
neutrophil adhesion and then migration into the wound site as part of the inflammatory 
phase of wound healing (Lu et al., 1999, Radisavljevic et al., 2000, Kim et al., 2001). 
These processes all stimulate angiogenesis (Dvorak, 2000). Hypoxia stimulates VEGF 
production and angiogenesis through HIF-1α as well as other pathways involving 
MEK/ERK molecules and the gene for early growth response-1 (EGR-1), a 
transcription factor produced at the wound site (Semenza, 2000, Michiels et al., 2000, 
Lo et al., 2001). Treatment with oxygen induces VEGF expression in endothelial cells 
and macrophages (Maniscalco et al., 1995, Deaton et al., 1994, Darrington et al., 1997), 
and increases VEGF protein expression in wounds in vivo (Sheikh et al., 2000). 
Exposure to oxygen triggers ROS production which in turn stimulates cells such as 
fibroblasts, keratinocytes and macrophages to release VEGF and enhance angiogenesis. 
For example, H2O2, produced by the respiratory burst activity of neutrophils, up 
regulates VEGF expression in keratinocytes (Kuroki et al., 1996). 
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1.6 Hyperbaric oxygen (HBO) therapy 
Hyperbaric oxygen therapy is defined by the Undersea and Hyperbaric Medical Society 
(UHMS) as a mode of medical treatment that involves intermittent inhalation of 100% 
oxygen whilst inside a treatment chamber compressed to a pressure greater than one 1 
ATA (Jain, 2004b). In order for this treatment to be delivered to the patient, monoplace 
and multiplace chambers are used. Monoplace chambers, as the name indicates, are 
designed to treat a single patient at a time. Multiplace chambers, on other hand, are 
larger and can accommodate more than one person (up to 12 patients). Oxygen can be 
delivered through face masks, nasal hoods or endotracheal tubes (Rowe, 2001, 
Broussard, 2004). 
The development of hyperbaric medicine is linked to the history of diving medicine. 
The first hyperbaric chamber was designed in 1662 by the British physician Henshaw 
who used compressed air for medical purposes, as oxygen was not discovered until 
1775, by Joseph Priestley. In 1834, Junod used a hyperbaric chamber to treat pulmonary 
diseases with two to four atmospheres of pressure. The Junod trial report in 1800 
triggered an expansion of the use of hyperbaric chambers worldwide. For treating 
diving accident victims, a system using HBO was proposed by Dräger in 1917 
(Yarbrough and Behnke, 1939, Jain, 2004b), but it was not until 1937 that the first 
medical application of HBO was reported for the treatment of decompression sickness 
(Severinghaus, 2003). 
Since the 1930s, HBO therapy has been widely used in diving medicine and for 
numerous other medical conditions. The UHMS evaluates and regulates the current and 
potential indications for hyperbaric oxygen therapy and they update their guidelines 
periodically. Using HBO for these indications is evidence-based with literature showing 
significant results in the treatment outcomes (Broussard, 2003, Feldmeier et al., 1997). 
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The UHMS recommends HBO as treatment of choice for several conditions: 
a) Air or gas embolism, carbon monoxide poisoning, and decompression illness. 
b) As an adjunctive therapy for clostridial myonecrosis, crush injury, compartment 
syndrome and other acute ischaemia, enhanced healing in selected problem wounds, 
exception anaemia, interaction abscess, necrotizing soft tissue infections, refractory 
osteomyelitis, radiation tissue damage, compromised skin grafts and flaps and thermal 
burns.  
Patients with chronic wounds which have not responded to standard treatments, 
including antibiotics, topical dressings, debridement of non-vital tissue and correction 
of vascular problems within at least 30 days may be considered for HBO (Broussard, 
2004). To identify patients that should respond well to HBO, transcutaneous oxygen 
monitoring (TCOM) is used. This is a quantitative measure of oxygen availability to 
tissue, demonstrated as the wound transcutaneous oxygen tension (TcPO2) at 
atmospheric pressure. Patients with wound TcPO2 < 40 mmHg that improves to >100 
mmHg whilst breathing 100% oxygen at 1 ATA are considered suitable for adjunctive 
HBO (Fife et al., 2009, Sheffield, 1998). The wound TcPO2 is then tested under HBO, 
with values of 200 mmHg in non-diabetic patients and 400 mmHg in diabetic patients 
being considered as indicators of a patient exhibiting a good response to HBO. 
Patients with hypoxic wounds are subjected to HBO treatment usually delivered at 1.9-
2.5 ATA for sessions of 90-120 min each. During treatment the patient breathes 100% 
oxygen while the chamber is compressed over 5 min. To minimise the risk of oxygen 
toxicity, patients have 5 min “air-breaks” after 30 min and 65 min of treatment, during 
which they breathe air instead of oxygen. The treatments are usually given once a day, 
and up to five times per week in conjunction with other appropriate treatment(s), 
including antibiotics, wound debridement and dressing. 
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1.6.1 Side effects and counter indications 
Although HBO is a relatively safe treatment, there are several potential side effects 
caused by the increased pressure and hyperoxia, which occur in less than 1% of all 
patients. The commonest side effect is middle ear barotrauma, of which there is an 
estimated incident rate of 52 cases per every 10,000 patients (Thackham et al., 2008), 
and occurs in any closed air space where the patient’s ears are not properly cleared 
during compression and decompression. Boyle’s law states that as pressure increases 
volume decreases at a constant temperature, so in spaces where air may be trapped, such 
as the ear or sinuses, the air is compressed and then, during decompression, increases in 
volume, leading to the barotrauma (Thackham et al., 2008, Broussard, 2000). Another 
side effect of HBO is myopia, a lens deformation resulting from oxidative damage to 
the lens protein (Foster, 1992, Tibbles and Edelsberg, 1996, Gill and Bell, 2004) which 
can develop after extensive HBO treatment (more than 20 treatments), but usually 
resolves within eight weeks post-treatment (Kindwall, 1995, Jain, 2004b). Oxygen 
toxicity is a rare side-effect of HBO. It involves either the pulmonary or central nervous 
system with an incident rate estimated at between 1 and 3 cases per 10,000 treatments 
(Al-Waili and Butler, 2006, Kulikovsky et al., 2009). 
Recent studies on HBO have reported that toxic effects correlate with high pressures (4-
5 ATA) and/or long exposure durations of over 2 h (Harabin et al., 1990, Kleen and 
Messmer, 1999, Wada et al., 2001). The cellular damage through oxidation of lipids, 
protein and DNA is the most characteristic feature of oxidative stress induced by HBO 
(Speit and Bonzheim, 2003) in both human and animal models, and has been found to 
be related to pressure and time of exposure (Table 1.3). The “air breaks” mentioned 
above are designed to minimise the risk of oxygen toxicity. Overall, the side effects of 
HBO treatment are rare and most can be avoided or treated without any long-term effect 
on patients. 
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An absolute contraindication to HBO is an untreated pneumothorax, which must be 
excluded before treatment (Hampson, 1999). Other absolute contraindications include 
chemotherapy treatment with antibiotics (e.g. doxorubicin and bleomycin or 
adriamycin), the cardiac and pulmonary toxicity of which is exacerbated by HBO. 
Relative contraindications include respiratory infections, severe asthma/chronic 
obstructive pulmonary disease and steroid treatments, seizure disorders and pregnancy. 
 
Table. 1.3 Oxidative effects of prolonged exposure to HBO 
HBO treatment  Model  Treatment effects Reference 
 
100% oxygen at 
2.5 ATA for total 
30 min  
(1 session/day) 
Patient with 
pathological conditions 
related to hypoxia. 
Repeated exposure to HBO 
(15th session) led to a significant 
increase in malondialdehyde, a 
significant decrease in SOD and 
catalase expression by 
erythrocytes compared to 1
st
 
HBO session. 
 
(Benedetti et al., 2004) 
2.5 ATA for 60 
min  
Patient with 
pathological conditions 
related to hypoxia. 
 
Repeated HBO sessions did 
cause significant changes on 
erythrocyte antioxidant capacity 
and lipid peroxidation. 
 
(Eken et al., 2005) 
100% oxygen at  
1, 1.5, 2, 2.5 and 3 
ATA, respectively 
for 3 h 
Sprague-Dawley rats. Elevated levels of oxidative 
markers TBARS and SOD were 
found in lung, brain and 
erythrocytes after 2 h of HBO 
exposure. 
 
(Oter et al., 2005b) 
3 ATA for 30, 60, 
90 and 120 min 
Rat brain tissue. TBARS and SOD were found to 
increase in a time-dependent 
manner. 
 
(Korkmaz et al., 2008) 
2.8 ATA For 2 h  
(1 session/ day) 
over seven days 
Sprague-Dawley rats 
with streptozotocin 
(STZ)-induced 
diabetes. 
The levels of blood glucose and 
TBARS increased significantly 
and the activity of SOD 
decreased significantly in the 
erythrocytes and all 
organs of rats with diabetes 
subjected to HBO exposure. 
(Matsunami et al., 2010) 
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1.6.2 Physical mechanisms of HBO 
Ambient air contains 21% oxygen, 79% nitrogen, and 0.04% carbon dioxide at sea 
level. The total pressure of this mixture at sea level is defined as 1 atmosphere absolute 
(ATA). This is equivalent to 760 mmHg. This value is calculated using “Dalton’s law” 
which states that “the total pressure exerted by a gases mixture equals the sum of the 
partial pressures of different gases in the mixture”. According to this law, the partial 
pressure of oxygen (PO2) in the room air we breathe equates to 160 mmHg. 
PO2 = 760 mm Hg × 21%/100% = 160 mm Hg 
However, the partial pressures exerted by gases dissolved in water or body fluids differs 
from those in ambient air (Bookspan, 2003). Henry’s law describes the solution of gases 
in liquids, and states that “at constant temperature, the amount of a gas dissolved in a 
liquid is proportional to the partial pressure of the gas above the liquid” (Gill and Bell, 
2004). Henry’s law is represented by the following formula: 
Concentration of dissolved gas = gas partial pressure × solubility coefficient 
Oxygen is the example of the gas in this case, whilst the plasma represents the liquid. 
The solubility coefficient decreases with increasing temperature. 
Boyle’s law states that “at constant temperature for a fixed mass of gas, the absolute 
pressure and the volume of a gas are inversely proportional”. The law can be stated in 
another way, that is, that the product of volume and absolute pressure will remain 
constant. 
Pressure × Volume = K (constant) 
Together, Boyle’s and Henry’s laws constitute the basis for hyperbaric therapy. 
Increasing the PO2 of oxygen has little effect on the oxygen bound to haemoglobin 
(Hb), as Hb is 97-98% saturated at sea level in normal air, giving an O2 content of 
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approximately 200 ml O2 l
-1
 arterial blood. Additionally, 3.2 ml O2 l
-1
 blood is dissolved 
in plasma and is carried in solution (Hunt et al., 2004). Oxygen passes from the ambient 
air to the alveolar air and continues through the pulmonary alveoli, diffusion from the 
pulmonary capillary and venous blood to the systemic arterial and capillary blood. 
Finally, oxygen moves into the interstitial and intracellular fluids where it is consumed 
in the endoplasmic reticulum, and mitochondria. The concentration gradient controls 
oxygen diffusion from the alveoli to the blood. The partial pressure of oxygen differs in 
the arterial and venous circulations. The partial pressure of oxygen in the alveoli (PAO2) 
equals 104 mmHg, while in the arterial blood (PaO2) equals 90 mmHg and in venous 
blood (PvO2), 40 mmHg. The difference between PAO2 and PvO2 (64 mmHg) causes 
oxygen to diffuse from the alveolar side to the arterial side and then to the tissue 
capillaries where it is released from Hb for use by cells (Tibbles and Edelsberg, 1996, 
Jan et al., 2006). Normally 97% of oxygen carried in the arterial blood is chemically 
bound to haemoglobin while the remaining 3% is dissolved in plasma. One gram of Hb 
can combine with a maximum of 1.34 ml of oxygen. The normal concentration of Hb is 
15 g per 100 ml of blood; when Hb is fully saturated (100%) with oxygen, 100 ml of 
blood can transport 20 ml of oxygen. After leaving the lung, Hb carries about 19.5 ml of 
oxygen per 100 ml of blood. In passing through tissue capillaries, this amount is 
reduced to 5 ml of oxygen per 100 ml blood. Hyperbaric oxygen increases the amount 
of oxygen dissolved in plasma. By applying the previously-described laws to the air that 
we breathe (containing 21% O2), at 1 ATA the amount of dissolved oxygen in 100 ml of 
plasma equals 0.499 ml, when inhaling 100% oxygen at 1 ATA, the O2 concentration 
increases to 1.5 ml/100 ml of plasma, and when the pressure is increased to 3 ATA, the 
amount of dissolved oxygen in 100 ml of plasma increases to 6.422 ml (Tibbles and 
Edelsberg, 1996, Jan et al., 2006, Marx et al., 1990) which is enough to meet the basic 
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metabolic needs of healing processes in tissues without need for the contribution of Hb 
(Gabb and Robin, 1987, Leach et al., 1998). This is the principle mechanism of HBO. 
1.6.3 Evidence for the effectiveness of HBO in the treatment of chronic wounds 
Several studies have been conducted into the healing potential of HBO, the majority 
investigating chronic non-healing wounds (Table 1.4). Wattle et al. (1991) reported in a 
non-controlled study that HBO accelerated the healing of diabetic foot lesions. Another 
prospective controlled study with chronic diabetic foot lesions carried out by Doctor et 
al. (1992) found better control of infection and less need for amputation in the group 
treated with conventional management and four sessions of HBO compared with the 
group treated only with conventional management. In a randomised study, Faglia et al. 
(1996) compared HBO with comprehensive protocols for decreasing the risk of 
amputation in 70 patients with diabetic foot ulcers who received either HBO (35 
patients) or conventional treatment (35 patients). The study demonstrated a significant 
difference in amputation rates between the two groups, with less amputation in the HBO 
group, and concluded that HBO in addition to conventional therapy was effective in 
decreasing the need for amputation. A study by Zamboni et al (1997) showed that HBO 
treatment caused significant decreases in wound size area in comparison to wounds in 
control subjects. The wound PO2 in the HBO-treatment group was raised from 12 mm 
Hg in room air to 560 mm Hg under HBO. Baroni et al. (1987) conducted a non-
randomized study in patients with diabetic gangrene. The study reported significant 
wound healing in patients who received HBO compared with subjects who had not 
received HBO. In a small randomised study by Kessler et al. (2003), a doubling of the 
healing rate of non-ischaemic chronic foot ulcers was found in selected diabetic patients 
with HBO treatment. The study consisted of 28 patients with chronic foot ulcers 
subjected to conventional treatment, with 14 of them additionally receiving HBO. The 
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wounds responded well to HBO with an increase in TcPO2 near ulcers from a mean of 
21.9 mmHg to 454.2 mmHg during the treatment. Another small randomized study, by 
Abidia et al. (2003), demonstrated an improved healing rate with HBO treatment in 
diabetic ulcers compared to the placebo group receiving hyperbaric air. 
The effects of HBO on non-diabetic problem wounds, including venous stasis ulcers, 
were examined in a study by Hammarlund and Sundberg (1994) in which 16 patients 
were subjected to HBO. A significant decrease in wound size area was reported in the 
HBO group compared to the control group. 
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Table 1.4 In vivo clinical trials using HBO as adjunctive treatment for chronic wounds 
 
No. of 
patients 
Description 
of wounds 
HBO treatment Control treatment outcomes Studies 
 
59 
 
Diabetic foot lesions, 
ischaemic or 
neuropathic wounds 
 
Multi-disciplinary wound 
care plus HBO 29 times, 45 
min, 2.5 ATA 
 
Patients with diabetic foot 
lesion treated with multi-
disciplinary wound care only. 
 
 
Complete healing: 52 (88%) of 
59, major amputation 7 (11.8) of 
59. 
 
 
(Wattel et al., 1991) 
30 Diabetic patients with 
chronic foot lesions 
(over 2 year). 
Multi-disciplinary wound 
care plus HBO 4 times, 45 
min, 3 ATA over 2 weeks. 
Surgery, antibiotics, local 
wound care. 
Above ankle amputations: HBO, 
2 (13%) of 15; control,7 (47%) 
of 15; minor (other) 
amputations: HBO, 4 (27%) of 
15; control, 2 (13%) of 15. 
 
(Doctor et al., 1992) 
70 3 month foot ulcers, 
Wagner grade 2-4, 
signs of neuropathy 
similar in both groups 
Multi-disciplinary wound 
care plus HBO 30 times, 90 
min, 2.2-2.5 ATA. 
Diabetic patients with chronic 
wounds treated with multi-
disciplinary wound care only. 
 
Major amputation: HBO, 3 of 
35 (8.6%); control 11 of 35 
(33.3%). 
(Faglia et al., 1996) 
10 Diabetic chronic non-
healing lower 
extremity wounds.. 
Multi-disciplinary wound 
care plus HBO 30 times, 90 
min, 2.0 ATA. 
Diabetic patients treated with 
multi-disciplinary wound care 
only. 
 
Complete healing: HBO, 4 
(80%) of 5; control, 1 (20%) of 
5; no amputation in either 
group. 
 
(Zamboni et al., 1997) 
29 Duration not specified, 
chronic Wagner grade 
0-2 foot ulcers 
Control treatment not 
specified plus HBO 30 
times, 120 min, 2.5 ATA. 
Control treatment not 
specified plus air at 2.5 ATA. 
 
The ulcers resolved completely 
following a course of HBO. 
(Lin et al 1996) 
18 Ischaemic ulcers > 6 
weeks, 1-10 cm in 
diameter. 
Multi-disciplinary wound 
clinic plus HBO therapy 30 
times, 90 min, 2.4 ATA. 
Diabetic patients with chronic 
wounds treated with air at 2.5 
ATA plus multi-disciplinary 
wound clinic. 
Proportion of ulcers healed, 
minor/major amputation. 
(Abidia et al., 2003) 
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 Table continued     
No. of 
patients 
Description  
of wounds 
HBO treatment Control treatment outcomes Studies 
 
28 
 
>3 month, chronic 
Wagner grade 1-3 foot 
ulcers, signs of 
neuropathy in all 
patients.  
 
Multi-disciplinary wound 
care plus HBO 30 times, 90 
min, 2.4 ATA. 
 
Patients with chronic wound 
treated with multi-
disciplinary wound 
management. 
 
Wound size reduction, 
proportion of ulcers healed. 
 
(Kessler et al 2003) 
 
16 
 
1 year duration, 
normal distal blood 
pressure at the ankle 
and the first digit. 
 
Usual care plus HBO 30 
times, 90 min, 2.5 ATA. 
 
Patients with chronic wounds 
treated with air at 2.5 ATA 
plus multi-disciplinary wound 
clinic. 
 
Proportion of ulcers healed, 
wound size reduction. 
 
 
(Hammarlund and 
Sundberg, 1994) 
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1.6.4 Effects of HBO on wound healing 
The primary effect of hyperbaric oxygenation is to produce a favourable gradient for 
oxygen diffusion from capillaries to ischaemic tissue sites, because under HBO (2-2.5 
ATA), haemoglobin becomes fully oxygenated and oxygen dissolves in plasma in direct 
proportion to the PO2 thereby becoming sufficient to meet the requirements for tissue 
oxygen without needing the support of oxygen bound to haemoglobin (Fife et al., 
2002). Secondary effects include reduction of oedema formation, neovascularisation, 
stimulation of neutrophil-oxidative killing mechanisms, phagocytosis of bacteria 
(Dellinger, 2005) and improved collagen synthesis and crossing-linking (Sheikh et al., 
2000). 
Oxygen is an important component of the healing process; HBO improves wound 
healing in patients with chronic leg ulcers as tissue oxygen tension increases (Bishop, 
2008, Jain, 2004a). Increased oxygen pressure, above 2 ATA, but below 3 ATA, 
increases oxygen diffusion into the tissue. Hypoxic areas benefit substantially from this 
increase (Gill and Bell, 2004). 
Studies have shown that HBO has a direct effect on anaerobic bacteria, which lack 
antioxidant defences such as superoxide dismutase (SOD) and catalase, so any oxidative 
stress caused by HBO is toxic to these bacteria (Barriere et al., 2001, Thom, 1990). For 
example, HBO has a bactericidal effect in, and is used as treatment for, necrotizing 
fasciitis and osteomyelitis, due to the high oxygenation of wound tissue and production 
of ROS. Not only that, HBO has been shown to enhance the activity of various 
antibiotics, for example aminoglycosides against Pseudomonas aeruginosa (Muhvich et 
al., 1989, Park et al., 1991). 
Hyperbaric oxygen has been shown to have a positive effect on collagen synthesis; 
HBO increases arterial PO2 resulting in an increase in wound oxygen tension in hypoxic 
 38 
 
wounds (Broussard, 2004). Consequently collagen production is at an optimum with an 
PO2 of 150 mmHg (Hopf et al., 2001). Hyperbaric oxygen also promotes granulation 
tissue formation, epithelialisation (Lavan and Hunt, 1990) and fibroblastic activity 
(Hehenberger and Hansson, 1997). 
1.6.4.1 Effect of HBO on the immune system 
Hyperbaric oxygen is used as adjunctive therapy for various inflammatory conditions 
(as described in section 1.6), including gas gangrene, refractory osteomylelitis, 
necrotizing soft tissue infection, burns and chronic wounds (Camporesi, 1996). Effects 
of HBO on the immune response have been previously reported (Benedetti et al., 2004, 
Benson et al., 2003, Bitterman et al., 1994, Brenner et al., 1999). Some changes in 
cellular and humoral components of the immune system were indicated. Hyperbaric 
oxygen has been shown to affect some aspects of host defence such as enhancing the 
respiratory burst activity of neutrophils and subsequently bacteria killing, although the 
results of studies on this are conflicting (Table 1.5). However, overall HBO effects 
seem to be immunosuppressive and lead to an anti-inflammatory response (Brenner et 
al., 1999). Several mechanisms have been proposed, including inhibition of the 
production of inflammatory mediators such as cytokines, a decrease in lymphocyte 
proliferation (Gadd et al., 1990), and impairment of leukocyte and macrophage function 
(Murphy et al., 1975). 
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Table 1.5 Effects of HBO on respiratory burst activity of neutrophils 
stimuli HBO treatment outcome study 
None HBO: 2.4ATA for 90 
min. 
Demonstrated a marked increase 
in the magnitude of a signal with 
properties consistent with free 
radicals by low temperature 
electron spin resonance 
spectroscopy in human blood 
following HBO exposure. 
 
(Narkowicz et al., 1993) 
Phorbol ester HBO: 2.8 ATA or 
3ATA for 45 min. 
HBO had no effect on respiratory 
burst (using DCF-diacetate by 
human neutrophils). 
 
(Thom et al., 1997) 
10
-7
 M FMLP HBO: 1.8ATA for 45 
min.  
HBO induced phagocytosis by 
neutrophils and H2O2 in 10 human 
volunteers. 
 
(Labrouche et al., 1999) 
Zymosan, PMA 
and FMLP 
HBO: 2.4ATA for 90 
min. 
Zymosan-induced respiratory 
burst was reduced by HBO, while 
FMLP- or PMA-induced 
respiratory was not affected. 
 
(Kaln et al., 2002) 
Escherichia coli, 
or priming with 1 
µg ml
-1 
TNF-α 
followed by 
10
-7
 M FMLP
 
HBO treatment (2.8 
ATA for short and 
long-term (five days) 
90 min exposure. 
No significant changes in 
respiratory burst (using 
dihydrorhodamine) and 
phagocytic activity (determined 
by intake of FITC-labelled 
opsonized E. coli) in human 
neutrophils after HBO treatment. 
 
(Jüttner et al., 2003) 
FMLP HBO treatment (2.8 
ATA for 45 min) 
HBO increases intracellular ROS 
production, in both FMLP-
stimulated and unstimulated 
neutrophils. 
(Thom et al., 2008) 
 
Hyperbaric oxygen treatment may also enhance wound healing by reducing pathological 
inflammation (immunosuppressive effects; Al-Waili and Butler, 2006, Zhang et al., 
2008). Hyperbaric oxygen treatment significantly decreased TNF-α and IL-1β 
production in LPS-stimulated monocytes and macrophages from rats or human 
peripheral blood (Lahat et al., 1995, Benson et al., 2003; Table 1.5). In animal models 
of ischaemia, HBO has been shown to reduce immunocompetent cell sequestration and 
synthesis of TNF-α (Yang et al., 2001), due to a decrease in ICAM-1 expression levels 
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(Buras et al., 2000). The immunosuppressive effect of HBO is also demonstrated by the 
inhibited development of Th cells, suppression of autoimmune systems, decreased 
responses to antigens, a decrease in circulating lymphocytes and leukocytes, and 
increased allograft survival (Satio et al., 1991, Xu et al., 1997, Hansbrough et al., 1980, 
Erdmann et al., 1995). Additionally, HBO reduces the expression of the 
cyclooxygenase-2 (COX-2) mRNA, an enzyme involved in inflammation, and the 
expression of hypoxia induced factor-1α (HIF-1α), a transcription protein associated 
with hypoxia (Yin et al., 2002, Li et al., 2005). HBO treatment every day at 2 ATA 
causes significant increase in Bcl-2, an inhibitor of apoptosis (Wada et al., 2000). 
Moreover, HBO has been shown to reduce the number of inflammatory cells and 
protein levels in the aqueous humour in rabbits (Ersanli et al., 2005). HBO inhibits 
inflammation in various clinical conditions including cerebral ischaemia (Helms et al., 
2005), acute colitis (Akin et al., 2002), severe acute pancreatitis (Balkan et al., 2006) 
and compartment syndrome (Abdullah et al., 2006). This suggests that the anti-
inflammatory effects of HBO contribute to decreasing the inflammatory mediators such 
as NO that play important roles in immunological responses and wound repair (Bredt 
and Snyder, 1992, Garthwaite, 1991). Nitric oxide production and bioactivity has been 
established as a major signalling messenger in physiological processes such as 
angiogenesis, vasodilation, granulation tissue formation, and collagen deposition that 
are critical to normal wound healing (Schwentker and Billiar, 2003, Fukumura et al., 
2001). NO is produced continuously by nitric oxide synthase activity (NOS); this 
enzyme catalyses NO formation from the amino acid L-arginine, with consumption of 
oxygen. To date, tissue oxygen is known to significantly affect endogenous NOS 
production in articular cartilage where the tissue PO2 is comparable to that in ischemic 
wounds (Fermor et al., 2007). Studies in rodents investigating the effect of HBO on 
ROS and NO formation have provided evidence of increased NO concentrations as a 
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result of NOS stimulation (Thom, 1993). Another group of inflammatory mediators is 
the prostaglandins (PGs) that are generated in response to injury and inflammation. 
HBO treatment causes a significant decrease in prostaglandin E2 (PGE2) production, a 
potent immunosuppressive in alveolar bone, splenic macrophages and brain (Chen et 
al., 2002, Mialon and Barthelemy, 1993, Inamoto et al., 1991). These studies confirm 
that HBO might possess anti-inflammatory properties. 
1.6.4.2 HBO, growth factors and cytokines in wound healing 
Hypoxia at the site of a wound due to injury to the blood vessels develops and triggers 
production of inflammatory cytokines which play an important role in the wound 
healing process. Hyperbaric oxygen affects the release of several types of cytokines and 
growth factors that are vital in wound healing (Table. 1.6). While hypoxia is required to 
initiate angiogenesis, oxygen supplied via HBO therapy has additional angiogenic 
effects through continued release of VEGF (Sheikh et al., 2000). VEGF promotes 
endothelial cell proliferation and migration, inhibits apoptosis, and increases vascular 
permeability (Neufeld et al., 1999). It has been observed that VEGF upregulates 
endothelial ICAM-1 expression in vitro, and promotes neutrophil apoptosis (Lu et al., 
1999, Radisavljevic et al., 2000, Kim et al., 2001). A previous study by Fok et al (2008) 
has shown that HBO increased the levels of VEGF in rabbits with bone lesions after 6 
weeks of treatment. VEGF production is related to oxygen tension; as oxygen tension 
increases the VEGF production increases which in turn enhances angiogenesis and the 
progress of wound healing (Ozaki et al., 1997). Studies on the ischaemic rabbit ear ulcer 
model suggest that HBO stimulates PDGF production thereby enhancing granulation 
tissue formation (Kang et al., 2004). These effects seems to be mediated by an increase 
in ROS (Sen et al., 2002). 
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Studies have shown various effects of HBO on cytokines. HBO exposure transiently 
suppressed stimulus-induced pro-inflammatory cytokines in monocytes (Benson et al., 
2003). In another study, exposure of healthy volunteers to hyperoxia, high pressure 
alone, or HBO for 90 min, stimulated IFN- secretion from lymphocytes after HBO 
(Granowitz et al., 2002). In ischaemia-reperfusion injury, treatment with HBO increased 
TNF-α and TGFβ1 in tissue (Grunenfelder et al., 2002). HBO has been shown to have 
an immunosuppressive effect; this is clear from the marked decrease in IL-1 and IL-2 
production and a significant decrease in PGE2 production by monocytes (Inamoto et al., 
1991). This suggests that the reduction of PGE2 production may play an important role 
in the anti-inflammatory effects of HBO. 
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Table 1.6 HBO effects on cytokines and growth factors 
 
cytokine source HBO treatment Comment/Outcome  Author, year 
IL-1 Monocytes-macrophages HBO, 2.4 ATA, 90 min Inhibits LPS-induced IL-1β synthesis  (Benson et al., 2003) 
TNF-α, 
IL-1β 
Monocytes-macrophages HBO, 2.0 ATA, 90 min Inhibits stimulus-induced TNF-α and IL-1β 
synthesis. 
(Inamoto et al., 1991, Lahat et 
al., 1995) 
 
IL-2 Monocytes  HBO, 2.5ATA, 90 min Decrease in IL-2 production and IL-2 receptor 
expression. 
(Ginaldi et al., 1991) 
TNF-α Monocytes-macrophages HBO, 2.4ATA, 90 min Inhibits TNF-α production.  (Benson et al., 2003) 
TGFβ Chronic ischaemic wounds  
in rabbit  
HBO, 2.4 ATA, 90 min Increases levels of TGFβ and produces a 
synergistic effect on a chronic wound model in 
young rabbits, but not in old rabbits. 
 
(Zhao et al., 1998, Bonomo et 
al., 2000) 
PDGF-β Acutely ischaemic wounds  
in rabbit  
 
HBO, 2.0 ATA, 90 min Increases expression of PDGF-β receptor. (Bonomo et al., 2000) 
 
VEGF HUVECs HBO, 2.5 ATA, 2-8 h Up regulates VEGF production and release.  (Lee et al., 2006, Eliss et al., 
2005) 
IFN-γ Lymphocytes HBO, 2 ATA, 90 min Reduces PMA/PHA-stimulated release of IFN-γ 
by lymphocytes. 
 
(Granowitz et al., 2002) 
FGF Muscle cells HBO, 3 ATA, 1 h/day 
for 14 day 
Up regulates FGF expression. (Asano et al., 2007) 
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1.7 Hypotheses and aims 
1.7.1 Hypotheses 
In chronic wounds, the healing sequence appears to halt at the inflammation stage. 
Failure to resolve the inflammatory phase is critical to the prevention of wound healing. 
This study focused on two cell types central to the resolution of inflammation and 
progression of healing in chronic wounds, neutrophils, whose primary function is to 
prevent or limit infection, which tends to sustain the inflammatory phase, and 
macrophages, which serve to clear apoptotic neutrophils and initiate the proliferative 
phase. Therefore, the interplay between these two cells types is of key importance. HBO 
enhances chronic wound healing by increasing the amount of oxygen available to the 
wound tissue, while some of the therapeutic effects of HBO involve revascularisation 
and improved bacterial killing.  
The main hypothesis is that increased oxygenation also assists chronic wound healing 
by reducing tissue damage resulting from over-recruitment of neutrophils. Specifically, 
the hypothesis is that HBO mediates two effects: (a) it improves the non-inflammatory 
antimicrobial function of neutrophils, and (b) it enhances neutrophil apoptosis and 
hence phagocytosis by macrophages, leading to resolution of the inflammatory response 
(Fig 1.5). 
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Fig. 1.5 Schematic diagram showing hypothesised HBO-induced anti-inflammatory pathways and their 
effects on wound healing. HBO enhances the respiratory burst activity of neutrophils and ROS. The 
antimicrobial effects of HBO are associated with enhanced neutrophils apoptosis as a consequence of an 
increase in ROS production by the cells themselves. Apoptotic neutrophils are safely removed by 
macrophages, leading to resolution of inflammation and subsequent wound healing. 
 
1.7.2 Aims and objectives 
The aims of this study were therefore to investigate the effects of HBO on neutrophils, 
to elucidate those elements that are affected by oxygen tension and also the interplay 
between these cells and macrophages. Differentiated HL-60 cells and bovine 
neutrophils were used as in vitro models for experiments on neutrophils and in co-
culture experiments. An in vivo study on blood from patients with chronic wounds was 
also used to investigate the long-term effects of HBO treatments on some biochemical 
parameters.  
The specific objectives were: 
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1. To develop a model for neutrophil function and the inflammation cascade that 
could be investigated after treatment with HBO. 
2. To examine the effects of HBO on the function of human neutrophils and 
longevity (apoptosis). 
3. To establish the effects of HBO on the inflammatory mediator molecules such as 
pro- and anti-inflammatory cytokines, in order to understand the molecular 
mechanism of inflammation. 
4. To examine the effects of HBO on macrophage phagocytosis of apoptotic 
neutrophils. 
5. To conduct an in vivo study tracking changes in biochemical parameters from 
patients with chronic wounds over a course of HBO treatment. 
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CHAPER TWO 
GENERAL METHODS 
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2.1 Material and methods 
2.1.1 Hyperbaric oxygen and pressure control treatments 
Hyperbaric chambers were obtained from Process Projects Limited (Hampshire, UK) 
and connecting hoses from Pressure Lines Ltd (Plymouth, UK). Different gas mixes 
were kindly donated by the DDRC (Plymouth, UK). To obtain hyperbaric oxygen 
conditions, the gas in the chambers was flushed for 4 min at 3 l min
-1
 with 97.9% O2, 
2.1% CO2, and then pressurized to 2.4 atmosphere absolute (ATA) over 2 min; 2.1% 
CO2 at 2.4 ATA was used to achieve a CO2 concentration equivalent to 5% CO2 at 1 
ATA in a conventional incubator (Fig. 2.1). To investigate the effect of pressure alone, 
cells were treated with 8.8% O2, 2.1% CO2 and 89.1% N2 at 2.4 ATA; 8.8% O2 was 
used such that the O2 concentration would be equivalent to 21% at 1 ATA. For 
normobaric hyperoxic or hypoxic treatments, cells were also flushed with a gas mixture 
containing a 95% O2, 5% CO2 or 5% O2, 5% CO2 balanced with N2 (Table 2.1) for 2-4 
min at a rate of 4 l min
-1
 in gas-tight plastic boxes (21.5 cm × 21.5cm× 11cm). This 
achieved the correct concentration inside the chamber box, based on direct measurement 
with an air flow meter (PCE-007, Dwyer Instruments Ltd High Wycombe, UK). Since it 
has been estimated that physiological hypoxia is 1-5 % O2 (Ivanovic, 2009), 5% O2 was 
chosen as the hypoxic environment for neutrophils, although this is slightly higher than 
observed in chronic wounds (2% O2). Control cell cultures for each experiment were 
placed in similar boxes under 21% O2, 5% CO2, 74% N2, at 1 ATA. All gas mixes were 
prepared by the DDRC. Treatments were continued for 90 min, after which the cells 
were removed (pressure chambers were decompressed over 8-10 min) and centrifuged 
for 5 min at 400 g followed by washing and re-suspension to either 1 × 10
6
 or 2 × 10
6
 
cells ml
-1
 in PBS, supplemented RPMI-1640 medium or Hank’s Balanced Salt Solution 
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(HBSS) as appropriate. Cells were used immediately in the assays described below. All 
treatments were carried out at room temperature. 
Table 2.1 In vitro conditions. Two pressure treatments were used in this study, an HBO 
treatment, representing patient treatment conditions, and a pressure control treatment, 
used to examine the effect of treating cells with increased pressure, but with no increase 
in the amount of available oxygen (Table 2.7). CO2 (5 %) was included in both 
conditions to represent the presence of CO2 at the cellular level. Hyperoxic conditions 
were used to examine the effect of increased oxygen. 
 
Treatment Gas composition Pressure 
HBO 
Pressure control 
Hyperoxia 
Hypoxia 
Normoxia (control) 
97.9% O2, 2.1% CO2 
8.8% O2, 2.1% CO2, balance N2 
95% O2, 5% CO2 
5% O2, 5% CO2, balance N2 
21% O2, 5% CO2, balance N2 
2.4 ATA 
2.4ATA 
1 ATA 
1 ATA 
1 ATA 
 
Fig. 2.1 Experimental design Cells were placed inside the hyperbaric chamber, which was then, sealed 
using a clamp seal. The chamber was compressed with a gas mix (depending upon the experiment) to 2.4 
ATA, and then the outlet valve was sealed. For normobaric hyperoxic or hypoxic treatments, cells were 
flushed with a gas mixture containing a 95% O2, 5% CO2 or 5% O2, 5% CO2 balance N2 (Table 2.1) for 2-
4 min at a rate of 4 l min
-1
 in gas-tight plastic boxes. After 90 min of treatment, the chamber was 
decompressed by slowly releasing the outlet valve over 8-10 min until the gauge pressure fell to 0 ATA. 
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2.1.2 Measurement of NBT reduction 
Nitroblue tetrazolium (NBT) is a yellow low water-soluble nitro-substituted aromatic 
tetrazolium compound that reacts with superoxide ions produced by the respiratory 
burst activity of neutrophils to form blue-black formazan deposits. The ability of NBT 
to be reduced by cells was determined by light microscopy. 
Respiratory burst activity measurements using NBT were performed as described by 
Verstuyf et al. (1995). Neutrophil-like cells (100 μl of 106 cells ml -1 in RPMI-1640) 
(section 3.2.2) were mixed with 100 μl of 100 ng ml-1 PMA and 100 μl of 5 mg ml-1 
NBT (Sigma, Poole, UK) and incubated for 30 min at 37 °C. After incubation, the 
percentage of cells containing intracellular reduced blue-black formazan deposits was 
then determined by microscopy following preparation of cytospin slides of the 
incubated cells (400 g for 5 min using a Shandon Cytospin centrifuge). At least 200 
cells were assessed per slide (×100 magnification). Conversion of NBT to the blue-
black formazan (NBT positive) after stimulation indicates the oxidative burst 
characteristic of mature granulocytes. 
2.1.3 Assay of extracellular hydrogen peroxide  
The horseradish peroxidase (HRP)-catalysed oxidation of the fluorogenic probe 
homovanillic acid by H2O2 can be used to assess the H2O2 release from neutrophils 
during respiratory burst activity. With an excess of HRP, the change in fluorescence of 
homovanillic acid (excitation 320 nm / emission 420 nm) is proportional to the amount 
of H2O2, and a standard curve can be constructed and used to calculate the H2O2 in 
samples (Marco et al., 1986). 
An HRP -linked assay was used to measure production of H2O2 by neutrophils or 
neutrophil like cells (section 3.2.2), using homovanillic acid. Briefly, 100 µl of cell 
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suspension in HBSS, containing 10
6
 cells ml
-1
 (cells counted as described in section 
2.1.5) were added to each well of a 96-well plate. Then 100 µl of HBSS containing 200 
µM homovanillic acid, 10 U ml
-1
 HRP, sigma (Pool, UK) and 100 ng ml
-1
 PMA were 
added per well, and the fluorescence measured after 120 min at 37 °C using a CytoFluor 
II fluorescence microplate reader (PerSeptive Biosystems, Framingham, USA). A 
standard curve (0-100 µM H2O2) was used to determine the H2O2 concentration in each 
well (Fig. 2.2). 
 
Fig. 2.2 Standard curve of H2O2 assay. H2O2 concentrations (0 to 100 μM) were prepared in dH2O and the 
data points are the mean of triplicates ± SEM.  
 
2.1.4 Assay of phagocytic activity  
This assay is based on the phagocytosis of particles or bacterial cells (in this case 
Staphylococcus aureus NCIMB 6571) that are incubated with the neutrophils. The 
neutrophil-like cells that had ingested bacteria were stained with modified Wright-
Giemsa stain and were counted using light microscopy. 
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The stock bacteria cultures were freeze-dried and kept at -20 °C. Each week, sample 
cultures were thawed and plated onto sheep blood agar (Sigma, Poole, UK), incubated 
overnight at 37 °C, and then stored at 4 °C. Before use, a single colony was transferred 
from a plate into 15 ml of tryptone soya broth (TSB, Sigma, Poole, UK) and incubated 
overnight at 37 °C. The bacteria were separated by centrifuging the broth at 400g for 5 
min and washing in PBS. A standard curve of bacterial growth (A600) versus the number 
of colony forming units (CFU) was used to calculate bacterial numbers required for 
each experiment (Fig. 2.3). Neutrophil-like cells (10
6
 cells ml
-1 in PBS; section 3.2.2) 
were incubated with Staphylococcus aureus NCIMB 6571 (re-suspended in PBS) at a 
ratio of 1:10 for 30 minutes at 37 °C in a shaking water bath. Phagocytosis was stopped 
by adding of ice-cold PBS into the cell-bacteria mixture followed by centrifugation at 
400 g for 5 min. After another wash with ice-cold PBS, cytospin slides of the cells that 
had ingested bacteria were prepared (400 g for 5 min using a Shandon Cytospin 
centrifuge), prior to being fixed in methanol for 5 min. Slides were stained using 20% 
modified Wright-Giemsa stain (pH 7.0, Sigma, Poole, UK) for 10 min, washed with 
three changes of distilled water and air dried thoroughly before evaluation. A minimum 
of 500 cells were examined by light microscopy (×100 magnification), and the 
phagocytic index was calculated as described by Campbell et al. (2001), according to 
the following formula: phagocytic index = (percentage of cells containing at least one 
bacterium) × (mean number of bacteria per positive cell). This takes into account both 
the number of phagocytes containing bacteria and the mean number of phagocytised 
bacteria in these cells. 
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Fig. 2.3. An example standard curve for bacteria grown in TSB. Staphylococcus aureus NCIMB 6571 
dilutions (1 × 10
7
 to 28 × 10
7
 bacteria ml
-1
)
 
were prepared in TSB and data points are the mean of 
triplicates ± SEM.  
 
2.1.5 Assay for cell viability 
The trypan blue assay is based on the principle that viable cells possess intact cell 
membranes that exclude the dye, whilst non-viable cells, with damaged membranes 
stain blue. The assay gives an indication of the overall viability of the cell population, 
but does not distinguish between apoptotic and necrotic cells. Samples of each 
suspension of cells (50 µl of 10
6
 cells ml
-1
 in supplemented RPMI-1640) were mixed 
with 50 µl of 0.4% trypan blue solution and incubated at room temperature for 5 min. 
Total and non-viable (i.e. trypan blue stained) cells were counted using a 
haemocytometer. 
2.1.6 MTT assay 
3-(4,5-dimethylthiaol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) is an electron 
acceptor that is easily reduced by cellular dehydrogenases in metabolically-active cells, 
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causing cleavage of the tetrazolium ring in the soluble yellow MTT to form an insoluble 
purple crystal (MTT formazan; Vistica et al., 1991). DMSO is added to dissolve the 
insoluble purple MTT formazan product. The absorbance of MTT formazan can be 
measured at 540 nm to indicate the level of MTT reduction, which is proportional to the 
number of viable cells. Cells were resuspended in RPMI-1640 at 10
6 
cells ml
-1
. Samples 
of each cell suspension (100 µl) were placed in the wells of 96-well plates and then 10 
µl of MTT (5 mg ml
-1
 in PBS; Sigma, Poole, UK) were added to each well and 
incubated for 3 h at 37 °C. After incubation, 100 µl DMSO was added to each well and 
incubated for 30 min at room temperature to solubilize any formazan product. The 
plates were read on a VersaMax plate reader (Molecular Devices, Sunnyvale, CA, USA) 
at 540 nm. 
2.1.7 Gene expression  
Real-time polymerase chain reaction (RT-PCR) enabled the analysis of mRNA 
expression of multiple genes. For the present study, 4 genes (NF-B, Bcl-2, TNF-α and 
IL-10) involved in both apoptosis and inflammation, and known to be expressed by 
neutrophils, were quantified, along with an endogenous control (β-actin; Table 2.2).  
2.1.7.1 RNA extraction 
Total RNA of neutrophils was extracted using the GenElute
TM
 Mammalian Total RNA 
Miniprep Kit from (Sigma Aldrich, Poole, UK) according to the manufacturer’s 
instructions. Briefly, 1 × 10
6 
cells were washed with PBS (1 ml). Cells were lysed and 
homogenised by mixing with lysis buffer (250 µl containing 2.5 µl 1% β-
mercaptoethanol) in Eppendorf tubes (1.5 ml) for 10 s to ensure complete lysis of the 
cells in order to improve the yield of extracted RNA. The cell lysates were centrifuged 
for 2 min at 8,000 × g (MSE Micro Centaur). The supernatant containing the RNA was 
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gently pipetted into a filtration tube and centrifuged for 2 min at 8,000 × g. 350 μl of 
molecular grade 70% ethanol was added to the eluate which was then transferred to the 
binding spin column to assist the selective binding of RNA. The column was then 
centrifuged for 15 s at 13000 × g at room temperature; the eluate was discarded and the 
sample washed with solution 1 and solution 2. 
2.1.7.2 DNA digestion 
In order to remove any contaminating genomic DNA from total RNA, DNA digestion 
was used to digest any DNA contamination using the on-column DNaseI Digestion set 
(Sigma Aldrich, Poole, UK). DNase (80 µl), was added to RNase-free tubes containing 
RNA samples, before incubation at room temperature for 15 min for DNA digestion and 
then centrifuged at 13000 × g in a microcentrifuge (Micro Centaur, MES, UK). The 
impurities were removed by washing three times with different swash buffers before 
being eluted with 40 µl elution buffer into a new collection tube for 1 minute at 13000 × 
g at room temperature. 
2.1.7.3 Quantitation of RNA 
The concentration and purity of the RNA was quantified using a NanoDrop UV 
spectrophotometer (ND-1000) (Labtech International Ltd., Luton, UK). The absorbance 
was measured at 260 nm for determination of RNA concentration, and samples with 
acceptable purity (i.e. A260/A280 ratio 2.0-2.23) were used for reverse transcription. An 
A260/A280 ratio greater than 1.8 is usually considered an acceptable indicator of good 
RNA (Sambrook 1989). RNA samples were stored at -80 C until use. 
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2.1.7.4 Reverse Transcription for synthesis of complementary DNA (cDNA) 
DNA is more stable than RNA and so is a useful starting point for RT-PCR. The 
complementary DNA (cDNA) is made from RNA by reverse transcription. The reaction 
is primed by random nonamer primers that anneal to the mRNA. The resulting cDNA is 
then used as a template for the polymerase chain reaction (PCR) or quantitative PCR 
where the gene of interest is amplified until there are millions of copies. 
Reverse transcription was employed to convert mRNA into cDNA by using ImProm-
II™ Reverse Transcriptase (Promega, Southampton, UK). Briefly 1 µg of total RNA 
was incubated with random nonamers (1 µM; Sigma, R7647) and nuclease-free water to 
a final volume of 10 µl in thin-walled PCR tubes. The mixture was placed in a Gen 
Amp PCR system 9700 Thermal cycle. RNA was denatured at 70 
○
C for 10 min. The 
reactions were quickly cooled on ice for 5 min and subsequently 10 µl of master mix 
(Table 2.2) containing 1 unit of ImProm-II™ Reverse Transcriptase were added to each 
reaction. Reactions were then incubated at room temperature for 10 min to ensure the 
elongation of random primers. The cycling conditions were: 25 °C for 5 min, 42 °C for 
60 min and 70 °C for 15 min for heat-inactivation of the ImProm-II™ Reverse 
Transcriptase. Samples were then stored at 4 °C for up to a month or at -20 °C until 
used. Negative controls consisting of reactions lacking RT were run in all cDNA 
experiments. 
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Table 2.2 Preparation of Reverse Transcription Mix. 
Reagent Volume 
RNA template (1 µg) 
Random nonamers (Polymerse containg 
nine repeating units) 
Molecular biology quality water to final 
volume 
up to 1 µg 
1 µl 
 
10 µl 
10 min at 70 °C then cooled on ice for 5 min 
Improm-II
™
 Reverse Transcriptase 
5× ImProm-II
™
 reaction buffer 
10 mM dNTP 
25 mM MgCl2 
Molecular biology quality water 
1 µl 
4 µl 
1 µl 
3 µl 
up to 15 µl 
 
To check the purity of DNA and the molecular weight of the PCR product, the cDNA 
agarose gel electrophoresis was run after amplication. The primers were designed using 
the mRNA sequence of genes which obtained from a Primer Blast in the NCBI 
(National Centre for Biotechnology Information) 
(http://www.ncbi.nlm.nih.gov/BLAST/). The use of a housekeeping gene in the same 
well reduces potential error caused by differences in the contents of each well, i.e. 
template or primer concentrations. The criteria for designing primers for qPCR included 
a GC content of 50-60%, an annealing temperature of 55-60C and that primers be in 
the range of 18 to 28 nucleotides in length (Table. 2.3). β-actin was used as a house 
keeping gene control in this case to normalize RNA levels. A total of 23 µl mix was 
made up as described in Table 2.4 and added for each sample, in which specific primers 
were used. Then, amplifications were performed using a Gen Amp PCR system 9700 
instrument according to the conditions in Table 2.4. 
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Table 2.3. List of primer sequences for NF-KB, Bcl-2, TNF-α, IL-10 and β-actin RT-PCR analysis and their selection criteria. 
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Table 2.4 Preparation of PCR mix for one reaction. 
Reaction mix Volume Amplification conditions 
Sample 
Taq polymerase (Sigma) 
PCR reaction buffer 
25 mM MgCl2  
10 mM dNTP 
Forward primer (10 pmol µl
-1
) 
Reverse primer 10 pmol µl
-1
) 
Molecular biology-grade water  
2 µl 
0.2 µl 
2.5 µl 
1.5 µl 
1.0 µl 
0.5 µl 
0.5 µl 
16.8 µl 
 
94 °C    2 min 
94 °C    30 s 
60 °C    30 s  (40 cycles) 
72 °C    30 min 
4 °C       hold 
 
 
PCR mix (10 µl) was resolved on 1% agarose gels in order to confirm the size and the 
quality of the PCR product for specific primers. Electrophoresis gels (1%) were made 
with 1× Tris-Acetate-EDTA buffer (TAE, Fisher Scientific, Loughborough, UK). For 
example, 0.7 g of agarose (Fisher, Loughborough, UK) were dissolved in 70 ml TAE. 
SYBR
®
 safe (DNA gel stain, 3 μl) was added to enable UV visualisation of the 
amplified target. Then, 2.5 µl of Orange G dye were added to each sample (1/10 sample 
volume) as a colour marker to monitor the progress of agarose gel electrophoresis. 
Ladder (25 µl of a 1 kb) was prepared as follows; 16 µl molecular water, 2.5 µl dye and 
2.5 µl of ladder (100 bp, New England Bio Labs). Samples (25 µl) were loaded into the 
wells and the gel was run in 1 x TAE buffer at 90 V for 1 h. DNA band images were 
taken using a visualizer (UVItec Limited, England). The amplified product was 
visualized as a single compact band of the expected size under UV light dependent on 
primer set used.  
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2.1.7.5 Real-time quantitative polymerase chain reaction (Q-PCR) 
In the typical PCR, only large changes in starting mRNA can be measured. To remove 
this limit, quantitative PCR (qPCR) was developed, which enables accurate and 
absolute quantitation, high-throughput processing as well as multiplexing of samples. 
The newly-synthesised DNA is fluorescently probed, the increase in fluorescent signal 
being proportional to the amount of DNA synthesised at each cycle. An internal control 
is used to normalise the sample and run on the same plate, which gives the qPCR 
relative quantitation. The cycles at threshold fluorescence (Ct) is defined as the number 
of cycles required for the fluorescent signal to cross the threshold (i.e. exceed 
background level). Ct levels are inversely proportional to the amount of starting 
template. The earlier the fluorescence passes above the threshold, the more abundant the 
initial target. This allows quantification of the initial amount of target relative to a 
reference gene (normally a housekeeping gene such as β-actin or GAPDH). 
Quantitative RT-PCR using the DNA-binding dye SYBR
®
 green system was used for 
detection of PCR products. RNA was extracted and cDNA synthesised as described 
above. All qPCR reactions were performed in a 48-well plate using a 48 well Stepone 
PCR system linked to Stepone v.2 analytical software (Applied Biosystems Warrington, 
Cheshire, UK). The amplification was carried out in a final reaction volume of 25 µl 
containing PCR SYBR Green master mix prepared for one reaction (Table 2.5). The 
PCR protocol was designed for 40 cycles. The fluorescence signal was measured once 
in each cycle. For each gene of interest a negative control was used in which samples of 
cDNA were not added. The difference between the Ct of the reference and target gene 
was calculated and is known as ∆Ct. The Relative Quantity (RQ) of the treated sample 
can be calculated by comparing the ∆Ct of the treated sample to a control sample 
(known as ∆∆Ct): 
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∆∆Ct =∆Ct sample-∆Ct reference control 
RQ=2
-∆∆C
t 
 
Table 2.5 Preparation of Sybr
®
 Green PCR master mix for one reaction 
Reaction mix Volume (µl) Amplification conditions 
SYBR
®
 Green JumpStart Taq ready mix 
Reference dye 
Forward primer (10 pmol µl
-1
) 
Reverse Primer (10 pmol µl
-1
) 
Template cDNA 
Water molecular biology reagent  
(RNase and DNase free) 
 
Total volume 
12.5 
0.25 
0.5 
0.5 
2 
9.5 
 
 
25.25 
 
 
94 °C   2 min 
94 °C   30 s 
60 °C  30 s (for 40 cycles) 
72 °C  30 s 
 
2.1.7.6 Stability of β-actin following different treatments 
Previous studies on HBO treatment have used β-actin as a reference control gene (Gu et 
al., 2008, Matsunami et al., 2009, Speit and Bonzheim, 2003, Gaydar et al., 2011). 
However, β-actin, a cytoskeletal protein has been reported to be influenced by factors 
such as mechanical stress (Janmey, 1998). To check the selected reference gene, the 
expression of β-actin was determined by qPCR in both stimulated and unstimulated 
ATRA-differentiated cells following different treatments. The Ct values demonstrated 
that β-actin expression did not alter after exposure to HBO, pressure, hyperoxia and 
hypoxia compared to the normoxia condition (Fig. 2.4A). The PCR product for β-actin 
was confirmed by using 1% agarose gel electrophoresis (as described in section 
2.2.7.4). No difference in bands was seen after different treatments (two-way ANOVA, 
P > 0.05; Fig. 2.4A and B).  
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Fig. 2.4 The expression of β-actin in ATRA-differentiated cells. The expression of β-actin was measured 
by qPCR in ATRA-differentiated cells stimulated with TNF-α (10 ng ml-1) or control (unstimulated). 
Cells were subjected to different treatments for 90 min and stimulated with TNF-α (10 ng ml-1) for 3 h. 
The expression for β-actin is expressed as Ct value. Data are means ± SEM for three separate experiments 
(passages numbers 20, 24 and 28, n = 3) with triplicate measurements. Bars with the different lower case 
letters are significantly different (two-way ANOVA, P .> 0.05; A) RT-PCR product for β-actin in ATRA-
differentiated cells stimulated with TNF-α was loaded in agarose gel 1% to confirm the product quality, 
bands description: (1) normoxia (2) hypoxia, (3) hyperoxia,(4) pressure, (5) HBO (B). 
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2.1.8 Measurements of pro-and anti-inflammatory cytokines using multiplex 
Luminex bead assays 
The Luminex
®
 system by Millipore (Billerica MA, USA) uses internally colour-coded 
beads (microspheres) with two fluorescent dyes. By using different intensities of two 
dyes, 100 distinctly coloured bead sets can be created, each coated with a specific 
capture antibody (Fig. 2.5). After an analyte from a test sample is captured by the bead, 
a biotinylated detection antibody is introduced. The reaction mixture is then incubated 
with streptavidin-PE conjugate, to complete the reaction on the surface of each 
microsphere. 
 
Fig.2.5: The Luminex
®
 system: The beads on which the antibodies are fixed, are impregnated with 
different amounts of red and infrared fluorophores (from 
http://www.panomics.com/images/96_2_Bead_v1.jpg). 
 
Specific antibodies for specific cytokines are attached to each bead type such that one 
bead type will bind to one cytokine in a sample. After adding the biotinlyted detection 
bodies and the PE-conjugated streptavidin, PE will be indirectly attached to the 
cytokines. The microspheres are then allowed to pass through a laser which excites the 
internal dyes marking the microsphere set, and finally allows identification and 
quantification of each individual microsphere based on the fluorescent reporter signals.  
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Supernatant or plasma levels of TNF-α, IL-β1, IL-6 and IL-10 were quantified using the 
Luminex
®
 system (Millipore, UK), according to the manufacturer’s instructions. 
Antibody-immobilized beads were prepared by mixing 60 µl from each of the four 
antibody bead vials to the mixing bottle and bringing the volume to 3 ml with bead 
diluent. Mixtures were then vortexed for 30 sec and then for 1 min immediately before 
use. Standards of the cytokines of interest were prepared at concentrations of 3.2-10000 
pg ml
-1
 in the multiplex assays with standard buffer (1x). Samples or standard (25 µl per 
well) were incubated with the microspheres in a 96-well Luminex plate for 1 h at room 
temperature. After washing twice with washing buffer, 25 µl of biotinylated detection 
antibodies were added to each well and incubated for 1 h. After incubation, 25 µl of 
streptavidin-phycoerythrin mixture (0.5 mg ml
-1
) were added to each well containing 
detection antibodies and incubated for 30 min. After washing twice, the fluorescence of 
the PE bound to the microspheres was analysed using the Luminex 100
TM 
system with 
the mean fluorescence intensity (MFI) being directly proportional to the concentration 
of cytokines present. Concentrations (pg ml
-1
) of different analytes were determined by 
using the standard curves (Fig.2.6). Two quality controls were prepared with 250 µl of 
deionized water and used in the assay to take into account any quenching and 
autofluorescence.  
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Figure 2.6 Standard curves of IL-1β, IL-6, IL-10, and TNF-α. Cytokine concentrations (3.2-10000 pg ml-
1
) were prepared in the multiplex assays with standard buffer and data points are the mean of triplicates ± 
SEM. a is estimated response at zero concentration, b is slope factor, c is the mid-range concentration, d 
estimated response at infinite concentration and f is the asymmetry factor. 
 
2.1.9 Neutrophil isolation 
Neutrophils were separated from a sample of whole blood via density centrifugation 
using Polymorphprep
TM
 (Axis-Shield, Kimbolton, UK), a commercially available 
solution, containing 13.8% sodium diarizoate and 8.0% dextran-500 (Fig. 2.7). 
Briefly, 5 ml of anticoagulated whole blood was layered over 5 ml of Polymorphprep
TM
 
(Axis-Shield, Kimbolton, UK) in a 15 ml centrifuge tube. The samples were centrifuged 
for 500 × g for 35 min. The resulting layers of monocytes and neutrophils were 
removed separately from the solution using a plastic Pasteur pipette. Neutrophils were 
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then diluted in 15 ml HBSS solution. Following centrifugation at 200 × g for 5 min, the 
pelleted neutrophils were resuspended in 5 ml H2O for 30 s to hypotonically lyse 
erythrocytes, before 5 ml of 0.9% NaCl solution was added to restore osmolality. This 
step was repeated 2-3 times to ensure that all erythrocytes had been lysed. Neutrophils 
were then resuspended in 5 ml of RPMI-1640 and kept at room temperature until use 
(within 2 h). 
 
 
Fig. 2.7 Neutrophil isolation from human blood using Polymorphprep
TM
.
 
Density centrifugation (A) leads 
to pelleting of erythrocytes, and formation of both a monocyte cell band and a neutrophil cell band, which 
can be harvested and washed (B). Morphological study using modified Wright-Giemsa staining 
confirmed the neutrophil purity (C). 
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2.1.10 Statistical analysis 
Data are expressed as means ± SEM for three separate experiments (n = 3), unless 
otherwise stated, and analysed using Statgraphics Centurion XVI (Stat Point 
Technologies, Inc.). The Andersen-Darling test was used to check for normality (P < 
0.05 indicates that the data are non-normal). Levene’s test was performed to check that 
the variance of each group was not significantly different (P < 0.05 indicates a 
significant difference in variance between groups). In order to explore significant 
differences between reference and treatment groups one-way ANOVA or a non-
parametric ranking (Kruskal-Wallis) were carried out as appropriate. In cases where 
there were two sets of treatments two-way ANOVA was used. In ANOVA, where the 
interaction was non-significant, post hoc analysis using Tukey’s test was carried out, 
while for Kruskal-Wallis significant differences were determined by examining box and 
whisker plots with median notch. Where the interaction was significant, in order to 
understand the main effects, data were analysed further using pair-wise Mann-Whitney 
tests and/or one-way ANOVA. A P value of < 0.05 is considered significant throughout. 
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CHAPTER THREE 
CHARACTERISATION OF 
DIFFERENTIATED HL-60 CELLS AS A 
NEUTROPHIL MODEL FOR IN VITRO 
STUDIES 
  
 69 
 
Abstract 
Human leukaemic HL-60 cells are an established model for neutrophils for in vitro 
studies. DMSO and the retinoids, all-trans retinoic acid (ATRA) and 9-cis retinoic acid 
(9-cis RA), are common regulators of HL-60 cell proliferation and differentiation. The 
aim of this study was to evaluate the effects of these agents on the proliferation and 
differentiation of HL-60 cells. The ability of HL-60 cells to undergo terminal 
differentiation into neutrophil like-cells was assessed via trypan blue, NBT reduction, 
and assessment of morphological changes. Complete inhibition of growth of HL-60 
cells was seen with 1 µM of ATRA (Kruskal-Wallis, P < 0.05). Exposure of HL-60 
cells to ATRA (1 µM) for only 3-5 days was sufficient to inhibit cell growth with most 
cells positive for NBT (one-way ANOVA, P < 0.05), and showing the features of 
banded and segmented neutrophils. However, DMSO was as effective as ATRA in 
inhibiting proliferation (Kruskal-Wallis, P < 0.05). Non-additive effects on HL-60 cell 
differentiation were observed upon combination of ATRA and 9-cis RA at 1 µM. 
ATRA-differentiated HL-60 cells (1 µM, 5 days differentiation) displayed functional 
characteristics commonly associated with peripheral blood neutrophils, including 
enhanced phagocytosis of Staphylococcus aureus (Student’s t-test P < 0.05) in response 
to stimuli such as PMA and LPS, release of cytokines such as TNF-α, and induction of 
apoptosis. 
  
 70 
 
3.1. Introduction 
The human promyelocytic leukaemia cell line, HL-60, was isolated from an acute 
leukaemia patient and first grown in culture by Collins et al. (1978). These cultured 
cells display the typical features of leukaemia, namely an inability to respond to normal 
differentiation stimuli, unlimited proliferation capacity and decreased apoptosis. About 
5-10% of these cells spontaneously differentiate into mature cell types in culture (Palis 
et al., 1988; Fig. 3.1). 
 
Fig. 3.1 A general model of haematopoiesis. Blood cells are produced from haematopoietic stem cells 
(HSC), which can undergo either self-renewal or differentiation after stimulation with specific cytokines 
and growth factors into progenitor cells committed to multiple lineages. These include common lymphoid 
and myeloid progenitors. The myeloid progenitors further divide to give rise to granulocytes, 
macrophages and erythroid cells, while the lymphoid progenitors are committed to T cells, natural killer 
cells and B cells. HL-60 cells are transformed promyelocytes. A variety of agents can induce these cells 
to differentiate into monocyte-like or neutrophil-like cells (Cooper and Hausman, 2000). 
 
Various differentiation-inducing agents have been shown to induce differentiation of 
HL-60 cells into neutrophil-like cells, monocyte-like cells or eosinophil-like cells. 
These agents mediate their differentiation effects through different mechanisms 
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including remodelling of chromatin, interaction with respective receptors, alteration of 
DNA, inhibition of histone deacetylase, interference with DNA and RNA synthesis and 
disturbance of signal transduction (Tsiftsoglou et al., 2003). These agents vary not only 
in their mode of action but also in the timing of differentiation marker expression and 
differentiated phenotype which result. Chemical agents including retinoic acid (RA), 
which is commonly used to treat dermatological conditions as well as acute 
promyelocytic leukaemia (APML), and dimethyl sulphoxide (DMSO), are known to 
induce differentiation of HL-60 cells into cells with the morphological features of 
neutrophils (Breitman et al., 1980, Collins  et al., 1978). These cells show functionality 
and markers that are typical of mature neutrophils including changes in cell shape, 
nuclear condensation, superoxide (O2
•-
) production, increased ability to reduce NBT, 
chemotaxis, phagocytosis and expression of antigens specific to granulocytes (Collins 
and Foster, 1983, Newburger et al., 1979). Exposure to vitamin D3 results in 
differentiation of HL-60 cells into monocyte-like cells, as the cells begin to clump and 
acquire pseudopodia, and show increases in both non-specific esterase activity and 
levels of lysozyme (Birnie, 1988). Many factors can affect optimal differentiation: the 
concentration of inducing agent, the time of exposure and the proportion of cells in 
different stages of the cell cycle (Collins, 1987, Collins  et al., 1978). Recent studies 
have addressed the differentiation of HL-60 cells into neutrophil-like cells (Table 3.1). 
It is clearly important to standardize and optimize differentiation conditions in order to 
provide neutrophil-like cells suitable for use in in vitro experiments. 
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Table 3.1 A summary of inducing agents and the various outcomes of their use in differentiating HL-60 cells. 
Differentiating agent Concentration Outcome Study 
DMSO 1.25% Induced superoxide production with NBT dye reduction in DMSO-treated  
cells after stimulation with PMA; response to chemoattractants and  
development of complement receptor. 
 
(Collins et al., 1979) 
all-trans retinoic acid (ATRA) 1 pM-1 µM Maximal differentiation occurs at 1 µM ATRA as indicated by nitro blue reduction.  
The percentage of mature cells is directly related to the length of exposure. 
 
(Breitman et al., 1980) 
cAMP 500 µM Treated cells exhibited a decrease in proliferation, expressed complement  
receptors, reduced NBT, adhered to substrate and showed chemotaxis. 
 
(Chaplinski and Niedel, 1982) 
Combination of ATRA, DMSO 
and/or 5-aza-2’-deoxycytidine 
(AzadCyD) 
1 µM ATRA 
1 µM AzadCyD 
1% DMSO 
 
RA + DMSO + AzadCyD caused maximal NBT reduction after 72  
to 96 h of incubation, with complete differentiation in HL-60 cells. 
(Schwartsmann et al., 1987) 
DMSO or ATRA 1.25% DMSO, 1 µM 
ATRA 
 
Increase in the proportion of cells with mature neutrophil morphology  
and apoptosis.  
(Martin et al., 1990) 
ATRA + 9-cis RA 1 µM each Inhibition of HL-60 cells proliferation, expression of myeloid-specific  
differentiation antigens (CD11b and CD14) with NBT reduction. 
 
(Kizaki et al., 1994) 
combination of ATRA or  
9-cis RA 
and vitamin D 
0.1 µM ATRA 
0.1 µM 9-cis RA 
0.01 µM vit. D 
 
Exerts additive effects on inhibition of proliferation and induction of HL-60  
cells differentiation. 
(Verstuyf et al., 1995) 
ATRA 1 µM ATRA induces HL-60 cell differentiation with increased percentage of NBT 
 positive cells and CD11b expression after 1, 2 and 3 days 
(Jian et al., 2011) 
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The main aim of this study was to choose an effective agent for the induction of 
differentiation of HL-60 cells into neutrophil-like cells for use in in vitro experiments. 
A further aim was to examine the response of differentiated cells to stimuli that induce 
neutrophil activation or apoptosis. Such observations would provide information as to 
whether this cell line is a suitable model for mature granulocytes. 
 
3.2 Materials and methods 
The majority of cell culture reagents used, including fetal bovine serum (FBS), L-
glutamine, penicillin, streptomycin, RPMI-1640 medium and trypan blue were obtained 
from Lonza (Slough, UK). Sterile PBS and Hank’s balanced salt solution (HBBS) were 
obtained from Invitrogen (Paisley, UK). Tissue culture flasks, serological pipettes and 
other tissue culture plastic were obtained from Bibby Sterilin Ltd (Staffordshire, UK). 
Recombinant human TNF-α was obtained from Insight Biotechnology (Wembley, UK). 
TNF-α and IL-10 ELISA kits were purchased from R&D Systems, Inc. (Minneapolis, 
USA). ATRA, 9-cis RA, DMSO, superoxide dismutase (SOD), ferricytochrome c (from 
horse heart) and dipotassium ethylenediaminetetraacetic acid (EDTA) were obtained 
from Sigma Aldrich (Poole, UK). 
3.2.1 Cell culture 
HL-60 cells (passage 6) were acquired from the European Collection of Cell Cultures 
(ECCAC, 98070106) and were cultured in RPMI-1640 medium supplemented with 10% 
(v/v) fetal calf serum (FCS), 2 mM L-glutamine, 100 U ml
-1
 penicillin and 100 µg ml
-1
 
streptomycin in vented 75 cm
2
 tissue culture flasks. Cells were maintained at 37 °C in a 
humidified atmosphere under 5% CO2 (balance air). Passages 20 through to 45 were 
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used for experiments. However, for individual measurements passages that were closer 
in number (range of 4-8 passages) were used for replicate experiments. 
3.2.2 Experimental design 
ATRA and 9-cis RA stock solutions (10 mM) were prepared in 99% (v/v) ethanol and 
stored at -80 
○
C. Dilutions of stock solutions were made in growth medium to 
concentrations ranging from 1 pM to 1 µM so that the final concentration of ethanol in 
cultures was no higher than 0.1%. DMSO was diluted with RPMI-1640 to a 
concentration of 1.25% (final concentration) to induce differentiation. 
Differentiation of HL-60 cells was induced by incubation of 2.5 × 10
5
 cells ml
-1
 with 
ATRA (1 pM-1 µM), 9-cis RA (1 pM-1 µM), ATRA + 9-cis RA (1 µM) or DMSO 
(1.25%) for 5 days in a humidified atmosphere at 5% CO2 (balance air) at 37 °C. The 
cells were then washed twice in RPMI-1640, and subsequently counted and assayed as 
described below. Two controls were used in this experiment: in one, control cells were 
cultured in RPMI-1640 medium containing 0.1% absolute ethanol and in the other HL-
60 cells were cultured in RPMI-1640 medium alone (Fig. 3.2). 
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Fig. 3.2 HL-60 cells culture and differentiation. HL-60 cells (2.5 × 10
5 
cells ml
-1
) were incubated with 
different inducing agents (ATRA, 9-cis RA and DMSO) for 5 days at 37 
○
C in 5% CO2, and then washed, 
counted and assayed for further analysis. Three separate experiments with passage numbers (22, 24 and 
26) were performed. 
 
3.2.3 Assessment of differentiation 
The viability of cells was assessed by trypan blue exclusion assay. Cells were treated 
with differentiating agents and were collected at 0, 1, 2, 3, 4 and 5 days for viability 
analysis (section 2.1.5, Fig. 3.3). 
The respiratory burst activity of neutrophil-like cells obtained by differentiating HL-60 
cells was assessed by measuring NBT reduction (section 2.1.2). Cells were collected at 
0, 3 and 5 days after differentiation (Fig. 3.3).  
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Fig. 3.3 Timing of cell viability and NBT reduction assays. Samples were collected for viability analysis 
using trypan blue at the indicated time points (0, 1, 2, 3, 4 and 5 days, blue arrows) and for NBT 
reduction assay at the indicated time points (0, 3 and 5 days, red arrows) after inducing HL-60 cell 
differentiation with different agents. 
 
Cytospin slides of neutrophil-like cell suspensions (1 × 10
6
 cells ml
-1
) were prepared 
after 5 days differentiation using a Thermo Shandon Cytospin 4 centrifuge (Cheshire, 
UK; 400 ×g for 4 min). The slides were stained with Wright-Giemsa stain modified 
(section 2.1.4), and at least 500 cells were scored using a light microscope (equipped 
with a ×100 objective; Olympus, Japan). Mature granulocytes were identified by the 
multi-lobed structure of the nucleus (Verstuyf et al., 1995). One of the most common 
species of bacteria that can cause infection at wound sites is Staphylococcus aureus 
(Tillotson et al., 2008). Therefore, the phagocytosis of Staphylococcus aureus NCIMB 
6571 by ATRA-differentiated HL-60 cells was investigated in this chapter (section 
2.1.4). 
3.2.4 Quantification of TNF- and IL-10 by ELISA 
Tumour necrosis factor alpha (TNF-α) and interleukin-10 (IL-10) are produced by 
neutrophils in response to stimulation and are important for their recruitment into the 
inflamed site. A convenient method to measure TNF-α is via Enzyme-Linked Immuno 
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Sorbance Assay (ELISA). Cell suspensions (100 µl of 1 × 10
5
 cells ml
-1
) of either HL-
60 cells differentiated using ATRA or 9-cis RA, or human neutrophils (section 2.1.9) 
were stimulated with 100 µl of PMA, LPS, PGN or FMLP in 96-well plates for 18 h at 
37 °C under 5% CO2 balance air. Samples were measured in triplicate. NuncMaxisorp® 
flat-bottom 96-well plates (eBiosciences, Ltd, Hatfield, UK) were coated with 50 µl of 
0.5 µg ml
-1
 mouse anti-human TNF-α or IL-10 monoclonal antibody (capture antibody) 
and incubated overnight at 4 °C. The plates were then washed 3 times with PBS 
containing 0.01% v/v Tween (PBST). Wells were blocked by adding 50 µl of PBST 
containing 2% (v/v) FCS for 4 h at room temperature. Standards (0 to 10000 pg m1
-l
) of 
human TNF-α and IL-10 were prepared and 50 µl of each were added to the 96-well 
plate in duplicate (Fig. 3.4). After this, 50 µl of cell supernatants were added to the 
same plate and incubated overnight at 4 °C. After three further washes with PBST, 50 
µl of biotinylated mouse anti-human TNF-α monoclonal antibody was added and the 
plate incubated for 4 h at room temperature. Following three further washes with PBST, 
50 µl of horseradish peroxidase (HRP)-streptavidin (1/250 dilution in PBS containing 
1% BSA) was added and the plate incubated for 2 h at room temperature. After three 
more washes with PBST, 100 µl of tetramethylbenzidine (TMB) reagent was added, as 
a substrate for the HRP, and the plate incubated for 30 min at room temperature. The 
reaction was stopped with addition of 50 µl per well of 2 M sulphuric acid and plates 
read at 450 nm in a plate reader (VersaMax, Molecular Devices, Sunnyvale, CA, USA). 
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Fig. 3.4 Standard curves for TNF-α and IL-10. Cytokine standards (0-1000 pg ml-1) for TNF-α (A) and 
IL-10 (B) were prepared in buffer and data points are the mean of duplicate measurements ± SEM; a is 
the estimated response at zero concentration, b is slope factor, c is the mid-range concentration, d is the 
estimated response at infinite concentration. 
 
3.2.5 Induction of apoptosis 
Members of the caspase family of cysteine proteases are the central mediators of the 
proteolytic cascade leading to cell death and elimination of compromised cells. As such, 
the caspases are tightly regulated both transcriptionally and by endogenous anti-
apoptotic polypeptides, which block productive activation (Earnshaw et al., 1999). 
Furthermore, the enzymes involved in this process indicate distinct pathways and 
demonstrate specialized functions consistent with their primary biological roles. Assays 
that directly measure caspase activity can provide valuable information about the 
mechanism of death in dying cells. 
Various agents have been described that induce apoptosis. The aim of this work was to 
investigate which of the available agents could induce apoptosis in neutrophil-like cells 
and thus would be suitable for use as a positive control. HL-60 cells differentiated using 
ATRA were resuspended at 1 × 10
6 
cells ml
-1
 in RPMI-1640 medium supplemented 
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with 10% fetal calf serum and 2 mM L-glutamine, and incubated at 37 °C in the 
presence or absence (control) of 10-100 ng ml
-1
 of TNF-α or H2O2 (33-132 µM) for 3 h 
at 5% CO2 (balance air). 
Caspase 3/7 activity was measured using a fluorometric substrate, rhodamine 110 bis-
(N-CBZ-L-aspartyl-L-glutamyl-valyl-L-aspartic acid amide, Z-DEVD-R110; Promega, 
Southampton, UK). Neutrophil-like cells (50 µl of 2 × 10
5
 cells ml
-1
) were incubated 
with 50 µl of the caspase 3/7 fluorometric substrate in a 96-well plate for up to 18 h, and 
the fluorescence was measured using a Cytofluor II fluorescence plate reader 
(PerSeptive Biosystems, Framingham, MA) with excitation wavelength 490 nm and 
emission wavelength 521 nm. Caspase 3/7 activity was expressed in terms of relative 
fluorescence units (RFU). 
3.2.6 Statistical analysis 
All data were analysed using Statgraphics Centurion XVI (StatPoint Technologies, 
Inc.). Data are expressed as means ± SEM for three separate experiments in triplicate, 
unless otherwise stated. The relationships between the effects of differentiation agents 
and time were determined using linear or non-linear regression as appropriate. 
Regressions (curve fitting) were carried out using Sigma Plot 12.0. Data were also 
analysed using ANOVA or Kruskal-Wallis as appropriate following the Andersen-
Darling test and Levene’s test. In one case (Fig. 3.12) data were log10 transformed 
before two-way ANOVA. For one-way ANOVA, Tukey’s test was used post hoc. A P 
value of < 0.05 is considered significant throughout. 
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3.3 Results 
3.3.1 Cell proliferation in response to ATRA, 9-cis RA and DMSO  
There was a clear relationship between the cell density and time after treatment with 
differentiation-inducing agents (Figs 3.5 and 3.6). A significant increase in cell density 
was found in ATRA-treated cells at low concentrations of 1 nM (linear regression, P = 
0.0004) and 1 pM (linear regression, P = 0.0021)] compared to undifferentiated cells on 
day 0 (control; Fig. 3.5A). However, treatment with 1 µM ATRA caused a slight but 
significant decrease in cell density (linear regression; P = 0.0002; Fig. 3.5A). Similarly, 
cells treated with 9-cis RA showed an increase in cell density in a time-dependent 
manner at 1 nM (linear regression, P < 0.0001) and 1 pM (linear regression, P = 0.0017; 
Fig. 3.5B), while no change in cell density was observed after treatment with 1 µM 9-
cis RA (linear regression, P = 0.251). A combination of 1 µM of both retinoids, or 
treatment with 1.25% DMSO, caused a slight but significant decrease in the cell density 
over time compared to the control on day 0 (linear regression, P = 0.009 in both cases; 
Fig. 3.6). The regression analysis was confirmed by using the Kruskal-Wallis test. 
There was a significant decrease in cell density after 3, 4 and 5 days of incubation with 
1 µM ATRA, 1 µM 9-cis RA and 1.25% DMSO (Kruskal-Wallis, P = 0.015, 0.001 and 
0.0009, respectively) compared to undifferentiated cells (Fig. 3.7). 
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Fig. 3.5 Regression analysis showing the relationship between cell density and time of treatment with 
differentiation inducing agents. HL-60 cells (2.5 × 10
5
 cells ml
-1
) were incubated for 5 days in the absence 
or presence of (A) ATRA or (B) 9-cis RA at concentrations ranging from 1 pM to 1μM to induce 
differentiation. Data are expressed as means ± SEM for three separate experiments (passage numbers 22, 
24 and 26; n = 3) with triplicate measurements. R
2
 values are 0.984, 0.995 and 0.977 for 1 µM, nM and 
pM of ATRA, respectively and 0.986, 0.999 and 0.310 for 1 µM, nM and pM of 9-cis RA, respectively). 
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Fig. 3.6 Regression analysis showing the relationships between cell density and time of treatment with 
differentiation-inducing agents. HL-60 cells (2.5 × 10
5
 cells ml
-1
) were incubated for 5 days in the 
absence or presence of (A) a combination of ATRA + 9-cis- RA (1 µM) or (B) 1.25% DMSO to induce 
differentiation. Viability was assayed by trypan blue dye exclusion. Data are expressed as means ± SEM 
for three separate experiments (passage numbers 22, 24 and 26; n = 3) with triplicate measurements. R
2
 
values are 0.987, 0.995 and 0.849 for undifferentiated cells + ethanol, 1 µM ATRA + 9-cis RA, 1.25% 
DMSO and undifferentiated cells, respectively. 
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Fig. 3.7 Cell density at 3, 4 and 5 days after differentiation with various differentiation-inducing agents. HL-60 cells (2.5 × 10
5
 cells ml
-1
) were incubated for 5 days in 
the presence or absence of ATRA (1 M), 9-cis- RA (1 µM) or 1.25% DMSO to induce differentiation. Viability of cells was assayed by trypan blue dye exclusion. 
Data are expressed as means ± SEM for three separate experiments (passage numbers 22, 24 and 26; n = 3) with triplicate measurements. For each treatment on each 
day, bars with different lower case letter are significantly different (Kruskal-Wallis, P < 0.05). 
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3.3.2 NBT reduction during differentiation of HL-60 cells by retinoids and DMSO 
The effectiveness of differentiation of HL-60 cells into neutrophil-like cells was 
demonstrated by measuring the percentage of NBT reduction (Fig. 3.8). In the case of 
unstimulated cells, by day 3 all cells exposed to differentiating agents (ATRA, 9-cis RA 
and DMSO) showed a higher degree of NBT reduction (one-way ANOVA, P = 0.0091) 
than undifferentiated HL-60 cells (Fig. 3.8A). By day 5 of incubation, both the 1 µM 
ATRA and DMSO treatments showed a significantly higher percentage of cells that 
reduced NBT (one-way ANOVA, P = 0.0085) compared to the control. Treatment with 
1 µM 9-cis RA did not show a significant difference in the percentage of NBT-reducing 
cells in unstimulated cells (one-way ANOVA, P > 0.05). 
A significantly higher % NBT stained cells was found at both day 3 and day 5 in PMA-
stimulated cells after differentiation with 1 µM ATRA, 1 µM 9-cis RA and 1.25% 
DMSO (one-way ANOVA, P = 0.001 and 0.0009, respectively) compared to non-
exposed control HL-60 cells (Fig. 3.8B). 
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Fig. 3.8 NBT reduction by HL-60 cells differentiated using different differentiating agents. HL-60 cells (1 
× 10
6 
cells ml
-1
) differentiated with ATRA, 9-cis RA and DMSO were incubated for 30 min with NBT (5 
mg ml
-1
) in the absence (A) or presence (B) of PMA (100 ng ml
-1
). Data are means ± SEM for three 
separate experiments (passage numbers 22, 24 and 26; n = 3) with triplicate measurements.
 
* indicates 
significant differences from undifferentiated HL-60 cells on the same day (control), bars with different 
letters indicate a significant difference between treatment (one-way ANOVA, P < 0.05). Examples of 
cytospin slides that were prepared and stained with Giemsa stain: (C) HL-60 cells; (D) ATRA; (E) 9-cis 
RA; and (F) DMSO. Original magnification × 40. 
  
 86 
 
3.3.3 Morphological alterations during HL-60 cells differentiation 
In the absence of a differentiating agent, HL-60 cells were predominantly typical 
promyelocytes (Fig. 3.9A) with large round nuclei, dispersed nuclear chromatin and a 
relatively high nuclear:cytoplasmic ratio. Incubation with either ATRA or 9-cis RA (1 
µM), or DMSO (1.25%) induced the majority of cells to undergo morphological 
changes characteristic of terminal differentiation of myeloid cells. The induced cells 
exhibited the following changes: small size, decrease in nuclear:cytoplasmic ratio and a 
marked reduction and segmentation of the nuclei (Fig. 3.9B, C and D). 
Cells treated with 1 µM ATRA exhibited morphological changes characteristic of 
mature cells in the granulocyte pathway by day 3; cells of mature neutrophil 
morphologies came to prominence on day 4 and remained the predominant cell type 
until termination of these cultures by day 5 as cells differentiated into banded 
segmented neutrophils (with nuclei with focal areas that are distinctly narrower than the 
width of the widest points and usually with irregular nuclear outlines; Fig. 3.9B). 
Treatment with 9-cis RA gave the same results (Fig. 3.9C). However, DMSO-treated 
cells displayed little tendency to mature morphologically beyond the myelocyte stage of 
development (Fig. 3.9D). 
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Fig. 3.9 Morphological changes induced in HL-60 cells after differentiation. Light microscopy images, 
produced using modified Wright-Giemsa staining showing morphology of (A) undifferentiated HL-60 
cells, showing promyelocytes with characteristic large round nuclei and cytoplasmic granules; (B) 
ATRA-treated cells and (C) 9-cis RA-treated cells, showing maturation to banded segmented neutrophils 
with large round nuclei, each containing 2-4 nucleoli; and (D) DMSO-treated cells showing 
metamyelocytes and neutrophilic bands rather than segmented neutrophils. Cytospin slides of cell 
suspensions were prepared and stained with Wright Giemsa stain to characterise the morphological 
changes (original magnification ×100).  
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3.3.4 Phagocytosis of Staphylococcus aureus NCIMB 6571 by differentiated HL-60 
cells 
Phagocytosis of Staphylococcus aureus NCIMB 6571 by undifferentiated and HL-60 
cells differentiated with 1 µM ATRA is shown in Fig. 3.10A. After incubation with 
ATRA for 5 days, 76% of cultured cells phagocytosed Staphylococcus aureus NCIMB 
6571 (Student’s t-test, P = 0.00002), while less than 12% of undifferentiated HL-60 
cells were capable of phagocytosing bacteria. Light micrographs of modified Wright 
Giemsa-stained, ATRA-treated cells incubated with Staphylococcus aureus NCIMB 
6571 showed more evidence of phagocytosis of bacteria (Fig. 3.10C) compared to 
undifferentiated cells (Fig. 3.10B). 
 
Fig. 3.10 Phagocytosis of Staphylococcus aureus NCIMB 6571 by undifferentiated and ATRA-
differentiated HL-60 cells. (A) HL-60 cells or ATRA-treated cells (1 × 106 ml-1) were incubated with 
Staphylococcus aureus NCIMB 6571 (1 × 107 ml-1) for 30 min at 37 °C, then cystospin slides were 
prepared, stained with Giemsa stain and cells counted to indicate the % of phagocytic cells. Data are 
expressed as means ± SEM for three separate experiments (passage numbers 26, 28 and 30; n = 3) with 
triplicate measurements. * indicates a significant difference versus undifferentiated HL-60 cells (control; 
Student’s t-test, P = 0.00002). Light microscopy study of phagocytosis of Staphylococcus aureus NCIMB 
6571 by (B) HL-60 cells and (C) ATRA-differentiated cells (original magnification × 100). 
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3.3.5 TNF-α production by neutrophil-like cells produced by differentiation of HL-
60 cells 
TNF-α production by differentiated HL-60 cells, both ATRA (Fig. 3.11A) and 9-cis RA 
treated (Fig. 3.11B; 1 µM for 5 days), and human neutrophils isolated from blood (Fig. 
3.11C) following stimulation with PMA, LPS, PGN or FMLP was quantified. 
Stimulation with PMA (100 ng ml
-1
), LPS (100 ng ml
-1
), PGN (10 µg ml
-1
), or FMLP 
(100 ng ml
-1
) resulted in significant increases in TNF-α levels in ATRA-differentiated 
HL-60 cells (Kruskal-Wallis, P = 0.0034). The highest levels were observed in LPS-
stimulated cells in comparison to control (unstimulated cells; Fig. 3.11A). PMA (25 ng 
ml
-1
) and FMLP (1 µg ml
-1
 and 10 ng ml
-1
) did not show an increase in TNF-α level 
compared to the control. Only 100 ng ml
-1
 PMA and LPS were found to produce a 
significant increase in TNF-α in 9-cis RA-differentiated HL-60 cells (Kruskal-Wallis, P 
= 0.00269) compared to the control (Fig. 3.11B). However, stimulation of human 
neutrophils (primary cells) with all stimuli increased TNF-α release (Kruskal-Wallis, P 
= 0.0139; Fig. 3.11C). The data presented were from a single experimental run due to 
the high reagent costs involved. However, based on these preliminary results two 
stimuli, LPS and PMA were further investigated with triplicate experiments. 
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Fig. 3.11 TNF-α production by differentiated HL-60 cells and human neutrophils. HL-60 cells were 
differentiated using (A) ATRA or (B) 9-cis RA. (C) shows the results using human neutrophils. Cells (1 × 
10
6
 ml
-1
) were incubated with different stimuli for 18 h under 5% CO2 and 37 °C. The supernatant was 
collected and assayed for TNF-α by ELISA. Data are expressed as means ± SEM for a single experiment 
(passage number 30; n = 1) with triplicate measurements. 
* 
indicates significant differences within this 
experiment only compared to the appropriate control in each case (Kruskal-Wallis, P < 0.05). 
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3.3.6 TNF-α and IL-10 production in response to oxygen exposure at different 
concentrations 
In a second experiment to explore the effects of oxygen exposure on cytokine 
production, neutrophil-like cells obtained by differentiation of HL-60 cells (1 µM 
ATRA for 5 days) were pre-treated with hyperoxia (95% O2) or hypoxia (5% O2) for 90 
min and then stimulated with 100 ng ml
-1 
PMA or LPS for 18 h. A non-significant 
interaction was found between the effects of treatment and stimulus on TNF-α and IL-
10 release from the neutrophil-like cells (two-way ANOVA, P > 0.05). There was a 
significant increase in TNF-α and IL-10 production in ATRA-treated cells in response 
to PMA and LPS stimulation compared to unstimulated cells (two way ANOVA, P < 
0.00005; Fig. 3.12A and B). Exposure to hyperoxia and hypoxia for 90 min at 20 °C, 
caused a significant decrease in TNF-α released by LPS and PMA-stimulated cells (two 
way ANOVA, P < 0.00005) compared to the normoxia (Fig. 3.12A).  
ATRA-differentiated HL-60 cells showed low levels of anti-inflammatory IL-10 
production (Fig. 3.12B). A significant decrease in IL-10 production in LPS and PMA-
stimulated cells was observed post hyperoxia treatment (two way ANOVA, P < 
0.00005) compared to normoxia (Fig. 3.9B). No change was observed in IL-10 levels 
post hypoxia treatment in LPS- or PMA-stimulated cells (76.8 ± 2.6 and 60.2 ±7.7 pg 
ml
-1
, respectively) compared with normoxia (66.6 ± 6.8 and 45.2 ± 4.9 pg ml
-1 
for LPS 
and PMA-stimulated cells, respectively). 
 
 
 
 
 
 
 
 92 
 
 
Fig. 3.12 TNF-α and IL-10 production by differentiated HL-60 cells following exposure to normoxia, 
hypoxia or hyperoxia. ATRA-differentiated HL-60 cells (1 × 10
6
 ml
-1
) were pre-treated with hyperoxia, 
hypoxia and normoxia (section 2.1.1) then incubated with different stimuli for 18 h under 5% CO2 and 37 
°C. The supernatant was collected and assayed for TNF-α and IL-10 by ELISA (section 3.2.4). Data are 
expressed as means ± SEM for three separate experiments (passage numbers 28, 30 and 33; n = 3) with 
triplicate measurements. * indicates significant differences from unstimulated cells, for each treatment, 
bars with different lower case letter are significantly different (two-way ANOVA, P < 0.05). 
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3.3.7 Induction of apoptosis in differentiated HL-60 cells 
Neutrophil-like cells obtained by differentiation of HL-60 cells were incubated with and 
without TNF-α and H2O2 as stimuli to induce apoptosis. Treatment with 10 ng ml
-1
 
TNF-α led to a statistically significant decrease in cell viability as measured by trypan 
blue uptake (one-way ANOVA, P = 0.0016). There was no change in cell viability with 
50 and 100 ng ml
-1 
TNF-α  (one way ANOVA, P > 0.05) compared to the control (Fig. 
3.13A). Cell apoptosis was confirmed by measurement of caspase 3/7 in neutrophil-like 
cells (Fig. 3.14A). TNF-α (10 ng ml-1) caused a significant increase in caspase 3/7 
activity (Kruskal-Wallis, P = 0.0264) compared to the control. Fig. 3.15 shows 
examples of time courses of the fluorescence intensity in caspase 3/7 assays. At 50 and 
100 ng ml
-1
 TNF-α, a significant increase in caspase 3/7 activity was also found in 
neutrophil-like cells compared to the control (Fig. 3.14A). In common with treatment 
with 10 ng ml
-1
 TNF-α, treatment with H2O2 at a concentration of 33 µM significantly 
decreased cell viability (one-way ANOVA, P = 0.001; Fig. 3.13B), and significantly 
increased caspase 3/7 activity (Kruskal-Wallis, P = 0.0268), but less than was observed 
with TNF-α (Fig. 3.14B). At high concentrations (66 and 132 µM) of H2O2 cell viability 
was also significantly decreased but was accompanied by a significant decrease in 
caspase 3/7 activity compared to the control (Fig. 3.14B). Again, the data presented 
were from a single experiment due to the high reagent cost involved. However, from 
these preliminary results, the effect TNF-α (10 ng ml-1) on inducing apoptosis was 
further investigated with triplicate experiments (Fig. 3.15). 
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Fig. 3.13 Effects of H2O2 and TNF-α on the viability of neutrophil-like cells. Neutrophil-like cells were 
incubated with H2O2 (A) or TNF-α (B) to induce apoptosis for 3 h at 37 C; viability was assayed by 
trypan blue dye exclusion (section 2.1.5). Data are expressed as mean ± SEM for a single experiment 
(passage number 35; n = 1) with triplicate measurements. 
* 
indicates a significant difference within this 
experiment only compared to the control (one-way ANOVA, P < 0.05). 
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Fig. 3.14 Effects of H2O2 and TNF-α on caspase 3/7 activity in neutrophil-like cells. Neutrophil-like cells 
were incubated with H2O2 (A) or TNF-α (B) to induce apoptosis for 3 h at 37 C after which caspase 3/7 
activity was measured over 18 h (section 3.2.5). Data are expressed as mean ± SEM for a single 
experiment (passage number 35; n = 1) with triplicate measurements, bars with different letters are 
significantly different (ANOVA or Kruskal-Wallis, P < 0.05). 
 
 
Fig. 3.15 Regression analysis illustrating the relationship between time and the production of the 
fluorescent product of reaction catalysed by caspase 3/7 in TNF-α induced apoptosis. Neutrophil-like 
cells were incubated with 10 ng ml
-1
 TNF-α to induce apoptosis for 3 h at 37 C after which caspase 3/7 
activity was measured (section 3.2.5.1). Data are expressed as mean ± SEM for three separate 
experiments (passage numbers 36, 38 and 40; n = 3) with triplicate measurements. 
  
 96 
 
3.4 Discussion 
Pre-treatment of HL-60 cells with 1 µM ATRA demonstrated a maximal differentiation 
as indicated by a number of measurable physiological and biochemical changes, which 
included a decrease in cell density, increased superoxide production and alterations in 
cell morphology compared to undifferentiated cells. The other retinoid, 9-cis RA (at 1 
µM), and 1.25% DMSO also significantly inhibited cell proliferation. When a 
combination of ATRA and 9-cis RA at 1 µM was added, there was no synergistic effect 
on the inhibition of cell proliferation. Possible explanations for this might be (1) that the 
two in combination may be mutually inhibitory, by modulating retinoid binding to the 
retinoid X receptors (RXRs) which play a key role in retinoid signalling and retinoid 
target genes (Mangelsdorf et al., 1992, Leblanc and Stunnenberg, 1995), or (2) due to 
differences in the metabolism of each retinoid as different retinoid-specific enzymes are 
involved. Another possible explanation is that the investigation of the effect of the 
retinoids was limited to 1 µM. Therefore future experiments using either of the 
individual retinoids or both in combination (at a concentration lower than 1 µM) may be 
potentially useful. Cell proliferation was decreased within about 2 days from the 
incubation with ATRA, suggesting that exposure for 2 days is a minimal requirement to 
promote terminal differentiation in a significant fraction of HL-60 cells; this may be 
explained by the sensitivity of cells to the inducer only during a particular phase of the 
cell division cycle (Tarella et al., 1982). The mechanisms responsible for ATRA-
induced HL-60 cells granulocyte differentiation are not well defined. It has been 
suggested that the endogenous retinoic acid receptor alpha (RAR-alpha) plays an 
important role (Collins et al., 1990). Moreover, some factors are known to be 
upregulated after ATRA exposure including genes associated with cell-cycle arrest, the 
ubiquitin/proteasome system, and the JAK/STAT, cAMP/PKA, PKC and calmodulin 
signalling pathways (Zhang et al., 2000). 
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Based on these results, the decision was made to use ATRA at 1 µM, so initial 
experiments were aimed at testing the function of these cells as a good model for 
neutrophils in in vitro studies. Cells differentiated with ATRA demonstrated a high 
percentage of NBT reduction. This was supported by an increase in their ability to 
phagocytose Staphylococcus aureus NCIMB 6571. This led to the conclusion that 
neutrophil-like cells have phagosomal respiratory burst activity. Differentiated HL-60 
cells have been found to generate superoxide in response to PMA and zymosan at early 
stages during differentiation; this occurred prior to morphological changes being 
observed, although the superoxide levels never reached those observed in primary 
neutrophils (Newburger et al., 1979). This may be explained by a low level of 
expression of the components required for activity, dysfunction of components or that 
only a percentage of the total cell population is responsive to the differentiation-
inducing agent. In addition, Nordenfelt et al. (2009) demonstrated that ATRA-
differentiated HL-60 cells possess azurophilic granules, while lacking the specific 
secondary granules with their associated oxidase components, therefore these cells 
develop an ability to mount a plasma membrane oxidative burst in the vicinity of 
forming phagosomes. 
The reasons for using HL-60 cells as a model for neutrophils are as follows: they are 
multipotent; the cells have the ability to undergo spontaneous differentiation in culture; 
they exhibit features which have also been identified in neutrophils; and they provide a 
continuous source of neutrophil-like cells. This is critically important for assays that 
require relatively large numbers of cells. However, HL-60 cells are a leukaemic cell line 
which is defined by their abnormalities in proliferation, differentiation and apoptosis. 
Therefore, this model may not suitable for some experiments of terminal differentiation 
events. It is also obvious that a terminally differentiated HL-60 cell does not exhibit the 
exact phenotype of its normal counterpart (Tagliafico et al., 2002), which can make data 
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interpretation difficult. Additionally, these cells lose differentiation capacity with 
increasing passage number, for example 50 passages (Palis et al., 1988). Consequently, 
if they are cultured for extended periods of time, the data may be non-consistent. 
Enhanced respiratory burst activity and phagocytosis are not the only functions that can 
be exhibited by neutrophil-like cells. A preliminary study was carried out to test a range 
of possible stimuli; the results of this were broadly consistent with effects already 
reported in the literature (Kubin et al., 1994, Grande et al., 1995). From this PMA and 
LPS were selected as being suitable stimuli for further investigation. Stimulation of 
ATRA- or 9-cis differentiated cells with PMA and LPS at 100 ng ml
-1
 caused a 
significant increase in TNF- production but less so than in human neutrophils. 
Consistent with previous studies, the present study provides further evidence that 
neutrophil-like cells display complete functional activation (De Gentile et al., 1994, 
Dubois et al., 1994). Grande et al. (1995) reported the expression of IL-1α, IL-1β, IL-3, 
IL-6 and TNF-α from ATRA-differentiated cells and LPS has been shown to be a potent 
stimulator (Bemelmans et al., 1994, Leeuwenberg et al., 1994). Differentiated HL-60 
cells produce IL-1β and IL-8 in response to stimuli such as LPS (Shuto et al., 2007). 
There are two possibilities as to why LPS could lead to activation of neutrophils: (a) via 
prolonged neutrophil life span and delayed apoptosis, and (b) via enhanced protein 
kinase C activity that is responsible for priming effects in neutrophils (Wightman and 
Raetz, 1984). This study focused on the effects of stimulation of neutrophil-like cells 
under normoxic conditions, but there is also a potential effect of elevated oxygen 
concentration on stimulus-induced cytokine release. In common with previous results, 
pre-treatment of neutrophil-like cells with LPS or PMA (100 ng ml
-1
) after exposure to 
hyperoxia or hypoxia resulted in a decrease in pro-inflammatory TNF-α, while anti-
inflammatory IL-10 levels decreased only after hyperoxia treatment. It has been shown 
that pre-treatment with hyperoxia decreases cytokine levels (for example TNF-α) 
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compared to normoxia as elevated oxygen concentrations inhibit stimulus-induced 
signal transcription, or translation (Granowitz et al., 2002), or enhance sensitivity of the 
cells to hyperoxia-mediated apoptosis. A decrease in TNF-α levels was also found post 
hypoxia, these results raised the possibility that hypoxia modulates transcription factors 
for example NF-B or HIF-1 α which may affect cytokines levels, depending on the cell 
type, and duration of hypoxic exposure (Matuschak et al., 2010). This is in agreement 
with Fritzenwanger et al. (2011) who demonstrated that short-term hypoxia decreased 
TNF-α concentrations in monocytes and INF-γ in CD4+ T lymphocytes (Zagόrska and 
Dulak, 2004). These findings explain the regulatory roles of HIF-1 under hypoxic 
conditions and its association with decreased levels of pro-inflammatory cytokines, and 
support the association between HIF and NF-B signalling in short term hypoxia. 
A wide range of stimuli have been used to induce apoptosis, some of which are 
components of pathological inflammatory diseases, such as TNF-α (Windsor et al., 
1993) or chemical agents such as H2O2 (Lundqvist-Gustafsson and Bengtsson, 1999). A 
preliminary study was carried out to test if possible stimuli induce apoptosis. From this, 
TNF-α (10 ng ml-1) was selected as being a suitable stimulus for further investigation. 
TNF-α (10 ng ml-1) treatment led to a decrease in viability and an increase in caspase 
3/7 activity in neutrophil-like cells. These results are consistent with the effects of TNF-
α previously demonstrated in neutrophils (Takeda et al., 1993). TNF-α-mediated 
regulation of neutrophil apoptosis has been shown to be concentration-dependent; with 
high concentrations, TNF-α induces apoptosis via initiation of death signals via the 
TNF-α receptor, and activation of the apoptotic caspase cascade with degradation of the 
anti-apoptotic protein, Mcl-2 (Van Den Berg et al., 2001). TNF-α at low concentrations 
enhances cell survival and activity through activation of NF-B (Liu et al., 1996b) and 
expression of the anti-apoptotic protein Bfl-1 (Cross et al., 2008). TNF-α also initiates a 
caspase-independent pathway in neutrophils (Maianski et al., 2003). In the present 
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experiments, addition of 33 µM H2O2 to neutrophil-like cells also increased caspase 3/7 
activity. However, with higher concentrations there was a decrease in activity perhaps 
as necrotic effects become more apparent than apoptotic effects with the increase of 
oxidative stress (Takeda et al., 1999). 
3.4.1 Conclusion 
ATRA induced differentiation of HL-60 cells into neutrophil-like cells. HL-60 cell 
differentiation is marked by a number of measurable biochemical changes which 
include a decrease in proliferation, increased superoxide production and alterations in 
cell morphology. ATRA-differentiated cells displayed multiple functional responses 
upon differentiation similar to those observed in mature neutrophils. This suggests that 
this cell line is a useful model system for in vitro studies of neutrophils, as a large 
number of cells can be easily obtained, although there are limitations to this model 
system such as the abnormalities in proliferation and differentiation which are 
associated with HL-60 cells being a leukaemic cell line. 
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CHAPTER FOUR 
THE EFFECT OF HBO ON 
ANTIMICROBIAL DEFENCE 
MECHANISMS IN NEUTROPHILS 
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Abstract 
The persistent presence of neutrophils is a feature of chronic wounds. The detrimental 
effects of neutrophils may be due to released oxidants, ROS and destructive enzymes. 
Hyperbaric oxygen (HBO) therapy, the intermittent inhalation of 100% oxygen at 
pressures greater than atmospheric, is an effective treatment for various inflammatory 
conditions, including chronic wounds, but the mechanisms involved are not well 
understood particularly with respect to neutrophils. In this study, HL-60 cells 
differentiated by ATRA were used as an in vitro neutrophil model to explore the effects 
of a single 90 min exposure to normoxia, hypoxia, normobaric hyperoxia, hyperbaric 
normoxia and hyperbaric oxygen on antimicrobial functions and degranulation. 
Differentiated HL-60 cells were treated with PMA to stimulate the respiratory burst 
activity post-exposure to the different treatments. A single 90 min HBO exposure 
caused a significant increase in the oxidative burst activity of neutrophil-like cells as 
shown by superoxide (O2
•-
) release (cytochrome c reduction; Kruskal-Wallis, P = 0.019), 
NBT staining (Kruskal-Wallis, P = 0.011) and H2O2 production (Kruskal-Wallis, P = 
0.016). In addition, phagocytosis of Staphylococcus aureus was increased (one-way 
ANOVA, P < 0.05). Antimicrobial effects of HBO were also accompanied by a 
significant increase in MPO production (Kruskal-Wallis, P = 0.015). Although no 
consistent pattern was observed, both hyperoxia and pressure alone seemed to 
contribute to the increase in antimicrobial activity induced by HBO in these neutrophil-
like cells. In conclusion, this data may go some way to explaining the effectiveness of 
HBO in the treatment of chronic wounds 
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4.1 Introduction 
Neutrophils consume oxygen to maintain the NADPH oxidase-driven respiratory burst 
which generates ROS (Hampton et al., 1998). Hypoxia is a feature of chronic wounds, 
where impaired microcirculation in wound area and increased oxygen consumption by 
cells such as leukocytes result in low oxygen levels especially at the centre of the 
wound. With a Km for O2 of 40-80 mm Hg, NADPH oxidase displays a relative 
resistance to hypoxia (Gabig et al., 1979). Even at infected sites where the PO2 is 
approximately 25 mm Hg (equivalent to 3% O2), neutrophils are still able to activate the 
respiratory burst to kill microorganisms but with limited capacity (Gordillo and Sen, 
2003, Hopf and Rollins, 2007). Superoxide production at 1% O2 has been shown to be 
more than 75% of the level produced at 21% O2 (Gabig et al., 1979). This suggests that 
at these oxygen levels, NADPH oxidase is still able to function although with reduced 
activity. Furthermore, in chronic wound conditions, inflammatory cytokines (for 
example TNF-α) and infection, may affect neutrophil oxidative burst activity (see 
section 1.4.2). In vitro, LPS enhances oxidative stress produced by neutrophils in a 
dose-dependent manner (Bohmer et al., 1992) with a significant effect at 1 ng ml
-1
, 
which is much higher than the levels present in chronic wound. TNF-α is only able to 
activate oxidative burst activity in neutrophils in vitro at concentrations of 250 ng ml
-1
 
or above (Berkow et al., 1987); again, this concentration is much higher than the levels 
found in chronic wounds. Priming of neutrophils with TNF-α at a concentration of 215 
ng ml
-1
 has been shown to significantly enhance the FMLP or LPS-induced respiratory 
burst activity, resulting in increased production of hydrogen peroxide (Wiemer et al., 
2010). Excessive neutrophil recruitment to the chronic wound site and high levels of 
inflammatory stimuli such as LPS and TNF-α, result in high levels of neutrophil 
degranulation leading to prolonged inflammation (Lee et al., 1993). Higher levels of 
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elastase, collagenase (MMP-8) and gelatinase (MMP-9) were observed in chronic 
wounds compared to acute wounds (Nwomeh et al., 1999). These MMPs cleave 
collagen types I, III, IV, V, VII, and destroy the growth factors necessary for wound 
healing such as bFGF and VEGF, thus impairing the wound healing process (Ai et al., 
2007).  
Investigations examining the effects of HBO on the respiratory burst of neutrophils 
have yielded conflicting results (Thom et al., 2008, Labrouche et al., 1999, Kalani et 
al., 2002, Jüttner et al., 2003). For example, HBO has been demonstrated to enhance 
neutrophil function in some infections through the correction of tissue hypoxia and 
providing the optimal oxygen tension for the oxidative burst (Labrouche et al., 1999, 
Mader et al., 1980). HBO enhances respiratory burst activity in neutrophils by 
increasing NADPH oxidase enzymatic activity, the major enzymatic source of ROS 
(Acker and Acker, 2004). NADPH oxidase is a complex enzyme composed of at least 
five components, the membrane-bound components being the flavocytochrome b558 and 
p22
phox
, which provide binding sites for cytosolic NADPH oxidase (Segal, 2005). The 
cytosolic components are p67
phox
, p47
phox 
and p40
phox
. Upon neutrophil activation, the 
cytosolic components translocate to the plasma membrane, to form the active oxidase 
(Roos et al., 2003). Recent evidence suggests that NADPH oxidase is involved in 
wound healing by modulating cell proliferation (survival), apoptosis, angiogenesis and 
fibrosis. After tissue injury, factors involved in haemostasis, coagulation (e.g. thrombin 
and PAF), and inflammation (e.g. TNF-α, IL-1β) may provide a local stress 
environment that trigger NADPH oxidase dependent ROS production (Holland et al., 
1998, Monaco and Lawrence, 2003). Moreover, inhibiting NADPH oxidase activation 
or down-regulating NADPH oxidase expression suppressed thrombin-induced 
mitogenic effects on vascular smooth muscle cells (Patterson et al., 1999). Exposure to 
hyperoxia can activate NADPH oxidase; Brueckl et al. (2006) demonstrated that 
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hyperoxia induced a rapid activation of NADPH oxidase in lung capillary endothelial 
cells, through intracellular Ca
2+
 elevation and Rac1 activation. Investigations of the 
effect of HBO on the NADPH oxidase complex are limited. In the pancreas of diabetic 
rats, exposure to HBO induces further ROS production and apoptosis through up 
regulation of expression of genes of subunits related to the NADPH oxidase complex 
(p47
phox
 mRNA expression; Matsunami et al., 2011). However, a study in a rat 
subarachnoid haemorrhage model demonstrated that HBO decreased NADPH oxidase 
expression (gp91
phox
 subunit), activity and the level of oxidative stress at 24 h after 
subarachnoid haemorrhage (Liu et al., 2007). This may be explained by the effects of 
HBO on the regulation of NADPH oxidase activators, including protein kinase C, 
cytokines and angiotensin II (Vignais, 2002) or oxygen sensing agents such as hypoxia-
inducible factor-1, HIF-1α (Huang et al., 1998; Fig.4.1). 
There is limited work examining neutrophil degranulation following HBO treatment. In 
a study using rat neutrophils, HBO (3 ATA for 45 min) had no effect on elastase release 
and MPO activity, suggesting no effect on primary granule release (Thom, 1993). 
Another study by Kang et al (2002) demonstrated that HBO increased the 
myloperoxidase content in the lung, and this may be attributed to an increase in 
neutrophil infiltration into lung tissue. 
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Fig. 4.1 The effect of HBO on NADPH oxidase. Increased tissue oxygenation enhances growth factor 
levels (e.g. VEGF and PDGF) and vasoconstriction. Upon binding of these factors to their receptor 
tyrosine kinases (RTK) or stimulation by G-protein coupled receptor (GPCR) agonists such as 
angiotensin II, NADPH oxidase is activated. ROS oxidize the essential cysteine residues of protein 
tyrosine phosphatases (PTPS), thereby inactivating these enzymes, and leading to enhanced activation of 
mitogen-activated protein kinases such as ERK1/2, MAPK and P38/JNK. NADPH oxidase-derived ROS 
may also elevate intracellular Ca
2+
 by enhancing the Ca
2+
 entry through the cell membrane or promoting 
Ca
2+
 release from the intracellular stores or activating HIF degradation; all these mechanisms may be 
involved in promoting cell proliferation, fibrosis and angiogenesis, which are critical components of 
tissue in healing processes (Ushio-Fukai, 2006, Sauer and Wartenberg, 2005, Datla et al., 2007, Gorin et 
al., 2004). 
 
The effect of HBO on neutrophil oxidative burst activity has been examined in several 
studies but there is no agreement on its effect, while the investigation of the effects of 
HBO on degranulation is limited. This study aimed to examine the effect of exposure to 
HBO (90 min at 2.4 ATA) on both respiratory activity and degranulation in neutrophil-
like cells. 
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4.2 Materials and methods 
4.2.1 Experimental design 
To investigate neutrophil function this study was divided into two parts. The first was to 
explore the effects of a 90-min exposure to HBO, pressure, hyperoxia, and hypoxia in 
respiratory function of neutrophil-like cells in vitro. Assays included quantification of 
superoxide production; NBT reduction (section 2.1.2); extracellular H2O2 levels (section 
2.1.3); measurement of Staphylococcus aureus NCIMB 6571 phagocytosis (section 
2.1.4); and nitrite (NO2
-
); and nitrate (NO3
-
; quantification as detailed below). The 
second part aimed to explore the effect of a 90-min exposure to 5 different treatments 
on MPO to determine the degranulation of neutrophil-like cells in vitro. The total 
glutathione (GSH) in neutrophil-like cells was also measured to assess redox status. The 
measured endpoints (in triplicate) for three separate experiments with a different 
passage number of HL-60 cells were used. HL-60 cells were cultured (section 3.2.2) in 
RPMI-1640 medium supplemented with 10% (v/v) fetal calf serum (FCS), containing 2 
mM glutamine, 100 U ml
-1
 penicillin and 100 µg ml
-1
 streptomycin in Corning 
polystyrene vented 75 cm
2
 tissue culture flasks. Cells were maintained at 37 °C in 5% 
CO2 (balance air); passages 20 through to 45 were used for experiments. Differentiation 
of HL-60 cells was induced by incubation of 2.5 × 10
5 
cells ml
-1
 with ATRA (1 µM) for 
5 days after which they were harvested for further assays (section 3.2.2). Cells were 
added to 96-well plates and divided into 5 different treatment groups. The normoxia 
treatment (control) was exposed to 21% O2 at 1 ATA; the hypoxia group was exposed 
to 5% oxygen at 1 ATA, the hyperoxia treatment was exposed to 95% O2 at 1 ATA; the 
pressure group was exposed to 8.8 % O2 at 2.4 ATA and HBO treatment was exposed to 
97.9% O2 at 2.4 ATA. Cells were treated for 90 min at room temperature (section 2.1.1). 
For the measurements of respiratory burst activity, cells were stimulated immediately 
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post-treatment with phorbyl myristate acetate (PMA) Sigma (Poole, UK; Fig. 4.2). The 
PMA solution was prepared by dilution with HBSS of a stock solution of 1 mg ml
-1
 in 
DMSO.  
 
Fig. 4.2 Diagram showing the experimental design. ATRA-differentiated HL-60 cells were exposed to 
different treatments, stimulated with 100 ng ml
-1
 PMA, and assayed for antimicrobial functions. Time of 
exposure, stimulus and end points are indicated. 
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4.2.2 Measurement of superoxide production via cytochrome c reduction 
The reduction of ferricytochrome c (Fe
3+ 
cytochrome c) to ferrocytochrome c (Fe2+ 
cytochrome c) by O2
•-
 produced by neutrophil-like cells can be monitored at 550 nm, in 
the presence and absence of superoxide dismutase (SOD) as a negative control. The 
absorbance of samples with SOD present is subtracted from the absorbance of samples 
with no SOD present to determine the proportion of cytochrome c reduction that is 
SOD-inhibitable, and therefore O2
•-
-dependent (Edwards, 1996). 
Ferricytochrome c (5 µl of 2 mM dissolved in potassium phosphate buffer; Sigma C-
7752) was added to each well in a 96-well plate followed by 50 µl of neutrophil-like 
cell suspension (10
6
 cells ml
-1
 in HBSS), 145 µl of HBSS, and 10 µl of 100 ng ml
-1
 
PMA. The PMA solution was prepared by dilution with HBSS of a stock solution of 1 
mg ml
-1
 in DMSO. Upon addition of the PMA, the absorbance at 550 nm was monitored 
in a plate reader (VersaMax, Molecular Devices, Sunnyvale, CA, USA) for 45 min at 
37 °C. Two controls were used, one in which the stimulus was replaced with 10 µl of 
HBSS, and the other in which the stimulus was replaced with 2 µl of 3000 U ml
-1
 SOD 
in ammonium sulphate suspension and 8 µl of HBSS (Sigma S-3409). The reduction of 
cytochrome c was calculated using an extinction coefficient of 21.1 mM
-1
 cm
-1
 and a 
path length of 0.66 cm. 
4.2.3 Assay of NO2
-
/ NO3
-
 
Griess reagent together with nitrate reductase is widely used for determining nitrate and 
nitrite (Schmidt and Kelm, 1996.). It involves the reaction of NO2
-
 at low pH with 
sulphanilamide (SAN). The resulting diazonium ion then reacts with a coupling reagent 
such as N-(1-naphtyl)-ethylenediamine (NED) to form an azo dye. The absorbance of 
the azo dye can be measured at 550 nm. Subsequently, the NO2
-
 can be converted to 
NO3
-
 by the use of NADPH-dependent nitrate reductase (NR). NO3
-
 can also be 
 110 
 
measured using Griess reagent. Aliquots (100 µl) of neutrophil like-cells in a suspension 
containing 1 × 10
6
 cells ml
-1
 in phenol red-free HBSS were added to the wells of a 96-
well plate and stimulated with PMA (100 ng ml
-1 
) for 30 min at 37 ºC. The plate was 
centrifuged at 200 × g to remove cells and the supernatant from each well was 
transferred to a new plate. The assay mixture was prepared by mixing (per ml) 0.72 ml 
of 50 mM sodium phosphate buffer (pH 7.4), 0.08 ml of 1.6 U ml
-1
 nitrate reductase 
(NR, Sigma N7265), and 0.2 ml of 1 mM NADPH (prepared fresh in phosphate buffer 
each day, stored on ice during use). Fifty microlitres of the NO3
-
 standard (up to 20 µM) 
or supernatant were mixed with 50 µl of the assay mixture to give a final concentration 
of 0.1 U ml
-1
 NR and 0.2 mM NADPH in the wells of a 96-well plate, and then the plate 
was incubated for 30 min at 20 ºC to allow completely reduction of NO3
-
 to NO2
-
. The 
diazotization reaction was started by adding 100 µl of sulphanilamide (1% [w/v] in 1 M 
HCl), followed by 100 µl of 0.1% NED 30-90 s later. The absorbance at 550 nm was 
measured a few minutes later in a plate reader (VersaMax, Molecular Devices, 
Sunnyvale, CA, USA; Moody and Shaw, 2006). A standard curve was plotted for the 
NO3
-
 and NO2
-
 (0-20 µM) to calculate the nitrite and nitrate concentration in the sample 
(Fig. 4.3). 
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Fig 4.3 Nitrite and nitrate standard curves. Nitrite (NO2
-
) and nitrate (NO3
-
) standards (0.5 to 20 µM) were 
prepared in dH2O. The data points are the means of triplicate measurements ± SEM. 
 
4.2.4 Myloperoxidase (MPO) assay 
MPO is stored in the primary granules of neutrophils and catalyses the conversion of 
H2O2 and Cl
-
 into the potent oxidant hypochlorous acid (HOCl), which can be 
quantitated by trapping the generated species with the β-amino acid, taurine. The 
resultant stable product, taurine chloramine, can be quantitated by the ability of iodide 
to catalyse its oxidation reactions with suitable chromophores such as 
tetramethylbenzidine (TMB), and absorbance can be measured at 650 nm (Dypbukt et 
al., 2005, Weiss et al., 1982). 
MPO activity was measured essentially as described by Dypbukt et al. (2005). 
Neutrophil-like cells were re-suspended in 10 mM phosphate buffer (pH 7.4), 
containing 140 mM sodium chloride and 10 mM potassium chloride. Taurine was then 
added to the cells (25 μl of 5 mM to 100 μl of 2 × 106 cells ml-1 in 1.5 ml microfuge 
tubes) and pre-incubated for 15 min at 37 °C. Finally, 125 μl of 100 ng ml-1 PMA, the  
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stimulus to release MPO, was added and the mixture incubated for 30 min at 37 °C. At 
the end of the incubation period, catalase (10 μl of 40 U ml-1) was added and the tubes 
placed on ice, after which they were centrifuged at 13,000 × g for 2 min to remove cells. 
The supernatants from each tube were transferred to a new plate. Taurine chloramine 
was detected by rapidly mixing 200 µl of supernatant or standard with 50 µl of 
developing reagent which was composed of 2 mM TMB in 400 mM sodium acetate 
buffer, pH 5.4, containing 10% dimethylformamide (DMF) and 100 µM sodium iodide. 
This solution was prepared by dissolving TMB in 100% DMF, diluting with acetate 
buffer to obtain the desired final concentration of TMB, and then adding sodium iodide. 
Formation of a blue product indicated the presence of chloramine. Five minutes after 
mixing the absorbance was recorded at 650 nm. A standard curve was plotted for the 
initial concentrations of hypochlorous acid (10-100 µM) versus the recorded increase in 
absorbance of the blue product to calculate the hypochlorous acid concentration in the 
samples (Fig. 4.4). 
 
Fig 4.4 Standard curve for the detection of MPO using HOCl. Standards (10 to 100 µM HOCl) were 
prepared in dH2O. The data points are the means of triplicate measurements ± SEM. 
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4.2.5 Measurement of total glutathione 
The usual procedure for total glutathione measurements in biological sample involves 
homogenization (if necessary), deproteination, and non-specific or specific 
measurement of thiol content, the latter being used for cases in which precise 
knowledge of the reduced glutathione (GSH) content is required (Kosower and 
Kosower, 1987). The thiol group analysis is based on the use of 5, 5-dithiobis-2-
nitrobenzoic acid (DTNB). In this assay, oxidized glutathione (GSSG) is reduced to 
GSH by NADPH in the presence of glutathione reductase (GR) and the total GSH is 
sequentially oxidised by DTNB. The rate of 2-nitro-5-thiobenzoic acid formation is 
monitored at 412 nm. 
Aliquots of neutrophil-like cell suspension (100 µl), containing 1 × 10
6 
cells ml
 -1
 were 
added to the wells of a 96-well plate after treatment with HBO, pressure control, 
hyperoxia, hypoxia or normoxia for 90 min. The cells were stimulated by the addition 
of 100 ng ml
-1
 PMA for 30 min; the total level of glutathione in the cell lysate (obtained 
by repeated freezing/thawing cells) was determined by the glutathione reductase 
enzyme recycling method as described by Adams et al. (1983). The reagent volumes 
were optimized to conduct this assay in 96-well plates. Samples or standard solutions of 
GSH (up to 20 µM) were mixed in a 1:1 ratio with buffered DTNB (10 mM DTNB in 
100 mM potassium phosphate, pH 7.5, containing 5 mM potassium 
ethylenediaminetetraacetate, EDTA). Buffer containing glutathione reductase (210 µl 
containing 0.6 U, Sigma G3664) and 40 µl of DTNB- treated samples were mixed in the 
wells of a 96 well plate. After equilibration for 1 min the reaction was started by adding 
60 µl of 1 mM NADPH, and the absorbance at 412 nm was measured for 10 min using a 
plate reader (VersaMax, Molecular Devices, Sunnyvale, CA, USA). In this method the 
rate of increase of A412 is proportional to the concentration of total glutathione (i.e. 
GSSG and GSH). 
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4.2.6 Statistical analysis 
All data were analysed using Statgraphics Centurion XVI software (Stat Point 
Technologies, Inc.). Data are expressed as means ± SEM for 3 separate experiments. 
The Andersen-Darling test for normality was used followed by Levene’s test to check 
that there were no significant differences in variance between the groups. Where 
appropriate, data were log10 transformed. Data were analysed using ANOVA (one-way 
or two-way ANOVA) or Kruskal-Wallis. After ANOVA, post hoc analysis using 
Tukey’s test was carried out. P value of < 0.05 was considered significant throughout.  
4.3 Results 
4.3.1 HBO enhances respiratory burst activity by differentiated HL-60 cells 
ATRA-differentiated HL-60 cells were exposed to hyperbaric hyperoxia (97.9% O2, 2.1% 
CO2 at 2.4 ATA), hyperbaric normoxia (8.8% O2 at 2.4 ATA), normobaric hyperoxia 
(95% O2, 5% CO2 at 1 ATA) or normobaric normoxia (21% O2, 5% CO2 at 1 ATA) for 
90 min at 20 °C. After exposure respiratory burst activity was assessed by measuring 
superoxide (O2
•-
) production using both cytochrome c reduction by quantifying the 
percentage of NBT-stained cells and by measuring H2O2 production using the 
horseradish peroxidase/homovanillic acid (HRP/HVA) method. In all cases, PMA was 
used to stimulate the neutrophil-like cells. 
Addition of PMA caused an significant increase in production of O2
•-
, indicating the 
successful differentiation to neutrophil-like cells compared to unstimulated cells (pair-
wise Mann-Whitney, P < 0.05; Fig 4.5A). For superoxide production, no treatment 
effect (Kruskal-Wallis, P > 0.05) was deserved on the O2
•-
 production in unstimulated 
cells (0.32 ± 0.06, 0.28 ± 0.11, 0.26 ± 0.14 and 0.27 ± 0.13 nmol per 10
6 
cells for HBO, 
pressure, hyperoxia and hypoxia, respectively) compared with normoxia (0.23 ± 0.13). 
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Exposure of PMA-stimulated cells to HBO (90 min at 2.4 ATA, at 20 °C) caused a 
significant increase in O2
•-
 production while hypoxia produced a significant decrease 
compared to normoxia (Kruskal-Wallis, P = 0.019; Fig. 4.5A). Pressure alone or 
hyperoxia did not lead to a change in PMA-induced O2
•-
 production (2.19 ± 0.25 and 
2.28 ± 0.04 nmol per 10
6 
cells, respectively) compared with normoxia (1.95 ± 0.10; Fig. 
4.5A).  
Stimulation of cells with PMA also resulted in an increase in the percentage of cells 
stained with NBT compared to unstimulated cells (pair-wise Mann-Whitney, P < 0.05). 
A significant increase in the percentage of cells stained with NBT was found after 
exposure to HBO, pressure or hyperoxia compared to the normoxia (Fig. 4.5B; Kruskal-
Wallis, P = 0.011). However, there was no effect on the percentage of cells stained with 
NBT after hypoxia (38.8 ± 5.5% for stimulated cells) compared with normoxia (48.4 ± 
3.2% for stimulated). Similar to O2
•-
 production, no treatment effect (Kruskal-Wallis, P > 
0.05) was observed on the percentage of unstimulated cells stained with NBT (34.3 ± 
9.3, 33.9 ± 5.5, 35.9 ± 3.9, and 18.5 ± 1.6% for HBO, pressure, hyperoxia and hypoxia, 
respectively) compared with normoxia (24.2 ± 2.1%). 
Respiratory burst activity was further assayed by measuring H2O2 production by 
neutrophil-like cells. Significantly higher H2O2 production by stimulated differentiated 
HL-60 cells was observed compared to unstimulated cells (pair-wise Mann-Whitney, P 
< 0.05; Fig. 4.6), as measured by oxidation of HVA. No significant effect was found on 
H2O2 production by unstimulated cells after different treatments (0.9 ± 0.1, 1.5 ± 0.1, 
0.8 ± 0.1 and 0.5 ± 0.1 nmol per 10
6
 cells for HBO, pressure, hyperoxia, and hypoxia, 
respectively; Fig. 4.6) compared with normoxia (0.8 ± 0.1 nmol per 10
6
 cells). Post-
HBO, there was a significant increase in the H2O2 release from PMA-stimulated cells; 
the same was also seen post exposure to pressure alone compared to normoxia (Kruskal-
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Wallis, P = 0.016; Fig. 4.6). However, there were no effects on the H2O2 release from 
PMA-stimulated cells after hyperoxia (5.5 ± 0.3 nmol per 10
6
 cells) compared to 
normoxia (5.6 ± 0.6 nmol per 10
6
 cells). Similar to superoxide production, H2O2 levels 
were significantly decreased after hypoxia in PMA-stimulated cells to (1.8 ± 0.5 nmol 
per 10
6
 cells). 
Phagocytic activity with Staphylococcus aureus NCIMB 6571 was measured in 
differentiated HL-60 cells (section 2.1.4). A significant increase in the percentage 
phagocytosis was seen post-HBO, pressure and hyperoxia (one-way ANOVA, P = 
0.0002), and phagocytic index post HBO and hyperoxia (one-way ANOVA, P < 
0.00005), but not post-pressure (68.1 ± 1.1, phagocytosis index). NO change was 
observed in the percentage phagocytosis and phagocytosis index post hypoxia (19.4 ± 
3.2, % phagocytosis and 49.4 ± 6.1, phagocytosis index; Fig. 4.7A and B) compared 
with normoxia (24.8 ± 1.3, % phagocytosis and 56.2 ± 5.3, phagocytosis index). 
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Fig. 4.5: O2
•- 
release and % NBT reduction by neutrophil-like cells exposed to normoxia, hypoxia, 
hyperoxia, pressure or HBO. ATRA-differentiated cells were exposed to a range of conditions for 90 min 
(section 2.1.1) after which superoxide production was detected either using cytochrome c (A) (as 
described in section 4.2.2) or NBT (B) (as described in section 2.1.2) in the presence or absence of PMA. 
Data are means ± SEM for three separate experiments (passage numbers 20, 24 and 28; n = 3) with 
triplicate measurements. * indicate significant differences from unstimulated cells (Mann-Whitney, P < 
0.05), bars with different lower case letters indicate significant differences between different treatments 
for stimulated cells (Kruskal-Wallis, P < 0.05). 
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Fig 4.6 H2O2 production by neutrophil-like cells following exposure to normoxia, hypoxia, hyperoxia, 
pressure or HBO. ATRA-differentiated HL-60 cells were exposed to a range of conditions for 90 min 
(section 2.1.1). After exposure, cells were washed, stimulated with PMA and H2O2 levels in the medium 
were determined in both stimulated and unstimulated cells using HRP/HVA (section 2.1.3). Data are 
expressed as the amount of H2O2 produced per 10
6
 cells. Data are means ± SEM for three separate 
experiments (passage numbers 30, 32 and 34; n = 3) with triplicate measurements. * indicate significant 
differences from unstimulated cells (Mann-Whitney, P < 0.05), bars with different lower case letters 
indicate significant differences between different treatments for stimulated cells (Kruskal-Wallis, P < 
0.05). 
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Fig 4.7 Phagocytosis of Staphylococcus aureus NCIMB 6571 by neutrophil-like cells following exposure 
to normoxia, hypoxia, hyperoxia, pressure or HBO. ATRA-differentiated cells were exposed to a range of 
conditions for 90 min (section 2.1.1), after which they were incubated for 30 min with Staphylococcus 
aureus NCIMB 6571 and % phagocytosis  (A) and phagocytic index (B) were assessed (section 2.1.4). 
Data are means ± SEM for three separate experiments (passage numbers 39, 42 and 45; n = 3) with 
triplicate measurements. Bars with different lower case letters indicate significant differences between 
different treatments (one-way ANOVA, P < 0.05). 
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4.3.2 Effect of HBO on NOx production from differentiated HL-60 cells 
Nitric oxide (NO) production in neutrophil-like cells was evaluated by measuring the 
concentrations of its direct oxidation products, nitrite and nitrate (NO2
-
 + NO3
-
), in the 
media. Pre-treatment with 100 ng ml
-1
 PMA caused a significant increase in NO2
-
, NO3
- 
and NOx levels in neutrophil-like cells compared to unstimulated cells (pair-wise Mann-
Whitney, P < 0.05; Figs 4.8A, B and C). No treatment effects were found for 
unstimulated cells (Kruskal-Wallis, P = 0.65; Fig. 4.8A). Post-HBO, pressure and 
hyperoxia treatments, NO2
-
 levels increased significantly in PMA-stimulated cells 
(Kruskal-Wallis, P = 0.02) compared to normoxia (Fig. 4.8A). No-treatment effects 
were found on NO2
-
 level after exposure to hypoxia (0.054 ± 0.007 nmol per 10
6
 cells) 
compared to normoxia (0.052 ± 0.005 nmol per 10
6
 cells). 
Interestingly, the supernatant from PMA-stimulated cells contained much more NO3
-
 
than NO2
-
 levels as shown in Fig. 4.8B. No change was found on NO3
-
 levels (Kruskal-
Wallis, P = 0.11) in unstimulated cells after different treatments (0.34 ± 0.02, 0.33 ± 
0.02, 0.40 ± 0.03 and 0.32 ± 0.01 nmol per 10
6
 cells
 
for HBO, pressure, hyperoxia and 
hypoxia, respectively; Fig. 4.8B) compared to normoxia (0.34 ± 0.02 nmol per 10
6
 
cells). There was a statistically significant effect on NO3
-
 levels from PMA-stimulated 
cells after HBO and hypoxia exposure (Kruskal-Wallis, P = 0.02) compared to 
normoxia (Fig. 4.8B). There was no effect following treatment with pressure and 
hyperoxia (0.59 ± 0.05 and 0.73 ± 0.39 nmol per 10
6
 cells)
 
compared to normoxia (0.62 
± 0.04; Fig. 4.8B). 
No change was found on NOx (NO2
-
 + NO3
-
) levels in unstimulated cells after different 
treatments (Kruskal-Wallis, P = 0.13; 0.34 ± 0.01, 0.33 ± 0.01, 0.40 ± 0.02, 0.341 ± 
0.004 nmol per 10
6
 cells
 
for HBO, pressure, hyperoxia and hypoxia, respectively; Fig. 
4.8C). NOx levels showed a significant increase in PMA-stimulated cells after HBO and 
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hyperoxia exposure compared to normoxia (Kruskal-Wallis, P = 0.03). No significant 
effects were found on NOx levels in PMA-stimulated cells after exposure to pressure 
alone and hypoxia (0.68 ± 0.05 and 0.53 ± 0.02 nmol per 10
6
 cells, respectively; Fig. 
4.8C) compared to normoxia (0.62 ± 0.03 nmol per 10
6
 cells). 
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Fig. 4.8 NO2
-
, NO3
-
 and NOx production by neutrophil-like cells following exposure to normoxia, 
hypoxia, hyperoxia, pressure or HBO. ATRA-differentiated HL-60 cells were exposed to a range of 
conditions for 90 min (section 2.1.1). After exposure, cells were washed, stimulated with PMA and NOx 
levels in the medium were determined by measurement of NO2
- 
and NO3
-
 (section 4.2.3). Data are 
expressed as the amount of NOx produced in nmol per 10
6
 cells. Data are means ± SEM for three separate 
experiments (passage numbers 36, 38 and 40; n = 3) with triplicate measurements. * indicate significant 
differences from unstimulated cells (Mann-Whitney, P < 0.05), bars with different lower case letters 
indicate significant differences between different treatments for stimulated cells (Kruskal-Wallis, P < 
0.05). 
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4.3.3 Effects of HBO on degranulation of differentiated HL-60 cells 
Degranulation was assessed by measuring myeloperoxidase (MPO) release. Stimulation 
with PMA produced significantly higher MPO activity in neutrophil-like cells compared 
to unstimulated cells (pair-wise Mann-Whitney, P < 0.05; Fig. 4.9). Pre-treatment with 
HBO significantly increased MPO activity in unstimulated cells (Kruskal-Wallis, P = 
0.005), while pre-treatment with pressure, hyperoxia and hypoxia had no effect (0.23 ± 
0.07, 0.16 ± 0.02 and 0.08 ± 0.03, respectively). There were significant increases in 
PMA-induced MPO release following HBO, pressure alone and hyperoxia (Kruskal-
Wallis, P = 0.015) with the greatest increases observed following pressure and HBO. 
Exposure to hypoxia had no significant effect on degranulation of PMA-stimulated 
neutrophil-like cells (0.48 ± 0.09 nmol per 10
6 
cells, respectively; Fig. 4.9) compared to 
normoxia (0.9 ± 0.18 nmol per 10
6 
cells for stimulated cells).  
  
 124 
 
 
Fig. 4.9 MPO activity from neutrophil-like cells following exposure to normoxia, hypoxia, hyperoxia, 
pressure or HBO. ATRA-differentiated cells were exposed to a range of conditions for 90 min (section 
2.1.1). After exposure cells were washed, stimulated with PMA and MPO activity in the supernatant was 
measured (section 4.2.4). Data are expressed as the amount of MPO produced per 10
6
 cells. Data are 
means ± SEM for three separate experiments (passage numbers 19, 22 and 25; n = 3) with triplicate 
measurements. * indicate significant differences from unstimulated cells (Mann-Whitney, P < 0.05), bars 
with different lower case letters indicate significant differences between different treatments for 
stimulated cells (Kruskal-Wallis, P < 0.05). 
 
4.3.4 Effect of HBO on redox status 
A significant interaction between treatment and stimulation was found on total GSH 
levels in neutrophil-like cells (two-way ANOVA, P = 0.0001). In general stimulation 
with PMA caused a decrease in total glutathione (two-way ANOVA, P = 0.032), except 
for the case of pre-exposure to hypoxia, which explains the interaction. Because of the 
interaction unstimulated and stimulated data were further analysed separately using one-
way ANOVA. Exposure to HBO and pressure alone did not affect the glutathione level 
in both PMA-stimulated cells (0.42 ± 0.08 and 0.39 ± 0.07, respectively) and 
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unstimulated cells (0.82 ± 0.09 and 0.81 ± 0.08, respectively). A significant effect on 
total glutathione levels was found after treatment with hypoxia and hyperoxia in 
unstimulated cells (one-way ANOVA, P = 0.006) compared with normoxia (0.89 ± 
0.12) and after hyperoxia in stimulated cells (one-way ANOVA, P = 0.01) compared 
with normoxia (0.49 ± 0.05; Fig. 4.10.). 
 
Fig. 4.10 Total glutathione production by neutrophil-like cells following exposure to normoxia, hypoxia, 
hyperoxia, pressure, or HBO. ATRA-differentiated cells were exposed to a range of conditions for 90 min 
(section 2.1.1). After exposure, cells were washed, stimulated with PMA and total glutathione was 
measured in the cell lysate in absence or presence of PMA (section 4.2.5). Data are expressed as the 
amount of GSH produced in nmol per 10
6
 cells. Data are means ± SEM for three separate experiments 
(passage numbers 19, 22 and 25; n = 3) with triplicate measurements. Bars with different lower case 
letters indicate significant differences between different treatments for unstimulated and stimulated, 
respectively (two-way ANOVA, P < 0.05). 
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4.4 Discussion 
Pre-treatment with HBO enhanced the respiratory burst activity of neutrophil-like cells 
as shown by increased O2
•-
 and H2O2 production compared to normoxia-treated cells. 
These results are consistent with the work of Labrouche et al (1999) who found that 
circulating neutrophils isolated from volunteer divers who had intermittently inhaled 
100% O2 for 135 min at 1.8 ATA showed increased bacteria-induced phagocytosis and 
respiratory burst activity. Similar results were obtained in a study on neutrophils 
isolated from patients receiving HBO therapy for treatment of diabetic foot infections 
(Top et al., 2007). However, other studies are not consistent with these findings. For 
example, Jüttner et al. (2003) found no effect on respiratory burst or phagocytic activity 
of neutrophils isolated from healthy volunteers given repetitive HBO exposures. Kaln et 
al. (2002) found HBO treatment decreased opsonized zymosan-stimulated respiratory 
burst and had no effect on PMA-induced respiratory burst in neutrophils from healthy 
donors pre-exposed to HBO. 
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that has been 
widely implicated in the regulation of the antimicrobial activity of granulocytes, 
including neutrophils (Cramer et al., 2003, Peyssonnaux et al., 2005, Walmsley et al., 
2005). Steady state levels of the HIF-1α subunit are regulated in an oxygen-dependent 
manner, but there is debate over the precise mechanism(s) by which oxygen affects 
levels of this protein. An obvious possibility is the oxygen-dependent hydroxylation of 
HIF-1α, which is the starting point for the sequence of events that lead to it being 
targeted for degradation by proteasomes (Epstein et al., 2001). It has been suggested 
that oxygen consumption by mitochondria may modulate intracellular oxygen levels 
and hence influence the hydroxylation of HIF-1α (Hagen et al., 2003, Doege et al., 
2005). HL-60 cells have fully functional mitochondria, but after differentiation to 
neutrophil-like cells they show the morphological (shift from punctate to tubular 
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structure) and functional (decreased expression of cytochrome c) changes to their 
mitochondria that are characteristic of neutrophils (Maianski et al., 2004b). Hence it 
seems unlikely that mitochondria in differentiated HL-60 cells would significantly 
affect intracellular oxygen levels. 
An alternative view of the role of mitochondria in HIF-1α signalling is that this is based 
on their production of ROS (Schroedl et al., 2002). This seems to be particularly 
pertinent in neutrophils where mitochondria, as a result of localized deficiencies in one 
or more of the electron transfer complexes, may be potent ROS producers (Fossati et al., 
2003). These two models for HIF-1α give rise to opposite expectations in neutrophil-
like cells under normobaric or hyperbaric hyperoxia; under these conditions any limited 
ability of the mitochondria to maintain an intracellular oxygen gradient would be 
expected to be overwhelmed (hence no stabilisation of HIF-1α), whereas mitochondrial 
ROS production would be expected to increase (hence stabilisation of HIF-1α). The 
present data on the respiratory burst activity of neutrophil-like cells are consistent with 
the stabilisation of HIF-1α via elevated mitochondrial ROS production under hyperoxic 
conditions. However, neither HIF-1α activity nor protein levels were measured in this 
study. Further investigation including measurement of HIF-1α, as well as another 
subunit, HIF-1β, following treatments could provide information as to whether the 
expression of HIF-1 is active, and whether it is also affected by HBO. 
Consistent with this, exposure to hypoxia significantly decreased O2
•-
 and H2O2 levels 
with impaired phagocytosis of bacteria in PMA-stimulated neutrophil-like cells. 
Neutrophils are capable of respiratory burst that depends on the activity of NADPH 
oxidase that uses oxygen to form O2
•-
. Mitochondria have been demonstrated as possible 
oxygen sensors (Tan and Ratcliffe, 1991). A recent study has implicated mitochondria 
in the O2 sensing that underlies the functional responses to hypoxia (Chandel et al., 
1996). Mitochondria generate ROS at ubisemiquinone sites (Turrens et al., 1985), and a 
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change in mitochondrial redox status during hypoxia could alter ROS production, which 
is known to participate in the activation of transcriptional responses for example the 
HIF-1 activation pathway (Schreck et al., 1991). Respiratory burst activity of 
leukocytes either stimulated with PMA or unstimulated was decreased after acute 
hypoxia, but was not affected by 24 h of hypoxia (Faoro et al., 2011). This explanation 
is supported by the inhibition of MPO in PMA-stimulated cells post hypoxia. It has 
been demonstrated that ROS are required for full protease function within the 
phagosome (Reeves et al., 2002). Therefore, the protective bactericidal effects may be 
impaired under these conditions. Our finding of impaired antimicrobial activity in 
neutrophil-like cells after hypoxia treatment is consistent with previous studies (Jonsson 
et al., 1988, Ahn and Mustoe, 1990, Kivisaari and Niinikoski, 1975, Knighton et al., 
1986). 
However, previous studies are not in agreement about the effects of HBO on neutrophil 
respiratory burst activity. Research on HBO has been shown to reduce, increase, or have 
no effect on ROS production in neutrophils (Jüttner et al., 2003, Kaln et al., 2002, 
Labrouche et al., 1999, Thom et al., 2008). The present study supports the argument for 
enhanced respiratory burst activity following HBO, which has been presented by both 
Labrouche et al (1999) and Thom et al (2008) as described previously. 
Pre-treatment with HBO enhanced the phagocytic activity of neutrophil-like cells. This 
was supported by an HBO-induced increase in myeloperoxidase (MPO) activity, i.e. 
evidence of degranulation (exocytosis). Phagocytosis requires a controlled 
rearrangement of the actin cytoskeleton (May and Machesky, 2001). The same is also 
true of exocytosis. For example, Mitchell et al. (2008) found that depolymerisation of 
cortical F actin is essential for exocytosis of primary granules, which contain MPO. It 
has been shown that HBO inhibits adhesion of circulating neutrophils via inhibition of 
B2 integrins (Thom, 1993, Thom et al., 2008) and evidence has been presented that this 
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is mediated via nitrosylation of actin, which is ultimately dependent on an HBO-
induced increase in NO production by stimulating isoforms of NOS (Thom et al., 2008). 
iNOS and MPO co-localize within neutrophil primary granules and are responsible for 
excessive S-nitrosylation of β-actin, when neutrophils are subjected to hyperoxia (Thom 
et al., 2008). The nitrosylation of actin was shown to influence the polymerisation of 
actin. Hence, this could be the basis of an explanation for the enhancement of 
phagocytic activity following HBO pre-treatment seen in this study. 
The present study also demonstrated that HBO effects are not only due to elevated 
oxygen concentration, but that there is also potential for HBO-induced effects to be 
mediated by pressure alone (Grim et al., 1990). There was no consistent pattern of the 
effect of pressure alone on the antimicrobial activity of neutrophil-like cells. On one 
hand, the increase in H2O2 production following HBO pre-treatment could be due to 
pressure alone, since hyperoxia under normobaric conditions had no significant effect. 
On the other hand, it appears that pressure might have an inhibitory effect on 
phagocytosis since a greater increase in phagocytic activity was seen after treatment 
with normobaric hyperoxia compared to HBO, and pressure alone had significant effect 
on % phagocytosis but not on phagocytosis index. Two possible general mechanisms by 
which pressure alone could influence the activity of neutrophils are (a) via deformation 
during the pressure treatment and (b) via the formation of microbubbles during the 
decompression, both of which could lead to the activation of mechanoreceptors 
(Makino et al., 2006). 
Inflammatory factors in chronic wound conditions such as hypoxia and high levels of 
TNF-α or LPS cause an increase in neutrophil degranulation (Lee et al., 1993). 
However, in the present study, treatment with hypoxia failed to enhance respiratory 
burst activity and increase degranulation as was expected. A possible explanation for 
this is that the hypoxic conditions used in the present study (5% O2 for 90 min) were at 
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a higher concentration than hypoxic conditions in chronic wounds (2% O2). 
Additionally, other chronic wound conditions, such as TNF-α or LPS, were not applied 
in the present study and this may have resulted in insufficient production in neutrophil 
degranulation. In this study the changes in NOx, which are the products of oxidation of 
NO, were investigated. The results provide additional evidence of increased NO 
production in PMA-stimulated cells in response to HBO treatments, suggesting that 
HBO-treated cells appeared to show higher levels of NOS activity. Inducible NOS 
(iNOS)-derived NO in neutrophils has been proposed to be key mediator of some 
effects of HBO on neutrophil function. HBO-induced increases in eNOS activity levels 
are thought to result from accelerated cycling of ferrous haem in the active site of the 
enzyme to ferric haem via oxidation due to increased availability of oxygen, which 
increases the activity of the NOS ten-fold (Thom et al., 2003). Another possible 
mechanism of increased NOS activity following HBO treatment includes increased 
phosphorylation associated with increased heat shock protein (HSP-90; Cabigas et al., 
2006, Buras et al., 2000). However, in this study iNOS enzyme activity and expression 
were not investigated; further investigations of this kind would be helpful in order to 
determine whether and how the enzyme activity and expression are affected by HBO. 
Exposure to pressure alone showed a significant effect in NO2
-
 levels but not in NO3
-
 
levels in PMA-stimulated neutrophil-like cells. Thom et al. (2003) observed no changes 
in perivascular NO production in the aorta following treatment with a pressure control 
(7.46% O2 at 2.8 ATA for 45 min). The possible explanation is that NO produced under 
pressure treatment was oxidized to NO2
-
 but not further to NO3
-
. NO could react with 
other ROS, for example O2
•-
, to form ONOO
-
. This in turn could react with tyrosine, 
forming 3-nitrotyrosine (nitration), or thiols, forming S-nitrosothiols (S-nitrosylation; 
Halliwell and Gutteridage, 2007, Gaston et al., 2003). These reactions would decrease 
the likelihood of NO undergoing oxidation to NO2
-
 and NO3
-
. 
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GSH is oxidised to GSSG which is then reduced back to GSH in the cell to maintain the 
intracellular redox state. Glutathione redox cycle balance is important for cell integrity 
and function. Exposure to high oxidative stress results in cell damage and/or cell death 
and the subsequent release of GSH and other intracellular contents that are associated 
with harmful oxidative stress (Aoki et al., 1996). In the present results no change was 
observed in total glutathione levels in unstimulated and PMA-stimulated cells after 
HBO and pressure compared to the control. Studies to date on the effects of HBO on 
total glutathione levels indicate that HBO increases total glutathione in both rats and 
mice (Yuan et al., 2009, Kudchodkar et al., 2007, Wang et al., 2012). This might be 
explained as ROS and lipid peroxidation mediating the induction of anti-oxidant 
production as has been demonstrated for glutathione, GPx and catalase (Ishii et al., 
2002). In another study, HBO treatment was found to decrease total glutathione in free 
skin grafts in rats (Lemarie et al., 1998). In the present study, exposure to hyperoxia led 
to a decrease in total glutathione compared to normoxia in both unstimulated and PMA-
stimulated cells. A possible explanation of this might be that post hyperoxia there is an 
increase in production of ROS such as H2O2, which produces oxidative stress. The ROS 
may oxidize GSH through an enzymatic mechanism involving glutathione peroxidase, 
leading to the rapid transport of cytosolic GSSG out of the cell as a response to 
oxidative stress. Since mitochondria are a major source of ROS due to their 
consumption of molecular oxygen, redox control mechanisms are more limited in 
mitochondria than cytosol. Mitochondria are unable to export GSSG and must depend 
on NADPH reducing equivalents and glutathione reductase enzyme activity to 
resynthesize GSH (Olafsdottir and Reed, 1988). A decreased capacity to control 
endogenous and exogenous ROS causes mitochondria to be more susceptible to 
oxidative stress/dysfunction which can increase ROS generation; this could explain a 
decrease in total glutathione in PMA-stimulated cells. However, the present results 
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indicate that total glutathione is decreased by hypoxia in unstimulated cells. The present 
findings confirm a previous report showing hypoxic inhibition of glutathione synthesis 
in human fibroblasts (Bannai et al., 1989) and identify mitochondrial ROS as the 
intracellular signal mediating this effect, although this may depend on cell type and 
local environment. Overall, this study did not show any significant decrease in total 
glutathione following a 90-min exposure to HBO or pressure alone; this was 
inconsistent with the H2O2 results. However, therapeutic application of HBO in vivo 
never exceeds 3 ATA or 90 min, which could keep the ROS generation under control 
and allow the antioxidant system to work efficiently to control oxidative stress. 
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4.4.1 Conclusions 
Exposure of HL-60 cells differentiated with ATRA (neutrophil-like cells) to HBO 
enhanced the antimicrobial activity of the cells. Both the hyperoxia and pressure 
components of HBO contributed to the effects on neutrophil-like cells. These 
observations support the hypothesis that this could be responsible for some of the 
reduction in the infection observed in chronic wounds over the course of HBO 
treatment, the effects of which are only partially understood. The data are consistent 
with the possibility that HBO-mediated ROS may result in cytoskeletal changes and 
inhibition of B2 integrin, which in turn are responsible for the therapeutic action of 
HBO. In terms of inflammation, this could be detrimental to wound healing because it 
enhances a pro-inflammatory environment. However, neutrophil apoptosis, regulated in 
part by ROS, is a key process both in resolving inflammation during wound healing and 
in the prevention of the release of intracellular contents that may cause tissue damage. 
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CHAPTER FIVE 
THE EFFECTS OF HBO ON 
NEUTROPHIL VIABILITY AND 
APOPTOSIS 
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Abstract 
Chronic wounds are characterised by extensive neutrophil infiltration and their 
prolonged survival. Neutrophil apoptosis is essential for the successful resolution of 
inflammation. Delayed apoptosis and/or clearance of neutrophils prolong tissue injury. 
Recent evidence has shown that exposure to HBO (elevated oxygen fraction 
administrated at > 1 ATA) enhances apoptosis of various cell lines. Therefore to analyse 
the mechanism by which HBO induces neutrophil apoptosis, neutrophil-like cells from 
differentiated HL-60 cells by ATRA were exposed to normoxia (21% O2 plus 5% CO2), 
normobaric hyperoxia (95% O2 and 5% CO2), hyperbaric normoxia (8.8% O2, 2.1% 
CO2, balance N2 at 2.4 ATA) and hyperbaric oxygen (97.9% O2, 2.1% CO2 at 2.4 
ATA). Several assays such as quantification of caspase 3/7 activity and a morphological 
study were used to identify apoptosis. A single 90-min exposure to HBO was shown to 
have a pro-apoptotic effect as demonstrated by decreased cell viability (one-way 
ANOVA, P = 0.0004), increased caspase 3/7 activity in both untreated and TNF-α-
treated cells (Kruskal-Wallis, P < 0.05) and apoptosis-associated morphological 
changes using Giemsa (one-way ANOVA, P = 0.0006) or SYBR
®
 Safe staining of cells 
(Kruskal-Wallis, P = 0.03). Additionally, HBO treatment demonstrated suppression of 
LPS-induced TNF-α and IL-1β production (two-way ANOVA, P < 0.05) while IL-10 
was increased (two-way ANOVA, P = 0.002) suggesting that HBO-induced apoptosis is 
associated with a suppressive inflammatory response. Both pressure and hyperoxia 
seemed to contribute to increased apoptosis induced by HBO. However, hypoxia 
treatment had either the opposite effect to HBO or a non-significant effect. In 
conclusion, a single exposure to HBO enhanced spontaneous and stimulus-induced 
apoptosis in neutrophil-like cells and this seems to be associated with an alteration in 
inflammatory mediators such as cytokines. 
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5.1 Introduction 
Tissue injury and inflammation result in a decrease in oxygen tension at the wound site 
(Niinikoski et al., 1972, Hunt et al., 2004). Hypoxia has been shown to induce apoptosis 
in different cell types such as endothelial cells both in vitro (Matsushita et al., 2000) and 
in vivo (Stempien-Otero et al., 1999, Lee et al., 2005), and in fibroblasts (Saed and 
Diamond, 2002) as well as in macrophages in vitro (Yun et al., 1997). However, 
neutrophil apoptosis has been shown to be impaired by hypoxia (Hannah et al., 1995, 
Walmsley et al., 2005, Leuenroth et al., 2000). It is thought that in low oxygen areas 
such as in arthritic joints (Cross et al., 2006), neutrophils can function and survive for 
an extended length of time. Hypoxic inhibition of neutrophil apoptosis is regulated 
directly by the HIF-1α hydroxylase oxygen-sensing pathway and NF-B expression 
(Walmsley et al., 2005), and indirectly by the release of anti-apoptotic factors such as 
Mac-1 and MAPK (Leuenroth et al., 2000). 
In chronic wounds, apoptosis of cells involved in the wound healing process is also 
affected by inflammatory cytokines and growth factors. TNF-α is the predominant 
inflammatory cytokine in chronic wound fluids, and seems to mediate apoptotic 
pathways in a number of cell types, including fibroblasts (Alikhani et al., 2004). 
However, in neutrophils, the effect of TNF-α on apoptosis is dose-dependent, at low 
concentrations (≤ 1 ng ml-1) impairing apoptosis via activation of survival signals by 
NF-B, (Van Antwerp et al., 1998) whereas inducing apoptosis at high concentrations 
(≥ 10 ng ml-1). In chronic wound fluids, the TNF-α concentration is around 1 ng ml-1, so 
neutrophil apoptosis is impaired, and inflammation prolonged. Other cytokines such as 
granulocyte-macrophage-colony stimulating factor (GM-CSF), IFN-γ and IL-3 have 
also been shown to protect neutrophils from apoptosis through reduction in the levels of 
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pro-apoptotic Bax protein (Dibbert et al., 1999). IL-8 has also been shown to have anti-
apoptotic effect on neutrophils (Hirata et al., 2008). 
Bacterial infection in chronic wounds can induce apoptosis in different cell types 
involved in the healing process such as fibroblasts, natural killer cells, macrophages and 
epithelial cells (Zhang et al., 2008, Pan et al., 2004, Chung et al., 2009). LPS, a major 
component of the cell membrane of Gram-negative bacteria, induces apoptosis in 
endothelial cells (Zeng et al., 2005, Koide et al., 2007) and in macrophages (Munshi et 
al., 2002) via the extrinsic pathway. In contrast, bacterial infection by Escherichia coli, 
Staphylococcus aureus or Pseudomonas aeruginosa has been shown to enhance 
neutrophil survival (Lee et al., 1993, Nishimaki et al., 2007), in which LPS, and the 
chemotactic peptide, C5a, stimulate GM-CSF, which in turn exerts inhibitory effects on 
neutrophil apoptosis (Lee et al., 1993). 
Few studies have investigated the effects of HBO on apoptosis. A single HBO treatment 
(100%, 3 ATA) for 1 h reduced apoptosis in brain tissue following 
ischaemic/reperfusion (I/R) injury (Calvert et al., 2003) via a reduction in caspase-3 
activation. Also, treatment with HBO reduced cell apoptosis in ischaemic wounds, by 
reducing the expression of pro-apoptotic proteins such as p53, and increasing Bcl-2 
expression (Zhang et al., 2008). However, in this study tissue homogenates were used 
and the effects of HBO on individual cell types were not indicated, although overall 
results demonstrated a reduction in apoptosis. 
In leukocytes, HBO treatment causes DNA damage immediately after exposure, which 
is quickly repaired (Speit et al., 1998), while in Jurkat cells and a T-lymphocyte cell 
line, HBO has been shown to induce apoptosis via loss of mitochondrial membrane 
potential and increased caspase-9 activation (Weber et al., 2009a). Increased pressure 
showed the same effects in these cells (Chen et al., 2007b). Gunguly et al. (2002), in a 
further study using Jurkat cells, demonstrated that Fas-induced apoptosis was enhanced 
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by HBO (97.9% O2 and 2.2% CO2 at 2.4 ATA). In the same study, apoptosis of 
granulocytic HL-60 cells also increased following 3 h of HBO treatment, but there was 
no effect after 90 min, as applied in patient protocols. HBO-induced apoptosis was 
reduced upon incubation with the antioxidant ascorbate, suggesting that oxidative stress 
is involved in the apoptotic effects of HBO. Furthermore, HBO also increased apoptosis 
in NCI-H929, an immortal B-cell line, but also under conditions not representative of 
patient treatment (Chen et al., 2007b). The exposure to HBO at 2.5 ATA for 120 min 
increased apoptosis of cultured fibroblasts, while short term exposure to HBO, 30-60 
min at 2.5 ATA enhanced cell growth (Conconi et al., 2003). 
HBO may enhance wound healing by accelerating the death of inflammatory cells that 
are found in wounds. Thus, the aim of this study was to investigate the effects of HBO 
on the apoptosis of neutrophil-like cells obtained by differentiation of HL-60 cells. The 
results presented in Chapter 4 demonstrated that oxidative stress caused by HBO 
exposure in neutrophil-like cells induces ROS production. ROS production is associated 
with neutrophil apoptosis, so the hypothesis in the present study is that HBO may exert 
a beneficial effect by inducing apoptosis in neutrophils and limiting release of their 
injurious contents into surrounding tissue. 
5.2 Material and methods 
5.2.1 Experimental design 
Neutrophil-like cells, obtained by differentiation of HL-60 cells using ATRA (1 μM for 
5 days), were used as an in vitro model for neutrophils (section 3.2.2). Neutrophil-like 
cells were exposed to different treatments: normoxia (21% O2 plus 5% CO2), hypoxia 
(5% O2 plus 5% CO2, balance N2), normobaric hyperoxia (95% O2 and 5% CO2), 
hyperbaric normoxia (8.8% O2, 2.1% CO2, balance N2 at 2.4 ATA) and hyperbaric 
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oxygen (97.9% O2, 2.1% CO2, balance N2 at 2.4 ATA) for 90 min at 20 C (Fig. 5.1). 
After treatment, washed neutrophil-like cells were incubated at 37 °C for 3 h in the 
presence or absence of 10 ng ml
-1
 TNF-α (final concentration; Insight Biotechnology, 
Wembley, UK) to induce cell apoptosis (90 μl of 106 cells ml-1 in PBS plus either 10 μl 
of 100 ng ml
-1
 TNF-α or 10 μl of PBS). Additionally, to test whether the accumulation 
of H2O2 was involved in HBO-induced apoptosis, catalase (200 U ml
-1 
final 
concentration; Sigma, Poole, UK) was added to neutrophil-like cells and incubated at 37 
°C for 3 h to remove extracellular H2O2 (90 μl of 10
6 
cells ml
-1
 in PBS plus 10 μl of 
2000 U ml
-1
 catalase). Caspase inhibitor (10 µM final concentration zVAD-FMK; 
Promega, Southampton, UK) was added to neutrophil-like cells (90 μl of 106 cells ml-1 
in PBS plus 1 μl of 1 mM zVAD and 9 μl of PBS) as a negative control. The measured 
end points were cell viability (trypan blue and MTT; see sections 2.1.5 and 2.1.6); cell 
apoptosis (caspase-3/7 activity; see section 3.2.5); apoptosis-associated morphological 
changes using Wright-Giemsa and SYBR
®
 Safe staining (as detailed below); and 
quantification of anti-apoptotic NF-B and Bcl-2 gene expression via qPCR. For qPCR 
experiments, cells (1 ×10
6
 cells ml
-1
) were washed with PBS, treated with TNF-α (10 ng 
ml
-1
) and incubated for 3 h at 37 °C at 5% CO2 (balance air). RNA was extracted and 
expression of both NF-B and Bcl-2 was analysed using qPCR (section 2.1.7.5). NF-B 
protein was determined by Western blotting (as detailed below). Inflammatory response 
measurement was also investigated by using the Luminex technique (i.e. measurement 
of pro- and anti-inflammatory cytokines; section 2.1.8). 
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Fig. 5.1 Experimental design. Neutrophil-like cells obtained from ATRA-differentiated HL-60 cells were 
exposed to different oxygen treatments, after which cells were washed and incubated with 10 ng ml
-1
 
TNF-α for 3 h at 37 °C to induce apoptosis. Different assays were conducted to determine cell viability 
(trypan blue and MTT), cell apoptosis (caspase 3/7 activity and apoptosis associated morphological 
changes). Pro-and anti- inflammatory cytokines as well as the expression of NF-B and Bcl-2 were also 
measured. 
 
5.2.2 Morphological assessment of cell apoptosis 
Following exposure to the five different treatments cells were washed in PBS. 
Cytocentrifuge preparations of 10
6
 neutrophil-like cells, made up to a volume of 100 μl 
with supplemented RPMI-1640 medium, were prepared using a Shandon Cytospin 
centrifuge (Cheshire, UK; 400 g for 5 min). Cells were then stained using modified 
Wright-Giemsa stain (section 2.1.4). Morphological changes characteristic of apoptosis 
were assessed microscopically using a ×100 objective (Olympus BH, Japan). At least 
500 cells per slide were counted. Triplicate slides were prepared for each condition. 
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This method has been previously demonstrated to correlate closely with other 
parameters of apoptosis (Savill et al., 1989). Apoptotic cells were characterized by 
condensed, pyknotic nucleus, while membrane integrity was maintained. 
5.2.3 Assessment of apoptosis by fluorescence microscopy 
Quantitation of apoptosis was performed using the fluorescent DNA-binding dye 
SYBR
®
 Safe. With this method, fluorescence intensity was measured. Variations in 
intensity indicate the distribution of euchromatin and heterochromatin in non-apoptotic 
cell nuclei, while apoptotic nuclei exhibit highly condensed chromatin that is uniformly 
stained by SYBR
®
 Safe. 
Cytocentrifuge preparations of 10
5
 neutrophil-like cells, made up to a volume of 100 μl 
with supplemented RPMI-1640 medium and 10 μl of 1× SYBR® Safe (Sigma, Poole, 
UK), were prepared using a Shandon Cytospin centrifuge (400 g for 5 min). 
Morphological changes characteristic of apoptosis were assessed microscopically using 
a ×100 objective on a fluorescence microscope (Leica HC, USA, excitation 488 nm and 
emission 530 nm). At least 500 cells per slide were examined and triplicate slides were 
prepared for each condition. 
5.2.4 Preparation of nuclear protein extracts 
Neutrophil-like cells were exposed to the different treatments for 90 min at room 
temperature, stimulated with 10 ng ml
-1
 human recombinant TNF-α for 2 h then pelleted 
and resuspended in PBS at 5 × 10
6 
cells ml
-1
. Nuclear protein extracts were prepared in 
order to study the activation of NF-B. Cells were pelleted by centrifugation and 
washed with fresh PBS. After discarding the supernatants, an appropriate quantity of 
ice-cold hypotonic lysis buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, pH 7.9, 
freshly added 0.5 mM DTT, 0.5 mM PMSF, 30 µg ml
-1
 leupeptin, 5 µg ml
-1
 aprotinin 
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and 5 µg ml
-1
 pepstatin; Sigma, Poole, UK) was added (50-100 µl per 1 × 10
6
 cells). 
After incubation on ice for 10 min, nuclei were pelleted by centrifugation (13,000 g for 
5 min at 4 
○
C). The clear lysates were then removed and the nuclei were washed once in 
a hypotonic lysis buffer to remove contaminating cytosolic proteins. They were then 
resuspended in hypertonic extraction buffer (5 mM HEPES, 1 mM MgCl2 0.5 M NaCl, 
25% glycerol, pH 7.0, freshly added: 0.5 mM DTT, 0.5 mM PMSF, 30 µg ml
-1
 
leupeptin, 5 µg ml
-1
 aprotinin and 5 µg ml
-1
 pepstatin) for 1-2 h at 4 
○
C under agitation. 
Hypotonic lysis buffer prevents leaching of proteins out of the nucleus during lysis, 
whereas the hypertonic extraction buffer makes the nuclear membrane porous, allowing 
nuclear proteins to escape into solution. After centrifugation (13,000 g for 10 min at 4 
○
C), supernatants containing the nuclear protein were removed to fresh tubes and stored 
at -80 
○
C (Whiteside et al., 1992). 
5.2.5 Protein assay 
Bradford reagent was used to measure protein concentrations. This is a dye-binding 
assay, involving the use of Coomassie Blue dissolved in phosphoric acid solutions. In 
the acidic environment of the reagent, protein binds to the Coomassie dye. This results 
in a spectral shift from the brown form of dye to a blue form that absorbs light at 590 
nm (Bradford, 1976). 
Protein concentrations were determined using commercially-available Bradford reagent 
(Sigma, Poole, UK) according to the manufacturer
’
s instructions. Assays were 
performed in 96-well plates; standard curves were generated using dilutions of a bovine 
serum albumin protein standard ranging from 0-1 mg ml
-1
 in PBS. Reagent (200 µl) was 
added to 20 µl of sample or standard, and the plate was incubated at room temperature 
for 5 minutes after which the absorbance at 595 nm was determined for all wells using a 
plate reader (VersaMax, Molecular Devices, Sunnyvale, CA, USA). Both samples and 
 143 
 
standards were measured in triplicate and mean value calculated. The concentration of 
protein in each sample was then interpolated from the standard curve. 
5.2.6 Sodium dodecyl sulphate polyacrylamide gel electophoresis 
The separation of cellular proteins (polypeptides) according to their molecular mass was 
achieved using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) as described by Laemmli (1970). The SDS in the sample buffer and running 
buffer denatures the polypeptides in the sample, and applies a negative charge 
dependent on the mass of the polypeptide, removing any influence of the charge on the 
electrophoretic mobility, thus allowing separation of polypeptides depending on the 
size. The separated polypeptides can be stained with Coomassie Blue or transferred to a 
membrane that can be probed with antibodies as in western blotting. Polyacrylamide 
gels were made according to the protocol in Table 5.2. Briefly, the resolving gel was 
made by combining 30% (w/v) bis/acrylamide (Bio-Rad, Hemel Hempstead, UK), 
ddH2O and 1.5 M Tris pH 8.8, then freshly-made 10% (w/v) ammonium persulphate 
(APS) solution, 20% (w/v) SDS and tetramethlylethylenediamine (TEMED; Sigma, 
Poole, UK) were added to act as polymerising agents. 
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Table 5.1: Solutions used in SDS-PAGE.  
Solutions Concentration 
Solution A 30% acrylamide, 0.8% bis-acrylamide 
Solution B 1.5 M Tris-chloride, pH 6.8 
0.4% SDS 
Solution C 0.5 M Tris-chloride pH 6.8 
10% SDS 
Running buffer 5× 190 mM Tris-base 
1.92 M glycine 
1% (w/v) SDS 
Transfer buffer  250 mM Tris-base 
1.92 M glycine 
20% methanol 
Sample buffer  10 M Tris-chloride, pH 6.8 
20% (w/v) glycerol 
4% (w/v) SDS 
0.01% (w/v) bromophenol blue 
5% (v/v) β-mercaptoethanol 
 
Table 5.2: Composition of resolving and stacking gels. 
Reagent Gel percentage Stacking gel  
10% 12.5%  
Solution A (30% acrylamide/bis-acrylamide) 
 
Solution B (1.5 M Tris-chloride, 0.4% SDS, pH 6.8) 
 
H2O 
 
10% ammonium persulphate (APS) (0.1 g in 1 ml) 
 
TEMED 
3.3ml 
 
2.5ml 
 
4.2ml 
 
50 µl 
 
5 µl 
4ml 
 
2.5ml 
 
3.5ml 
 
50 µl 
 
5 µl 
 
0.67 ml 
 
1 ml 
 
2.3 ml 
 
30 µl 
 
5 µl 
 
 
The solution was swirled to mix and immediately pipetted between glass plates using a 
plastic Pasteur pipette. The plates were filled until approximately 2 cm below the top of 
the shorter glass front plate, in order to allow room for the stacking gel. A few drops of 
propan-2-ol were then layered onto the gel to ensure an even surface and to exclude 
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oxygen which inhibits polymerisation of the gel. The resolving gel was allowed to 
polymerise for 30-40 min, after which, the propan-2-ol was poured off and the gel was 
rinsed with ddH2O. The stacking gel was made according to the protocol in Table 5.2; 
30% (w/v) bis/acrylamide, ddH2O and 1 M Tris-chloride, pH 6.8, were combined, and 
then the polymerising agents 20% (w/v) SDS, 10% (w/v) APS and TEMED were added. 
The mixture was quickly pipetted onto the resolving gel until the glass plates were full. 
A plastic comb consisting of either 10 or 15 teeth was then inserted into the stacking 
gel, with care taken not to create any bubbles. The comb was left in the stacking gel as it 
polymerised (30-40 min). Protein samples derived from cell extracts were denatured by 
heating at 95 
○
C for 5 min in 4× SDS sample buffer (Tris-chloride, pH 6.8, 40% (w/v), 
glycerol and 10% (w/v) bromophenol blue, combined and made up to 5 ml with ddH2O, 
Table 5.1) with or without DTT depending on the form of the antigen recognised by the 
antibody being used and then cooled immediately on ice. Running buffer (Table 5.1) 
was poured into the tank, covering the gel. The comb was removed from the gel, taking 
care not to disturb the wells formed, before 20 μl samples were loaded onto the gel with 
10 μl biotinylated protein marker (New England Biolabs, Hertfordshire, UK) in a 
separate lane to allow sizing of the polypeptides. Gels were run at 90 V in running 
buffer (Table 5.1) whilst the samples moved through stacking gel, after which the 
voltage was increased to 120 V. The run was stopped after approximately 45 min when 
the dye front approached the bottom of the gel; the gel then was removed from the gel 
apparatus and from between the glass plates, and rinsed in dH2O. After electrophoresis, 
the polypeptides were transferred to a polyvinylidene difluoride (PVDF) membrane 
(Millipore, Bedford, MA) for Western blotting. 
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5.2.7 Western blotting 
Electrophoretically-separated polypeptides were transferred from the gel to a PVDF 
membrane, so that they could be probed with a primary antibody against a specific 
polypeptide, and then probed with a secondary antibody conjugated with horseradish 
peroxidase (HPR), which allowed for detection via chemiluminescence of the quantity 
of a specific polypeptide in the sample. 
Following SDS-PAGE, the separated polypeptides were transferred to a PVDF 
membrane by semi-dry blotting, according to the manufacturer’s instructions. The 
transfer process took 1 h at a constant voltage of 60 V with stirring by magnetic stirrer. 
The blot membrane was removed and washed three times (5 min each time) in PBS-T 
(PBS with 0.5% Tween 20; Sigma, Poole, UK), and then blocked using 5% BSA in 1× 
TBS containing 0.05% Tween 20 for 1 h at room temperature to prevent non-specific 
binding of antibodies. The membrane was then washed three times (5 min each time) in 
PBS-T, and incubated overnight with the specific primary antibody (polyclonal rabbit 
anti-NF-B p65 (RelA); Enzo Life Sciences, Exeter, UK; 50 µg diluted 1/1000 in 1× 
TBS containing 0.05% Tween 20) at 4 
○
C with gentle agitation. Following incubation 
with the primary antibody, the membrane was washed three times (5 min each time) in 
PBS-T. The membrane was then incubated with an HRP-conjugated goat anti-rabbit-
IgG antibody (R&D Systems, Minneapolis, USA, 1 mg diluted 1/1000 in 1× TBS 
containing 0.05% Tween 20) for 1 h at room temperature. After another three washes (5 
min each time) in PBS-T, the bound proteins were detected by using enhanced 
chemiluminescence (Amersham ECL reagent plus; GE Healthcare, Buckinghamshire, 
UK). According to the manufacturer’s instructions, solutions A and B were mixed in a 
ratio of 40:1 and added to the membrane in Saran Wrap
TM
 (Dow chemical Company, 
UK). After 3 min, excess ECL reagent was removed by blotting the membrane with 
filter paper in Saran Wrap and incubating for 1 min at room temperature. Finally, the 
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chemiluminescent images were acquired every 5 s for 10 min using an EC imaging 
system (Ultra-Violet Products Ltd, Cambridge, UK). 
5.2.8 Statistical analysis 
All data were analysed using Statgraphics Centurion XVI software (Stat Point 
Technologies, Inc.). Data are expressed as means ± SEM for 3 separate experiments. 
ANOVA (one-way or two-way ANOVA) or Kruskal-Wallis test were performed as 
appropriate to determine significant differences between treatments. After ANOVA, 
post hoc analysis using Tukey’s test was carried out. A P value of < 0.05 was 
considered significant throughout. 
 
5.3 Results 
5.3.1 Effects of treatments on neutrophil-like cell viability 
Cell viability was assessed using the trypan blue exclusion and MTT reduction assays 
(Fig. 5.2A and B). Under normoxia, the percentage viability of neutrophil-like cells was 
80.3 ± 1.1 using trypan blue. Immediately after HBO, pressure and hyperoxia, the 
viability of neutrophil like cells was significantly decreased (one-way ANOVA, P = 
0.0004) compared to normoxia (Fig. 5.2A), whereas no treatment effect was found after 
exposure to hypoxia (78.6 ± 1.8%). The changes in cell viability were confirmed by 
using the MTT reduction assay (based on reduction of MTT to an insoluble purple 
formazan by intracellular enzymes). The results were similar to those observed in the 
trypan blue assay in that HBO, pressure and hyperoxia caused significant decreases in 
MTT reduction (Kruskal-Wallis, P = 0.0229; Fig. 5.2B). Hypoxia treatment also did not 
significantly affect MTT reduction (0.42 ± 0.06). 
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Fig. 5.2 Effects of treatments on cell viability in neutrophil-like cells. ATRA-differentiated HL-60 cells 
were exposed to a range of conditions for 90 min (section 2.1.1), after which cells were washed. Cell 
viability was assessed using trypan blue (A) and MTT reduction (B) (sections 2.1.5 and 2.1.6). Data are 
means ± SEM for three separate experiments (passages numbers 20, 24 and 28) with triplicate 
measurements (n = 3). * significant difference versus normoxia. For each treatment, bars with the 
different lower case letters are significantly different (one-way ANOVA, P = 0.0004 for A; Kruskal-
Wallis, P = 0.0229 for B). 
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5.3.2 Effects of treatments on apoptosis of neutrophil-like cells 
The effects of HBO on apoptosis of differentiated HL-60 cells were investigated by 
measuring caspase 3/7 activity. The cells were treated with or without TNF-α to induce 
apoptosis after exposure to different treatments. HBO, pressure and hyperoxia produced 
a significant increase in caspase 3/7 activity in cells treated with TNF-α compared to 
normoxia (Kruskal-Wallis, P = 0.016; Fig. 5.3, overleaf). Pressure and HBO also 
increased caspase 3/7 activity in untreated cells compared to normoxia (Kruskal-Wallis, 
P = 0.02). Exposure to hypoxia resulted in a decrease in caspase 3/7 activity in TNF-α 
treated cells, but no change in untreated cells (687 ± 63 RFU). Previous studies have 
shown a link between H2O2 levels and apoptosis in undifferentiated HL-60 cells 
(Ganguly et al., 2002). To test whether extracellular H2O2 was involved in HBO-
induced apoptosis, catalase was added after exposure to different treatments. Contrary 
to expectation and similar to TNF-α, caspase 3/7 activity increased when cells were 
exposed to HBO or pressure in the presence of catalase (Kruskal-Wallis, P = 0.015) 
compared to normoxia. No increase was seen in cells exposed to hyperoxia (1409 ± 75 
RFU; Fig. 5.3) whereas hypoxia caused a decrease in caspase 3/7 activity (460 ± 0.9 
RFU) compared to normoxia. In all cases, addition of a caspase inhibitor to neutrophil-
like cells inhibited caspase 3/7 activity (Fig. 5.3). 
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Fig. 5.3 Effects of treatments on cell death in neutrophil-like cells. ATRA-differentiated HL-60 cells were exposed to a range of conditions for 90 min (section 2.1.1), 
after which cells were washed and stimulated to undergo apoptosis by incubation with TNF-α, then caspase 3/7 activity was assayed (section 3.2.5). Catalase was also 
added to test whether H2O2 was involved in apoptosis. The caspase inhibitor, zVAD-FMK, was added as a negative control. Data are means ± SEM for three separate 
experiments (passage numbers 33, 35 and 37, n = 3), with duplicate measurements. For each treatment, bars with the different lower case letters are significantly 
different (Kruskal-Wallis, P < 0.05). 
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5.3.3 Effects of HBO on morphological changes relating to cell apoptosis 
Apoptosis was confirmed by morphological assessment using modified Wright-Giemsa 
(Fig. 5.4, overleaf) and SYBR
®
 Safe staining (Fig. 5.5). Apoptotic cells showed nuclei 
with condensed chromatin but with plasma membranes still intact (Figs 5.4 and 5.5 B, C 
and D). Significant increases in cells showing morphological changes associated with 
apoptosis were seen following exposure to HBO and hyperoxia in Wright-Giemsa 
stained cells (one-way ANOVA, P = 0.0006) and post HBO, pressure and hyperoxia in 
SYBR
®
 Safe stained cells (Kruskal-Wallis, P = 0.03) compared to normoxia (Figs 5.4F 
and 5.5F). However, there was no change in the apoptosis-associated morphological 
changes in neutrophil-like cells post hypoxia treatment (Wright-Giemsa and SYBR
®
 
Safe staining; 8.8 ± 2.1% and 20.6 ± 1.8%, respectively) compared with normoxia 
(Wright-Giemsa and SYBR
®
 Safe staining; 15.2 ±1.9 and 21.3 ± 1.1, respectively). 
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Fig. 5.4 Effects of treatments on morphological changes associated with apoptosis in neutrophil-like cells 
using modified Wright-Giemsa staining. ATRA-differentiated HL-60 cells were exposed to normoxia (A) 
hypoxia (B) hyperoxia (C) pressure (D) and HBO (E) for 90 min, after which cells were washed and 
morphological changes were assessed using Giemsa staining by light microscopy (section 5.2.2). The 
percentage of apoptosis was assessed morphologically in triplicate slides for each experiment (F). Data 
are means ± SEM for three separate experiments (passages numbers 20, 24 and 28; n = 3). For each 
treatment bars with the different lower case letters are significantly different (one-way ANOVA, P = 
0.0006). Black arrowheads indicate chromatin condensation and fragmentation. 
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Fig. 5.5 Effects of treatments on morphological changes associated with apoptosis in neutrophil-like cells 
using SYBR Safe. ATRA-differentiated HL-60 cells were exposed to hypoxia (A), normoxia, (B) 
hyperoxia (C) pressure (D) and HBO (E) for 90 min, after which cells were washed and morphological 
changes were assessed using SYBR
®
 Safe staining by fluorescence microscopy (section 5.2.3). The 
percentage of apoptosis was assessed morphologically for triplicate slides for each experiment (F). Data 
are means ± SEM for three separate experiments (passages numbers 27, 29 and 32; n = 3). * significant 
difference versus normoxia (Kruskal-Wallis, P = 0.03). 
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5.3.4 Effects of oxygen treatments on NF-B and Bcl-2 gene expression in 
neutrophil-like cells 
Expression of the anti-apoptotic factors NF-B and Bcl-2 was quantified in neutrophil-
like cells following exposure to HBO, pressure, hyperoxia, normoxia and hypoxia by 
using qPCR (Fig. 5.6A and C). Neutrophil-like cells were treated with or without 10 ng 
ml
-1
 TNF-α after exposure to different conditions. For both genes, there was no 
significant interaction between the treatment and stimulation (two-way ANOVA, P > 
0.05). The addition of TNF-α up regulated the expression of NF-B and Bcl-2 in 
neutrophil-like cells when compared to the control cells (two-way ANOVA, P = 0.0002 
and 0.002, respectively). Exposure to HBO, pressure, hyperoxia and hypoxia 
significantly decreased the NF-B expression (two-way ANOVA, P < 0.00005) 
compared to normoxia (Fig. 5.6A, overleaf). Expression of Bcl-2 was significantly 
decreased following HBO, pressure and hyperoxia treatments (two-way ANOVA, P = 
0.004) compared with normoxia. No change was observed following exposure to 
hypoxia (1.1 ± 0.2 and 1.5 ± 0.3) compared to untreated cells following normoxia (Fig. 
5.6C). The gene expression results for both NF-B and Bcl-2 were confirmed by 
electrophoresis of PCR products on agarose gels (NF-B, Fig. 5.6B; Bcl-2, Fig. 5.6D). 
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Fig.5.6 Effects of treatments on gene expression in neutrophil-like cells. ATRA-differentiated HL-60 
cells were exposed to a range of conditions for 90 min (section 2.1.1), after which cells were washed and 
cDNA was synthesised from extracted RNA. qPCR was used to determine expression of NF-B (A) and 
Bcl-2 (C) (section 2.1.7.5). Results were normalised against unstimulated cells under normoxia (dotted 
line). Data are means ± SEM for three separate experiments (passage numbers 20, 24 and 28; n = 3). For 
each treatment bars with the different lower case letters are significantly different (two-way ANOVA, P < 
0.05). Photograph of PCR products showing NF-B (B) and Bcl-2 (D) in TNF-α stimulated cells after 
different treatments as well as in unstimulated cells under normoxic conditions in 1% agarose gels. 
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5.3.5 Effects of oxygen treatments on NF-B protein expression 
NF-B (p65 RelA) levels in the nuclear fraction in neutrophil-like cells treated with or 
without TNF-α after exposure to different treatments was analysed by western blotting 
(Fig. 5.7A and B). No significant effects were found on NF-B (p65, RelA) expression 
in untreated cells after exposure to different treatments (Fig. 5.7A). Immediately after 
exposure to HBO, pressure and hyperoxia there was a decrease in the expression of NF-
B (p65, RelA) in TNF-α –treated cells compared to normoxia, while hypoxia treatment 
did not significantly affect expression (Fig. 5.7B).  
 
 
Fig. 5.7 Effects of treatments on western blot analysis of NF-B protein in the nuclear fraction of 
neutrophil-like cells. ATRA-differentiated HL-60 cells were exposed to a range of conditions for 90 min 
(section 2.1.1), after which cells were washed and untreated (A) or treated with TNF-α (B). The nuclei 
were then isolated and levels of NF-B (p65, RelA) quantified by Western blotting (section 5.2.7). 
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5.3.6 Effects of oxygen treatments on pro- and anti-inflammatory cytokine release 
The levels of cytokines released from neutrophil-like cells were determined using the 
Luminex
®
 technique (see section 2.1.8). IL-6 levels were less than threshold values and 
hence were not detectable. A significant interaction was found between the treatment 
and stimulation (two-way ANOVA, P = 0.0001, 0.0189 and 0.0016 for TNF-α, IL-1β 
and IL-10, respectively). Stimulation with 100 ng ml
-1 
LPS caused an increase in levels 
of TNF-α, IL-1β and IL-10 released from neutrophil-like cells compared to 
unstimulated cells (two-way ANOVA, P < 0.00005; Figs 5.8A, B and C). No effects 
were found on TNF- α levels in unstimulated cells (one-way ANOVA, P = 0.112). 
TNF-α released from LPS-stimulated neutrophil-like cells was found to significantly 
decrease after HBO, pressure, hyperoxia and hypoxia pre-treatments compared with 
normoxia (one-way ANOVA, P = 0.005). 
Post HBO treatment there appeared to be a decrease in IL-1β released from LPS-
stimulated cells (two-way ANOVA, P = 0.03). However, because of the interaction, 
unstimulated and stimulated data were analysed separately using one-way ANOVA to 
further investigate the main effect of treatment. No effect was found on IL-1β levels in 
unstimulated cells (one-way ANOVA, P = 0.126; Fig. 5.8B). A significant decrease in 
IL-1β levels was found following HBO and pressure treatment (one-way ANOVA, P = 
0.043). No difference was found in IL-1β levels following hyperoxia and hypoxia 
treatments for LPS-stimulated cells (97.5 ± 18.3 and 105.5 ± 13.3 pg ml
-1
, respectively) 
compared with normoxia (114.4 ± 17.8 pg ml
-1
). Treatment with HBO and pressure 
significantly decreased IL-10 levels (one-way ANOVA, P = 0.002) in unstimulated 
cells compared with normoxia (18.8 ± 0.6 pg ml
-1
). No effects was found on IL-10 
levels in unstimulated cells following hyperoxia and hypoxia (17.7 ± 1.4 and 18.7 ± 1.7 
pg ml
-1
, respectively) compared with normoxia (18.8 ± 0.6). In contrast, the anti-
inflammatory cytokine, IL-10 showed a significant increase in HBO-treated neutrophil-
 158 
 
like cells compared to normoxia (two-way ANOVA, P = 0.002; Fig. 5.8C). Again, 
because of the interaction, unstimulated and stimulated data were further analysed 
separately using one-way ANOVA. A significant increase in IL-10 levels was found 
following HBO treatment for LPS-stimulated cells (one-way ANOVA, P = 0.003) but 
the differences in IL-10 values following pressure, hyperoxia and hypoxia treatment 
were not significant (74.9 ± 5.4, 44.9 ± 9.3 and 73.8 ± 6.3 pg ml
-1
, respectively) 
compared with normoxia (65.6 ± 5.0 pg ml
-1
; Fig. 5.8C).  
 
Fig. 5.8 Effects of treatments on cytokine production in neutrophil-like cells. ATRA-differentiated HL-60 
cells were exposed to a range of conditions for 90 min (section 2.1.1), after which cells were washed and 
stimulated by LPS. Cytokine production was measured by Luminex
®
 assay (section 2.1.8). Data are 
means ± SEM for three separate experiments (passages numbers 28, 30 and 32; n = 3) with duplicate 
measurements. * indicate significant differences from unstimulated cells. For each treatment bars with the 
different lower case letters are significantly different (ANOVA, P < 0.05). 
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5.4 Discussion 
Enhancement of neutrophil anti-microbial activity seems to be of benefit for the 
resolution of inflammation in chronic wounds. It has been demonstrated that 
antimicrobial activity of neutrophils is associated with their apoptosis (Kobayashi et al., 
2003, Nakazato et al., 2007, Watson et al., 1996). Increased neutrophil apoptosis and 
their clearance is essential for the resolution of inflammation, since chronic wounds are 
characterised by the persistence of an inflammatory and hypoxic environment in which 
there is prolonged neutrophil life at the wound site (Yager and Nwomeh, 1999). In the 
present study, pre-treatment with HBO treatment led to a decrease in viability (trypan 
blue and MTT) of neutrophil-like cells, and an increase in apoptosis as assessed by 
caspase 3/7 activity, Giemsa staining and fluorescence staining using SYBR
®
 Safe. 
These results are consistent with the effects of HBO previously demonstrated in a range 
of haematopoetic cells including undifferentiated HL-60 cells, Jurkat cells and murine 
thymocytes (Ganguly et al., 2002). For example, in HL-60 cells, HBO increased both 
spontaneous and γ irradiation-induced apoptosis, but normobaric hyperoxia or pressure 
alone had little effect (Ganguly et al., 2002). Hyperoxia increases apoptosis of other 
cells of hematopoietic origin such as thymocytes (Stefanelli et al., 1995), thymoma cell 
lines, lymphoma cell lines (Muschel et al., 1995) macrophage cell lines (Petrache et al., 
1999), as well as myocytes (Absher et al., 1994) and prostate carcinoma cells lines 
(Kalns et al., 1998). There is evidence that the increase in apoptosis associated with 
antimicrobial activity in neutrophils is a consequence of the increased ROS production 
by the cells themselves (Watson et al., 1996, Nakazato et al., 2007). Furthermore, 
mitochondria are likely to have a role in both ROS production and in the intrinsic 
apoptotic pathway (Maianski et al., 2004b). The results presented in Chapter 4 showed 
that there was an increase in ROS production and degranulation post-HBO treatment. It 
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has also been shown that ROS can activate death receptor signalling thereby promoting 
neutrophil apoptosis via the extrinsic pathway (Scheel-Toellner et al., 2004). 
Since exogenous H2O2 can cause cell apoptosis (Lin et al., 1997), the hypothesis in this 
study was that HBO induced apoptosis by increasing intracellular H2O2 levels. 
Therefore, catalase, a H2O2 scavenging enzyme, was added to the cells which were pre-
exposed to a range of oxygen conditions. Exogenous catalase did not inhibit HBO-
induced apoptosis in neutrophil-like cells and did not result in a significant difference in 
caspase 3/7 activity. This suggests that exogenous catalase does not decrease the H2O2 
levels, because it cannot penetrate the cell membrane due to its size and can only 
directly affect intercellular H2O2 levels by catalysing the degradation of extracellular 
H2O2 to O2 and H2O. However, diffusion of H2O2 from the cytoplasm into the medium 
is possible and this could eventually lead to a lowering of the intracellular H2O2 in the 
presence of extracellular catalase. 
The present study also demonstrated an increase in neutrophil-like cell apoptosis after 
treatment with pressure alone. This provides evidence that increased pressure can 
modify cell function and susceptibility to undergo apoptosis. A prior study by Oh et al. 
(2010) indicated that apoptosis of human H460 lung cancer cells can be initiated by 
increasing pressure to 2 ATA, which provides a mechanical and physiological 
stimulation. Previous research findings demonstrated that exposure to HBO or pressure 
alone inhibited both benign and malignant human mammary epithelial cell proliferation 
but did not induce apoptosis (Maianski et al., 2004b, Granowitz et al., 2005). The 
apoptotic effects of pressure can be explained by conformational changes and 
mechanical effects after pressure treatment that may affect G-protein-coupled receptors 
(GPCRs); these are trans-membrane receptors that activate G protein signalling 
pathways when bound by ligands and act as mechanoreceptors. They have been 
identified in a range of cells such as vascular smooth muscle cells (VSMCs), human 
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embryonic kidney (HEK) cells and neutrophils (Makino et al., 2006, Zou et al., 2004, 
Yasuda et al., 2008, Voets and Nilius, 2009). Mechanoreceptors are responsible for the 
response to fluid shear stress and initiate multiple receptor cellular pathways that have 
been implicated in apoptosis. 
Hyperoxia-induced death is well documented in many studies (Barazzone and White, 
2000, Ganguly et al., 2002). Hyperoxia enhances ROS formation and accumulation, 
which are present in many cells triggering apoptosis. ROS are primarily generated in 
mitochondria via mitochondrial respiration which initiates the signal pathways in the 
cells and often converges upon the mitochondria to promote release of cytochrome c to 
the cytoplasm and activate procaspase-9, which in turn activates the apoptotic cascade 
(Li et al., 1997, Reed, 1997). Additionally, ROS are involved in death receptor-initiated 
signalling pathways, especially in the TNF-α receptor 1 (TNFR1) pathway which 
initiates the caspase cascade (Shen and Pervaiz, 2006). The present results are consistent 
with these studies, as caspase 3/7 activity and morphological changes associated with 
apoptosis increased in neutrophil-like cells exposed to hyperoxia. 
HBO not only induced spontaneous apoptosis in neutrophil-like cells, but also enhanced 
apoptosis in the presence of TNF-α. A study by Ganguly et al. (2002) examined the 
effect of HBO in Jurkat and HL-60 cells induced to undergo apoptosis by CH-11 anti-
Fas antibody or -radiation, respectively. The study demonstrated no direct effect of 
HBO on apoptosis, although Fas-induced apoptosis was enhanced by HBO. 
Granulocytic differentiated HL-60 cells showed no change in apoptosis after 90 min 
with HBO treatment, a condition representative of patient treatment, but HBO increased 
apoptosis after 3 h. In this study, TNF-α was used to induce death in neutrophil-like 
cells after treatment with different oxygen conditions. TNF-α-induced death signalling 
is initiated by the activation of TNFR1. ROS are potent activators of TNFR1 that induce 
Jun N-terminal kinase (JNK) activation, a member of the mitogen-activated protein 
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kinases (MAPK) and its activation is one of key events in TNF-α induced cell death 
(Hongbo and Fabien, 2008). High concentrations of TNF-α (10-100 ng ml-1) induce 
spontaneous neutrophil apoptosis which is characterized by caspase activation, 
internucleosomal DNA, and morphological features of apoptosis, the increase in which 
is ROS-dependent (Van Den Berg et al., 2001). Consistent with these studies, in the 
present investigation, the caspase activity in neutrophil-like cells induced to die by 
TNF-α, was higher post HBO and pressure compared to normoxia. This suggests that 
HBO mediates its effects on TNF-α-induced apoptosis through increased ROS 
production. Previously it has been shown in rat alveolar Type II cells that the initiation 
phase of pulmonary oxygen toxicity causes an increase in TNF-α and its receptor 
TNFRI leading to activation of caspases 3 and 8 (Guthmann et al., 2005). However, two 
studies have shown that stimulation of neutrophils by TNF-α involves not only the 
classical caspase-dependent pathway, but also caspase-independent cell death, and it 
was found that the death of neutrophils treated with a combination of TNF-α and the 
caspase inhibitor zVAD was dependent on mitochondrial-derived ROS (Maianski et al., 
2004b, Liu et al., 2003). In support of this, a single exposure to HBO induced apoptosis 
in Jurkat-T-cells via mitochondria-dependent mechanisms and ROS production, which 
could have enhanced the formation of pro-apoptotic substances in cells such as the pro-
apoptotic members of the Bcl-2 family, Bik and Bax (Weber et al., 2009a). 
Hypoxia pre-treatment in this study resulted in no change in apoptosis of neutrophil-like 
cells compared with normoxia conditions. This agrees with a study by Hannah et al 
(1995) that indicated prolonged neutrophil survival under hypoxic conditions. The anti-
apoptotic effect of hypoxia is dependent on continuing protein synthesis, associated 
with upregulation of HIF-1α levels. HIF-induction inhibits neutrophil apoptosis and 
radiation-induced apoptosis in Jurkat cells (Vissers and Wilkie, 2007, Weinmann et al., 
2004). 
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Since mitochondrial outer membrane permeability is controlled by Bcl-2 (Green and 
Kroemer, 2005) and mitochondria may have a role in HBO induced apoptosis, in the 
present study the gene expression of Bcl-2 and its association with NF-B was 
investigated. Interestingly, the results demonstrated a down regulation in the expression 
of Bcl-2 after pre-treatment with HBO, pressure and hyperoxia in TNF-α treated cells, 
and NF-B at the transcription and protein levels after pre-treatment with HBO, 
pressure or hyperoxia in both TNF-α treated and untreated cells. TNF-α is known to 
trigger activation of NF-B, which requires phosphorylation and degradation of IBα. 
Following activation, NF-B translocates to the nucleus to control the expression of 
survival genes such as Bcl-2. Thus, the decline in the expression of NF-B in 
neutrophil-like cells is associated with a decrease in Bcl-2 expression. These results 
may be explained by a number of different factors. Firstly, that down regulation of Bcl-
2 expression occurs in response to apoptotic stress induced by HBO. Therefore, 
mitochondrial mechanisms dependent on Bcl-2 may be involved in the HBO-induced 
apoptosis. Bcl-2 down regulation may initiate lymphocytes to undergo apoptosis 
(Hotchkiss et al., 2005). A study by Li et al. (2005) has demonstrated the effects of 
HBO on apoptotic genes in rat brains after global ischaemia-hypotension; increased 
expression of caspase-8 and a decrease of Bcl-2 and HIF-1α expression was found 
following HBO treatment (3 ATA, 2 h). Release of mitochondrial pro-apoptotic factors 
is likely to be accompanied by a breakdown of mitochondrial membrane potential. 
Therefore, further experiments are needed to investigate the relevance of the Bcl-2 
down regulation and breakdown of mitochondrial membrane potential. The second 
factor which may explain these results is that Bcl-2 action is controlled by NF-B, 
which plays an important role in the regulation of granulocyte apoptosis (Ward et al., 
2004). Inhibition of NF-B enhanced the pro-apoptotic effects of TNF-α in neutrophils 
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and mediated its effects as a powerful inducer of eosinophil apoptosis (Ward et al., 
1999, Fujihara et al., 2002). 
Cell apoptosis is kept in balance by the presence of pro-and anti-apoptotic proteins. NF-
B affects this balance by up regulating expression of proteins that prevent apoptosis 
(Karin and Lin, 2002). In support of this, the present work found that HBO-induced 
apoptosis was associated with decreased NF-B expression and down regulation of the 
anti-apoptotic gene Bcl-2. Blocking NF-B activation results in Bax protein expression 
(Bentires-Alj et al., 2001) and down regulation of Bcl-2 (De Moissac et al., 1999). Thus 
HBO-inhibited NF-B activation shifts the balance towards apoptosis. The present 
results suggested that increased accumulation of IBα in the nucleus of neutrophil-like 
cells might be responsible of down regulation of NF-B by masking its nuclear 
localization sequence and inhibiting the ability of NF-B to bind to DNA (Beg et al., 
1992, Didonato et al., 1996). This may be identified as one of the underling 
mechanisms of HBO-induced apoptosis (Fig. 5.9). 
From the present findings, hypoxia pre-treatment showed no change in Bcl-2 expression 
in untreated and TNF-α cells compared with normoxia. The majority of gene expression 
after hypoxia is regulated by HIF-1. Under normoxic conditions, HIF-1 is degraded by 
proteasome function, while under hypoxic conditions HIF-1 is stabilised and acts as 
transcription factor for various genes involved in angiogenesis, energy metabolism, cell 
proliferation and viability, as well as apoptosis (Zagόrska and Dulak, 2004). 
Additionally, an association between HIF and NF-B has previously been identified 
(Gӧrlach and Bonello, 2008, Taylor and Cummins, 2009, Zagόrska and Dulak, 2004). 
NF-B activation is required the phosphorylation and degradation of IB (Chen et al., 
2007a). Subsequent phosphorylation and dimerization of NF-B subunits p50/p65 
permits NF-B translocation to the nucleus. However, this prevents HIF-1α degradation 
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and leads to an increase in HIF-1α concentration. The present study found a significant 
decrease in NF-B at the transcription levels in unstimulated and TNF-α stimulated 
cells following hypoxia, which may be explained by the cross talk between NF-B and 
HIF-1 signalling in short term hypoxia. Examination of changes in HIF-1α activity and 
protein expression could provide some information on the pathways involved. 
Neutrophil apoptosis exerts anti-inflammatory effects through limiting the release of 
toxic contents that could cause injury to the tissue. The present study provided further 
evidence of the immunosuppressive effects of HBO-induced apoptosis via its effect on 
cytokine production. HBO treatment led to a significant decrease in the release of pro-
inflammatory TNF-α and IL-1β, while a significant increase in the anti-inflammatory 
IL-10 release by LPS-stimulated cells was observed following HBO. Exposure to 
normobaric hyperoxia or pressure decreased only TNF-α levels and had no effect on the 
other cytokines. This suggests that HBO-induced inhibition of inflammation seems to 
be a function of both pressure and hyperoxia. The present results are in agreement with 
other studies that demonstrated that HBO inhibits LPS-induced IL-1 and TNF-α release 
in splenic macrophages (Inamoto et al., 1991), circulating monocytes/macrophages 
(Lahat et al., 1995) and human peripheral blood mononuclear cells (Granowitz et al., 
2002). However, there is no study to date on the effects of HBO on cytokine release 
from neutrophils. A possible mechanism for impaired pro-inflammatory cytokine 
production was the induction of apoptosis in the cytokine-producing cells. For example, 
HBO induced apoptosis in neutrophil-like cells as shown by increased caspase 3/7 
activity and a decrease in cell viability. Neutrophil apoptosis is down regulated by pro-
inflammatory mediators such as TNF-α, IFN-γ, G-CSF, GM-CSF and IL-2 (Colotta et 
al., 1992, Brach et al., 1992, Lee et al., 1993); this inhibition of neutrophil apoptosis not 
only increases the life span of cultured neutrophils but also prolongs their functional 
longevity (Lee et al., 1993), whereas IL-10 enhances neutrophil apoptosis and their 
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clearance by macrophages (Michlewska et al., 2009). In line with previous studies, 
HBO treatment caused a significant increase in IL-10 in neutrophil-like cells. Another 
mechanism by which HBO might suppress pro-inflammatory cytokine production is via 
its effects on signal transduction, transcription, and/or translation. For example, HBO 
inhibits cytokine production by down regulation of PGE2 production (Inamoto et al., 
1991), inhibition of cox-2 expression (Yin et al., 2002) and by inducing the formation 
of heat shock protein, HSP (Xie et al., 1999). HBO has been shown to increase ROS 
generation (Benedetti et al., 2004, Conconi et al., 2003) and this may play a role in 
inducing expression of HSPs, for example HSP-70, in response to oxidative stress. The 
intracellular HSP concentration has been demonstrated to be correlated to antioxidant 
enzymes under conditions of oxidative stress to attenuate ROS-dependent cellular and 
tissue damage (Currie et al., 1988, Mocanu et al., 1993). HSP-70 synthesis also 
correlates with a decrease in cytokine levels through transcriptional pathways; this is an 
example of a protective measure conferred by an HSP (Grunenfelder et al., 2001). 
Hypoxia pre-treatment resulted in no change in the pro-inflammatory cytokines TNF-α 
and IL-1β and anti-inflammatory IL-10 production by neutrophil-like cells. Studies on 
hypoxia have been shown to decrease (Fritzenwanger et al., 2011), increase (Ghezzi et 
al., 1991) or have no effect (Burki and Tetenta, 2013) on pro-inflammatory cytokines 
levels. However, the cellular response to hypoxia is highly regulated by HIF-1 α which 
plays a distinct role in regulating pro-inflammatory cytokines levels, in part by direct 
binding to the promoters of cytokine genes (Zagόrska and Dulak, 2004). 
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Fig. 5.9 Proposed mechanisms by which HBO may affect transduction or transcription signals by HIF-1 
and NF-B in neutrophil-like cells. Observations from the present study suggest that HBO-induced 
apoptosis in neutrophil-like cells is associated with mitochondrial function and ROS production. HBO 
also leads to enhanced IL-10 production, and taken together results in reduction of pro-inflammatory 
cytokines TNF-α and IL-1β. Since TNF-α is a potent stimulus for NF-B activation, a decreased TNF-α 
level results in a reduction of IBα phosphorylation and its degradation, down regulation of NF-B 
activity, and the subsequent transcription and expression of inflammatory proteins such as apoptotic 
protein Bl-2. Additional effects of HBO are pressure dependent, such as conformational changes which 
could lead to the activation of mechanoreceptors that are implicated in apoptosis. 
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5.4 1 Conclusion 
Neutrophil apoptosis is of key importance in the resolution of inflammation. A single 
exposure to HBO enhances spontaneous and TNF-α-induced apoptosis in neutrophil-
like cells via oxidative stress that may potentially result in the formation of pro-
apoptotic substances in the cells or in the medium. The hyperoxia and pressure 
components of HBO both contribute to effects on neutrophil-like cells. Apoptotic 
effects of HBO are associated with an anti-inflammatory response. These findings 
confirm the immunomodulatory effect of HBO. Further studies are needed to address 
the exact mechanisms as to how HBO mediates oxidative stress and activates apoptotic 
pathways. 
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CHAPTER SIX 
THE EFFECTS OF HBO ON 
NEUTROPHIL CLEARANCE BY 
MONOCYTE-DERIVED MACROPHAGES 
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Abstract 
A critical step in the resolution of inflammation is neutrophil apoptosis and their 
subsequent clearance by macrophages. Early findings indicated that HBO induced 
neutrophil-like cell apoptosis. However, the effects of HBO leading to the clearance of 
neutrophils by macrophages are still unclear. In the current study in vitro co-culture 
experiments with bovine neutrophils and monocyte-derived macrophages (MDMФ) 
were carried out to clarify the role of HBO, pressure, hyperoxia, hypoxia and normoxia 
in this process. Both fresh and 22 h-aged neutrophils were used as targets for 
phagocytosis. The results showed that phagocytosis of fresh and 22 h-aged neutrophils 
by MDMФ significantly increased after HBO treatment as assessed using flow 
cytometry and light microscopy (two-way ANOVA, P < 0.00005). The efficient 
recognition of apoptotic cells is associated with neutrophil respiratory burst activity, and 
pro-/anti-inflammatory cytokine secretion. Enhanced the clearance of neutrophils (fresh 
or 22 h old) was accompanied by a significant increase in H2O2 levels following HBO 
treatment (two-way ANOVA, P < 0.05 respectively), with up regulation of IL-10 (anti-
inflammatory cytokine) mRNA gene expression in MDMФ that ingested fresh or 22 h-
aged neutrophils. The gene expression of TNF-α (pro-inflammatory cytokine) mRNA 
did not change in LPS-stimulated MDMФ that ingested fresh or 22 h-aged neutrophils 
after HBO, pressure and hyperoxia (two way-ANOVA, P > 0.05). These findings 
suggest that HBO activated MDMФ participate in the clearance of apoptotic cells, and 
that this process is ROS-dependent. In addition, uptake of apoptotic neutrophils by 
MDMФ that are exposed to HBO may contribute to the resolution of inflammation, 
because HBO-induced apoptosis up-regulated IL-10 mRNA expression. 
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6.1 Introduction 
Phagocytic clearance of neutrophils undergoing apoptosis acts a key point in the 
inflammatory response, and probably for the subsequent progression of wound healing. 
Apoptotic cells undergo specific surface changes that allow phagocytes to recognise and 
ingest them (Brouckaert et al., 2004). Exposure of phosphatidyl serine (PS) on the outer 
leaflet of the plasma membrane, due to loss of plasma membrane asymmetry, is 
essential for the uptake of apoptotic cells by macrophages (Fadok et al., 2001b, Fadok 
et al., 1992). Oxidation of PS is an integral feature of programmed cell death, and 
exposure of oxidised PS may also serve to enhance the clearance of apoptotic cells 
(Kagan et al., 2002). It is known that the oxidative burst via NADPH oxidase activity is 
critical for PS exposure in PMA-stimulated cells and macrophage uptake (Engelich et 
al., 2001).  
In chronic wounds, previous studies have demonstrated that inefficient clearance of 
apoptotic cells leads to chronic inflammation (Kaneto et al., 1999). While neutrophil 
recruitment to the wound site is required to remove bacterial infection, macrophages are 
essential for resolving inflammation. Although monocytes are recruited from peripheral 
blood to the wound site later, tissue macrophages are already present within the tissue to 
phagocytose cell debris and contaminating bacteria (Haney, 2000, Heinrich et al., 
2003). Depletion of macrophages, but not neutrophils, from wound sites delays wound 
healing (Leibovich and Ross, 1975). Diabetic wounds are characterised by elevated load 
of apoptotic cells (Darby et al., 1997) which may contribute in part to impaired 
apoptotic clearance activity of the macrophages at the diabetic wound site. This is 
supported by a study by Khan et al. (2010) that demonstrated that the impairment of 
macrophage phagocytosis in diabetic wounds resulted in an increase of apoptotic cells at 
the wound site which in turn prolonged the inflammatory phase and the progress of 
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wound healing. At the wound site, successful phagocytosis of apoptotic cells results in 
suppression of pro-inflammatory cytokines and the progression of wound healing (Lee 
et al., 1993, Khanna et al., 2010). Increased levels of the pro-inflammatory cytokines 
TNF-α and IL-6, together with decreased IL-10, are characteristic of non-healing 
wounds such as diabetic wounds (Werner and Grose, 2003). IL-10 is well known to 
suppress the inflammatory response (Moore et al., 2001). A major source of the 
cytokines in wounds is macrophages (Werner and Grose, 2003) which in chronic 
wounds produce higher levels of pro-inflammatory cytokines than those in acute 
wounds. This leads to the suggestion that the inflammatory response in chronic wounds 
is due in part to increased pro-inflammatory cytokine production by wound 
macrophages. 
Also, the presence of bacterial products at the chronic wound site may affect the ability 
of phagocytes to ingest apoptotic cells. Chronic wounds are characterised by the 
presence of high levels of LPS (section 1.3.1). LPS induces TNF- production and 
initiates the inflammatory response which in turn can influence apoptosis of 
inflammatory cells (Lee et al., 1993, Murray et al., 1997). A previous study by 
Michlewska et al. (2009), reported that LPS inhibited phagocytosis of apoptotic 
neutrophils that contributed in part to the LPS-induced TNF-α production (Feng et al., 
2010). 
HBO can exert profound effects on immune function (section 1.6.4.1). HBO treatment 
has been found to increase apoptosis in HL-60 cells, Jurkat cells and lymphocytes 
(Weber et al., 2009a, Ganguly et al., 2002). Moreover, HBO has been shown to reduce 
cytokine expression by monocytes and macrophages collected from rats or from human 
peripheral blood after stimulation with LPS (Lahat et al., 1995, Benson et al., 2003). 
Due to the immunosuppressive effects of HBO, the contribution of the clearance of 
apoptotic cells in terms of cytokine production remains unknown. Therefore, the effects 
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HBO on clearance of apoptotic cells by macrophages may be potentially important in 
the resolution of inflammation and hence on the progression of wound healing. There 
has been no work to date examining the effect of HBO on neutrophil phagocytosis by 
macrophages. Previous studies have shown that mechanical stimuli such as pressure can 
modulate cell morphology and function in other cell types (Basson et al., 2000, 
Thamilselvan and Basson, 2004). Recent evidence suggests that physical forces, for 
example pressure and repetitive strain, may alter macrophage functions. Monocyte 
migration and receptor expression in macrophages increases with pressure (40-130 
mmHg; Sakamoto et al., 2001). Additionally, in response to very high cyclic pressure or 
high pressure combined with endotoxin stimulation, macrophages produce pro-
inflammatory cytokines (Mattana et al., 1996, Miyazaki and Hayashi, 2001). The 
mechanisms responsible for these effects are still not defined. Therefore, the current 
study aimed to determine whether HBO-induced apoptosis was able to enhance 
neutrophil clearance by MDMФ in a non-inflammatory response. In order to elucidate 
the effects of HBO on resolution of inflammation and the potential involvement of 
ROS-mediated apoptosis in this process, monocyte-derived macrophages (MDMФ) 
from bovine blood were used as a macrophage model to phagocytose apoptotic 
neutrophils and to determine any associated up regulation in pro- and anti-inflammatory 
cytokine gene expression by MDMФ that had ingested apoptotic cells. Whilst bovine 
neutrophil apoptosis has been studied, there has been no work examining apoptosis and 
phagocytosis of these cells and the effects of HBO. Therefore this study was interested 
in addressing this process, as well as the mechanisms of the clearance of apoptotic 
neutrophils by MDMФ and their safe removal at the site of inflammation. 
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6.2 Materials and methods 
6.2.1 Tissue culture solutions 
Dulbecco’s Modified Eagle Medium (DMEM) and Hank’s Balanced Salt Solution 
(HBSS) without Ca
2+
 and Mg
2+
 were obtained from Gibco Liga Technologies (Paisley, 
UK). Fetal calf serum was purchased from Lonza (Wokingham, UK) and was heat 
inactivated (56 
○
C, 1 h) before addition to the media (10%). All tissue culture solutions 
were stored at 4 
○
C and warmed to 37 
○
C prior to use. 
6.2.2 Experimental design 
The work described in this chapter is split into consecutive parts. This was essential in 
order to explore the effects of HBO, pressure alone, hyperoxia, hypoxia and normoxia 
on phagocytosis of apoptotic neutrophils by MDMФ. Neutrophils isolated from bovine 
blood were used in apoptosis and phagocytosis assays either immediately after isolation 
from blood (fresh) or after incubation at 37 °C at 5% CO2 balanced with air for 22 h 
(aged). The first experiment was conducted to explore the effects of a 90-min exposure 
to different treatments on neutrophil apoptosis. This was achieved by measurements of 
viability (trypan blue and MTT, sections 2.1.5 and 2.1.6), annexin V/PI staining, DNA 
fragmentation measurement and morphological study of Wright-Giemsa stained fresh 
and aged neutrophils (section 2.1.4). Neutrophils from at least three animals were used 
for each experiment and each assay was carried out in triplicate. Neutrophils from an 
additional three animals were used for morphological studies of apoptosis post exposure 
to different oxygen conditions (Fig. 6.1). 
The second experiment aimed to test the phagocytosis of neutrophils by MDMФ. The 
experiment was achieved by co-culture of fresh or 22 h-aged neutrophils (following 90 
min treatment, section 2.1.1) with MDMФ for 1 h at 37 C under 5% CO2 (balance air). 
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Phagocytosis was assessed using either flow cytometry or histochemical detection of 
MPO activity. The expression of genes for both pro- and anti-inflammatory cytokines 
was measured before and after co-culture of fresh and aged neutrophils with MDMФ 
(Fig. 6.1). The extracellular production of H2O2 was also measured (section 2.1.3) as a 
marker of respiratory burst activity of neutrophils before and after co-culture with 
MDMФ. 
 
 
Fig. 6.1 Experimental design. Neutrophils and monocytes were isolated from bovine blood and were used 
for apoptosis and phagocytosis assays either immediately after neutrophil isolation (fresh) or after 22 h 
incubation at 37 °C under 5% CO2, balance air (aged). Firstly, neutrophils were exposed to different 
treatments for 90 min then assessed immediately or after 22 for apoptosis. This was achieved by (trypan 
blue/MTT) viability assay, annexin V/PI staining, DNA fragmentation and morphological study by 
Wright-Giemsa staining for signs of apoptosis. Secondly, phagocytosis of neutrophils was investigated by 
co-culture of fresh or 22 h-aged neutrophils (following exposure to different oxygen treatments for 90 
min with MDMФ for 1 h at 37 °C under 5% CO2 balance 95% air. Phagocytosis was assessed using either 
flow cytometry or histochemical detection of MPO.  
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6.2.3 Bovine blood 
Samples of blood were obtained from twenty Holstein cows (age 220 ± 60 d, 12 female, 
8 male) slaughtered at Gage’s Abattoir (Gage’s Farm, Ashburton, Devon, UK). The 
animals had no clinical symptoms of disease. 
6.2.4 Cell isolation and culture 
Both monocytes and neutrophils were isolated from bovine blood as previously 
described (Quinn et al., 2007). The method involved lysis of contaminating red blood 
cells (RBC) with density centrifugation in Histopaque
®
 1077/1119 to obtain pure 
suspensions of neutrophils and monocytes. Briefly, 50 ml of blood was collected into 
Vacutainer
TM
 tubes containing EDTA. Whole blood was centrifuged at 500 × g for 10 
min at 4 
○
C, and then Platelet Rich Plasma (PRP) was removed. The buffy coat, found 
at the plasma-red blood cell interface was collected, washed and re-suspended in 
DMEM at a concentration of 4 × 10
6
 cells ml
-1 
(Fig. 6.2). Cell suspensions 
(monocytes/lymphocytes, 0.5 ml per well) were plated into individual wells in 24 well 
plates and incubated for 1 h (37 
○
C, 5% CO2 balance air) to allow monocyte adherence. 
Following 1 h incubation, tissue culture medium was removed and non-adherent cells 
including contaminating lymphocytes were removed by washing twice in DMEM. 
The remaining RBC and leucocytes (mostly neutrophils) were split between three 50 ml 
centrifuge tubes, diluted with 5 ml of cold H2O and gently mixed for about 2 min in 
order to lyse the RBC. Immediately after this period 2.5 ml of 0.2% NaCl was added to 
restore isotonicity. The suspension was centrifuged at 200 × g for 5 min at 4 
○
C, after 
which the supernatant was removed. These steps were repeated twice if necessary to 
lyse remaining RBCs. To obtain highly purified and functional neutrophils, the crude 
neutrophil suspension was layered above 10 ml of Histopaque
®
 1077/1119 mixture 
(Sigma-Aldrich, Poole, UK) and centrifuged at 440 × g for 25 min at room temperature. 
 177 
 
The pelleted neutrophils and any contaminating mononuclear cells remained at the 
sample/medium interface. The neutrophil pellet was washed in 50 ml HBSS and 
resuspended in DMEM medium (Fig. 6.2). 
 
Fig. 6.2 Leukocyte isolation from freshly drawn bovine blood. Density centrifugation over Histopaque
®
 
1077/1119 leads to pelleting of neutrophils and formation a monocyte cell band which can be harvested 
and washed for further analysis. 
 
6.2.5 Generation of monocyte-derived macrophages (MDMФ) 
Monocytes differentiated into MDMФ using fresh heat-inactivated autologous serum, is 
a good model for the in vitro study of phagocytosis of apoptotic neutrophils by 
macrophages. Monocytes (4 × 10
6 
cells ml
-1
) were cultured in DMEM (containing 2 
mM glutamine, 100 U ml
-1
 penicillin and 100 µg ml
-1
 streptomycin) and 10% (v/v) heat-
inactivated bovine autologous serum (derived from platelet-rich plasma by re-
calcification with 20 mM CaCl2 for 1 h at 37 
○
C in glass tubes) and plated (0.5 ml per 
well) in 24 well plates. The cells were incubated under 5% CO2 (balance air). The 
medium was replaced every three days and the cells were used for experiments within 
seven days of plating. 
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6.2.6 Induction of apoptosis 
Following isolation from peripheral blood using Histopaque
®
 (section 6.2.4), 
neutrophils were cultured at 37 
○
C under 5% CO2 (balance air) at a concentration of 5 × 
10
6
 cells ml
-1
 in DMEM. After treatment with different oxygen conditions (section 
2.1.1), neutrophils were either used fresh or aged by transferring 0.5 ml aliquots of cell 
suspension in DMEM supplemented with 10% (v/v) autologous serum to each well of a 
24-well plate and incubating for 22 h, at 37 
○
C under 5% CO2 (balance air), during 
which time a proportion of the cells underwent apoptosis (Savill et al., 1989). Cells 
were harvested at the indicated times and resuspended in DMEM (free serum) and 
analysed immediately. 
6.2.7 Assay of neutrophil apoptosis by annexin V binding and propidium iodide with 
flow cytometry 
The annexin V/PI cell apoptosis assay is dependent upon the exposure of PS on the 
surface of apoptotic cells. One of the major features of apoptosis is the loss of 
membrane asymmetry, which results in the translocation of PS (normally located on the 
inner membrane leaflet) to the outer membrane leaflet. The PS can be quantified by 
using a specific phospholipid binding protein, annexin V and flow cytometry (Van 
Engeland et al., 1998). The conjugation with fluorescein isothiocynate (FITC) allows 
identification of annexin V binding by flow cytometry, and is often used in conjunction 
with another stain such as propidium iodide (PI). Propidium iodide is a stain that will 
only penetrate the damaged membrane of dead cells and bind to their DNA, and hence 
will identify dead cells from viable and early apoptotic cells (Zhang et al., 1999). 
Necrotic cells will stain with PI, while both of these stains will fail to stain live cells. In 
the early stages of apoptosis, cells will express PS and so will stain positive for annexin 
V, but will still have intact membranes, and so will exclude the PI stain. Neutrophils 
 179 
 
were pelleted by centrifugation at 400 × g for 5 min. This was done either immediately 
after isolation or after aging. Cells were then resuspended in DMEM, after which the 
percentage of apoptotic neutrophils was determined by flow cytometry. Cells were 
washed in cold PBS and resuspended at a concentration 1-2 × 10
6
 cells in annexin V 
binding buffer. The cells in 100 µl of annexin V binding buffer were pelleted, before 
addition of FITC-conjugated annexin V (5 µl; eBioscience, Hatfield, UK). The tubes 
were incubated on ice in the dark for 15 min after which the cells were washed and 
resuspended in 100 µl of annexin V binding buffer, after which PI (1 µg) was added (5 
µl). Flow cytometric analysis of cell suspensions was performed by using an Arial
TM
 II 
FACS (excitation 520 nm and emission 620 nm, Becton-Dickinson, San Jose, USA) 
within 1 h of staining. Data for 10,000 events was analysed for each sample using 
Becton-Dickinson FACS Diva software. Neutrophils were initially gated by their 
characteristic forward scatter (FSC) and side scatter (SSC) profiles. Cell debris was 
gated out before analysis, on the basis of FSC and SSC properties. Controls included to 
set up compensation and quadrants were (1) cells stained with FITC-labelled annexin-V 
alone and (2) cells stained with PI alone. Cells were defined as apoptotic (AV
+
/PI
-
), late 
apoptotic (AV
+
/PI
+
), dead (AV
-
/PI
+
), or viable (AV
-
/PI
-
). Each subpopulation was 
expressed as a percentage of the total population of neutrophils (Fig. 6.3). 
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Fig. 6.3 Bovine neutrophils populations detected after staining with FITC-annexin V/PI. Neutrophils were 
stained with both FITC-annexin V and PI, and then analysed using flow cytometry. The plot of FITC-
annexin V/PI fluorescence was then used to differentiate the cells in various stages of cell death. 
Neutrophils were initially gated by their characteristic forward scatter (FSC) and side scatter (SSC) 
profiles. Cell debris and residual macrophages were gated out before analysis on the basis of forward- and 
side-scatter properties. Controls included to set-up quadrants were: cells stained with FITC-labelled 
annexin-V alone and cells stained with PI alone. Dead cells were defined as Annexin V
-
 and PI
+
 (Q1); late 
apoptotic cells were annexin V
+
 and PI
+
 (Q2); viable cells were annexin V
-
 and PI
-
 (Q3); and early 
apoptotic cells were annexin V
+ 
and PI
-
 (Q4). 
 
6.2.8 Assay of DNA fragmentation in apoptotic neutrophils 
During apoptosis, activated nucleases degrade the higher order chromatin structure of 
DNA into fragments (DNA laddering). This is considered to be an important marker of 
apoptotic cell death in many cell types. These fragments can be extracted from cells and 
visualized by agarose gel electrophoresis (Counis and Torriglia, 2000, Filipski et al., 
1990). 
Determination of apoptotic cell death was confirmed by detection of DNA laddering 
using gel electrophoresis. Briefly, apoptotic neutrophils were collected and washed with 
PBS, and the DNA was extracted with a Wizard
®
 genomic DNA purification kit 
(Promega Corp., Madison, WI, USA) according to the manufacturer
’
s instructions. 
Neutrophils were washed in PBS before addition of 150 µl of lysis buffer and 
subsequent mixing. Samples were then applied to the Wizard
®
 SV mini-spin columns 
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(placed in collection tubes) and centrifuged for 3 min at 13,000 × g. The eluate was 
discarded and columns were transferred to fresh collection tubes. Wash solution (650 
µl) was then added to the columns/collection tubes and centrifugation carried out as 
before. The columns were again transferred to clean collection tubes and eluate 
discarded. Washing with 650 µl of wash solution was repeated three times, giving a 
total of four washes of the minicolumns. To eliminate the possibility of wash solution 
carry over, collection tubes containing eluate were discarded and columns placed in 
fresh tubes for centrifugation at 13,000 × g for 2 minutes. The Wizard
®
 SV 
minicolumns were transferred to fresh 1.5 ml tubes and 250 µl of room temperature, 
nuclease-free water added to each and incubated for 2 min before being centrifuged at 
13,000 ×g for 1 min. DNA samples were stored at -80 
○
C until use. DNA fragmentation 
in neutrophils was assessed qualitatively by agarose gel electrophoresis. Extracted DNA 
samples were loaded on to a 1% agarose gel, containing SYBR
®
 Safe (1×) and 1 × TAE 
(section 2.1.7.4) for 1 to 2 h at 90 V. The gel was visualized under UV a using a 
visualiser (UVItec Limited, England). Gel images were evaluated for low molecular 
weight DNA fragments separated in size by 180 to 200 base pairs, a hallmark of 
apoptosis (Wyllie et al., 1980). DNA fragment sizes were determined by using DNA 
size marker (a mixture of fragments of known sizes; New England Biolabs, Hitchin, 
UK) providing molecular size markers of 0.5 to 12 kbp. A standard curve was plotted 
by measuring the distance migrated for each band on the gel (Fig. 6.4). 
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Fig. 6.4 DNA size marker was used to produce a standard curve. DNA size marker (0.5 to 12 kbp) was 
used to determine the DNA fragment sizes by measuring the distance migrated for each band on the gel. 
 
 
6.2.9 Detection of phagocytosis of apoptotic cells by flow cytometry 
For the flow cytometric phagocytosis assay, a previously described method was applied 
(Rossi et al., 2006). Neutrophils were used as targets to assess MDMФ phagocytosis by 
flow cytometry. Neutrophils were labelled with the fluorescent dye Tracker
TM
 Green (5-
chloromethyl fluorescein diacetate, CMFDA, 492 nm excitation and 516 nm emission, 
Invitrogen, Paisley, UK) at a final concentration of 2 μg ml-1 and seeded in 24-well 
plates at 5 × 10
6
 cells ml
-1
 for 15 min at 37 
○
C under 5% CO2, balance air. Target cells 
were then collected for co-culture with phagocytes. 
For co-culture, 0.5 ml of suspension containing 5 × 10
6
 target cells was added to each 
MDMФ-containing well (which had been washed with HBSS without Ca2+ and Mg2+ 
following 6-8 days differentiation, section 6.2.5), after which the cells were exposed to 
different conditions (section 2.1.1). Finally they were co-cultured at 37 
○
C under 5% 
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CO2 (balance air) for 1 h. After incubation, non-ingested neutrophils and medium were 
removed from the wells by washing with PBS. The remaining cells, i.e. MDMФ with 
ingested neutrophils, were detached from the plates using 300 µl of 0.25% trypsin/1 
mM EDTA for 15 minutes at 37 
○
C followed by 15 minutes at 4 
○
C (to avoid any 
clumping of cells leading to blockage of the flow cytometer’s sample intake nozzle), 
washed and resuspended in PBS and transferred to FACS tubes. In order to ensure that 
all the MDMФ were removed from wells, plates were examined by light microscopy. 
Cells were analysed using an Arial
TM
 II FACS (Becton-Dickinson San Jose, USA) using 
FACS Diva software
©
 (Becton-Dickinson) with (excitation 492 nm/ emission 517 nm). 
All quadrants were set up according to matched controls including unstained MDMФ 
and neutrophils stained with Tracker
TM
 green alone. 
Neutrophils and MDMФ that had ingested apoptotic neutrophils were separated (gated) 
by FSC and SSC profile, and at least 10,000 events were counted in each sample within 
the MDMФ gate. Uningested neutrophils were identified by the combination of their 
green fluorescence (FL-positive) due to Tracker
TM
 green labelling and their relatively 
smaller size (FSC) when compared with the MDMФ (Fig. 6.10). MDMФ populations 
were gated based on FSC and SSC scatter characteristics, and MDMФ demonstrating 
green fluorescence (FL-positive) were deemed to have ingested apoptotic neutrophils. 
The percentage of MDMФ that had ingested neutrophils was calculated: the number of 
Tracker
TM
 green positive
 
events/total number of MDMФ × 100 (Michlewska et al., 
2009). All results are reported as the percentage of total cells which were stained. 
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6.2.10 Detection of phagocytosis of apoptotic cells by light microscopy 
This assay is based upon identification of MPO activity, a component of neutrophil 
primary granules. MDMФ are fixed with glutaraldehyde and stained for MPO using 
H2O2 and dimethoxybenzidine as substrates. MPO activity leads to formation of a 
soluble yellow-brown product detectable by light microscopy (Hart et al., 1997). 
In order to assess phagocytosis by microscopy, MDMФ were incubated with 
neutrophils as described in section 6.2.9. Following phagocytosis, medium was 
removed from each well and the wells were washed three times with ice-cold PBS to 
remove all non-engulfed neutrophils. Next, the cells were fixed with 2.5% 
glutaraldehyde in PBS for 10 minutes and stained for MPO activity using one part of 
0.1 mg ml
-1
 dimethoxybenzidine as substrate to one part of freshly prepared 0.03% (v/v) 
H2O2 in PBS. To achieve an appropriate level of staining, cells were incubated at 37 
○
C 
for 60 min at room temperature. Finally, uptake of apoptotic neutrophils by MDMФ 
was assessed by light microscopy (Nikon, Japan). MDMФ that had ingested neutrophils 
were MPO positive (yellow-brown reaction product), while MDMФ which had not been 
MPO negative. Phagocytosis of apoptotic neutrophils was assessed by counting 500 
cells per three replicate wells. The percentage of MDMФ that had ingested different 
numbers of apoptotic neutrophils was expressed as phagocytosis percentage. 
6.2.11 Measurement of TNF-α and IL-10 expression using qPCR 
MDMФ were cultured at 5 × 106 cells ml-1 and stimulated with LPS (100 ng ml-1) for 2 
h before addition of neutrophils, and co-cultured for 1 h at 37 
○
C. They were then 
washed in PBS to remove non-ingested neutrophils. MDMФ that had ingested apoptotic 
neutrophils were detached from plate (section 6.2.9), washed in PBS and pelleted. Total 
RNA was isolated, cDNA synthesised and qPCR for TNF-α and IL-10 genes was 
carried out (section 2.1.7.5). For gene expression measurements, neutrophils were 
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stimulated with LPS (100 ng ml
-1
) for 2 h and total RNA was isolated and processed for 
qPCR as described above. 
6.2.12 Statistical Analysis 
Data are expressed as means ± SEM. Statistical analysis was carried out using 
Statgraphics Centurion XVI software (Stat Point Technologies, Inc.). Following the 
Andersen-Darling and Levene’s tests, data were analysed by two-way ANOVAs 
(parametric data) or Kruskal-Wallis (non-parametric). After two-way ANOVA, if the 
interaction was non-significant, Tukey’s test was used. If the interaction was significant, 
the data for fresh and 22 h-aged neutrophils were further analysed separately by one-
way ANOVA followed by Tukey’s. A P value of < 0.05 is considered significant 
throughout. 
 
6.3 Results 
6.3.1 Cell purity after isolation 
Isolated monocytes and neutrophils were assessed for purity using an Arial
TM
 II FACS 
flow cytometer (Becton-Dickinson, San Jose, USA). Forward scatter (SSC-A) and side 
scatter (FSC-A) were used to identify cell populations based on size and granularity. 
Morphological analysis of Wright-Giemsa stained cytospin preparations was also used 
(Figs 6.5A and B). Figure 6.5A shows the flow cytometer light scattering profiles of 
monocyte and neutrophil preparations, which were isolated using Histopaque
®
 
1077/1119. Monocyte and neutrophil preparations were routinely above 95% purity. 
Figure 6.5B shows cytospin preparations of monocytes and neutrophils visualized with 
modified Giemsa staining and light microscopy using a ×100 oil immersion objective. 
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Neutrophils are characterized by the presence of multi-lobed nuclei and monocytes by 
large ‘folded’ nuclei. 
 
Fig. 6.5 Purity of monocytes and neutrophils. Monocytes and neutrophils were isolated from freshly 
drawn bovine blood by Histopaque
®
 1077/1119. Whole blood (left) and neutrophil (right) preparations 
were assessed for purity by flow cytometry (A) and cell morphology (B). Neutrophils are characterized 
by the presence of multi-lobed nuclei and monocytes by large ‘folded’ nuclei. 
 
6.3.2 Effect of treatments on neutrophil viability 
Cell viability using trypan blue and MTT assays was assessed in fresh neutrophils and 
22 h-aged neutrophils and the results are presented in Figs. 6.6A and B. A significant 
interaction between time and treatment was found for trypan blue and MTT (two-way 
ANOVA, P < 0.05). There was a statistically significant decrease in the percentage cell 
viability in 22 h-aged neutrophils (two-way ANOVA, P < 0.00005 for trypan blue and 
MTT) compared with fresh neutrophils post different treatments. A significant decrease 
in viability was observed for both fresh and 22 h-age neutrophils pre-exposed to HBO, 
pressure, hyperoxia compared with normoxia (one-way ANOVA, P < 0.05 for trypan 
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blue and MTT). Hypoxia pre-treatment had no significant effect on the percentage cell 
viability in fresh and 22 h-aged neutrophils (98.8 ± 1.8, 74.6 ± 0.8%, trypan blue and 
84.6 ± 1.9, 64.1 ± 5.0%, MTT for fresh and 22 h-aged neutrophils, respectively) 
compared to normoxia (Figs 6.6A and B). 
Fig. 6.6 Neutrophil cell viability (% relative to normoxia) after pre-treatment with hypoxia, hyperoxia, 
pressure and HBO. Neutrophils were isolated from bovine blood and exposed to a range of conditions for 
90 min (section 2.1.1). After exposure, cells were washed, then immediately assayed or aged for 22 h to 
induce apoptosis. Cell viability was assessed using trypan blue (A) or MTT (B). Data are expressed as 
means ± SEM for three separate experiments with triplicate measurements (n = 3). Results are normalised 
against viability of fresh neutrophils pre-treated with normoxia for both trypan blue and MTT assays; 
control values were (86.5 ± 19.5% and 0.326 ± 0.057, respectively) for both fresh and aged neutrophils. * 
indicate significant differences from fresh neutrophils. For each treatment bars with the different lower 
case letters are significantly different (ANOVA, P < 0.05).   
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6.3.3 Effect of treatments on apoptosis 
The effects of different treatments on neutrophil apoptosis were assessed using several 
assays: FITC-annexin V/PI staining via flow cytometry, morphology using Giemsa 
staining and DNA fragmentation. Fig. 6.7A shows an example of neutrophils stained 
with FITC-annexin V/PI using fluorescence microscope after pre-treatment with 
normoxia (control). Cells staining with red fluorescence indicate late apoptosis, while 
cells staining with green fluorescence indicate early apoptosis. Fig. 6.7B shows the cell 
populations at different stages of death for both fresh and aged neutrophils after HBO 
treatment as measured using flow cytometric analysis. Following HBO treatment there 
was a significant increase in the cell population in late apoptotic (Q2) and early 
apoptotic (Q4).  
Dual staining with FITC-labelled Annexin V and PI showed a significant decrease in 
the percentage of live and an increase in early apoptotic cells in fresh neutrophils 
assayed immediately after HBO or pressure treatments (one-way ANOVA, P = 0.045 
and 0.02, respectively) compared with normoxia (81.2 ± 3.4 and 10.4 ± 1.5% for live 
and early apoptosis, respectively; Fig. 6.8A). Both hyperoxia and hypoxia pre-
treatments showed no significant effect on the levels of live cells (51.8 ± 12.7 and 84.5 
± 3.5%, respectively) and early apoptotic cells (12.7 ± 1.8 and 8.0 ± 2.1%, respectively). 
Also, there was no significant difference between treatments in the percentage of the 
cell population that was late apoptotic or dead compared to normoxia (6.4 ± 1.6% late 
apoptotic cells and 2.7 ± 1.4% dead cells, Fig. 6.8A). The same pattern was seen with 
neutrophils aged for 22 h post different treatments. There was a significantly higher 
proportion of early apoptotic cells (Kruskal-Wallis, P = 0.03) and a corresponding 
decrease in live cells (Kruskal-Wallis, P = 0.02) post-HBO and pressure treatments 
compared with normoxia (60.2 ± 8.7% live cells and 12 ± 4.3% early apoptotic cells, 
Fig. 6.8B), but not following hyperoxia (40.6 ± 9.0% live cell and 20.3 ± 5.7% early 
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apoptotic cells) and hypoxia treatments (70.4 ± 11.5% live cells and 11.8 ± 4.2% early 
apoptotic). Aged neutrophils also demonstrated no significant difference in the 
percentage of late apoptotic and dead cells (one-way ANOVA, P > 0.05) post 
treatments compared with normoxia (12.0 ± 2.1% late apoptotic cells and 17.9 ± 1.9% 
for dead cells, respectively). To further assess the effects of different treatments on 
neutrophil apoptosis, morphological changes were analysed by light microscopy using 
modified Wright-Giemsa staining (Figs 6.9A and B). These changes include membrane 
blebbing but not loss of integrity, nuclear and cytoplasmic condensation and 
fragmentation, and formation of apoptotic bodies. There was a significant increase in 
morphological changes that are typically observed during apoptosis in 22 h-aged 
neutrophils compared to fresh neutrophils (two-way ANOVA, P < 0.005). A significant 
increase was observed in morphological changes relating to cell apoptosis in both fresh 
and 22 h-aged neutrophils after exposure to HBO, pressure and hyperoxia (two-way 
ANOVA, P < 0.00005; Fig. 6.9B), compared with normoxia (15.1 ± 1.2%, fresh 
neutrophils and 21.9 ± 4.2%, aged neutrophils). As expected, the hypoxia treatment 
significantly decreased apoptosis of both fresh and 22 h-aged neutrophils compared 
with normoxia (Fig. 6.9B). 
The cleavage of chromatin into multi-nucleosome sized fragments also indicates that 
cell death has occurred via apoptosis. Figs 6.10A and B show the DNA ladders 
observed on agarose gels for fresh and 22 h-aged neutrophils after treatments. The 
amount of fragmented DNA in 22 h-aged-neutrophils increased compared to fresh 
neutrophils. The only characteristic DNA profile detected in fresh neutrophils was 
immediately after HBO treatment confirming cell death via apoptosis (Fig. 6.10A). The 
degree of DNA fragmentation was more marked in 22 h-aged neutrophils after HBO, 
with less genomic DNA visible (Fig. 6.10B). However, lower but detectable DNA 
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fragmentation was observed in 22 h-aged neutrophils after pressure, hyperoxia and 
hypoxia treatments compared to normoxia (Fig. 6.10B). 
 
Fig. 6.7 Representative analysis of neutrophil morphology and cell populations assessed via flow 
cytometry. Neutrophil cell apoptosis was determined by staining of 22 h-aged neutrophils with FITC-
annexin V (green) and PI (red) (section 6.2.8) using fluorescence microscopy (A) Neutrophils isolated 
from bovine blood were treated with normoxia or HBO or for 90 min. After exposure the cells were 
washed and then immediately assayed or aged for 22 h to induce apoptosis. Cells were stained with FITC-
annexin V and PI, and analysed using flow cytometry (section 6.2.8) (B). Neutrophils were initially gated 
by their characteristic forward scatter (FSC) and side scatter (SSC) profiles. Cell debris and residual 
macrophages were gated out before analysis on the same basis. Controls included to determine quadrants 
were: cells stained with FITC-labelled annexin-V alone and cells stained with PI alone. Dead cells were 
defined as annexin V
-
 and PI
+
 (Q1); late apoptotic cells were annexin V
+ 
and PI
+
 (Q2); viable cells were 
annexin V
-
 and PI
-
 (Q3); and early apoptotic cells were annexin V
+ 
and PI
-
 (Q4). 
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Fig. 6.8 Neutrophil populations after pre-treatment with normoxia, hypoxia, hyperoxia, pressure, and 
HBO. Neutrophils were isolated from bovine blood and exposed to a range of conditions for 90 min 
(section 2.1.1). After exposure, cells were washed, and then assayed immediately (fresh neutrophils) (A) 
or aged for 22 h to induce apoptosis (B). The proportions of dead, viable, late and early apoptotic 
neutrophils were assessed by flow cytometry after staining with both FITC-conjugated annexin V and PI 
(section 6.2.7). Data are expressed as means ± SEM for three separate experiments (n = 3) with triplicate 
measurements. * significant difference versus normoxia (Kruskal-Wallis, P < 0.05). 
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Fig. 6.9 Morphological analysis of apoptosis by light microscopy in neutrophils pre-treated with 
normoxia, hypoxia, hyperoxia, pressure and HBO. Neutrophils were isolated from bovine blood and 
exposed to a range of conditions for 90 min (section 2.1.1). After exposure, cells were washed, and then 
assayed immediately (fresh neutrophils) or aged for 22 h to induce apoptosis before assay. Cytospin 
preparations (500 g for 5 min) of neutrophils stained with Giemsa stain were used to analyse cell 
apoptosis morphology (A). Light microscopy of neutrophils (A) showing morphological changes in fresh 
and 22 h-aged neutrophils after exposure to normoxia and HBO. Neutrophils were characterised by their 
multi-lobed nuclei (upper left panel). Bold arrows indicate nuclear and cytoplasmic condensation and 
fragmentation. Cells were stained with Wright-Giemsa stain. In cells pre-treated with HBO there was a 
higher percentage of cells with typical features of apoptosis compared to those pre-treated with normoxia. 
Data are expressed as means ± SEM for three separate experiments (n = 3) with triplicate measurements. 
For each treatment bars with the different lower case letters are significantly different (two-way ANOVA, 
P < 0.05; B). 
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Fig. 6.10 An example of the electrophoretic ladder pattern of DNA fragmentation from neutrophils pre-
treated with normoxia, hypoxia, hyperoxia, pressure and HBO. Neutrophils were isolated from bovine 
blood and exposed to a range of conditions for 90 min (section 2.1.1). After exposure, cells were washed, 
and then assayed immediately (fresh neutrophils) (A) or aged for 22 h to induce apoptosis before assay 
(B). The DNA was extracted from cells (section 6.2.8) run on 1% agarose gels containing SYBR
®
 Safe 
(1×), and visualized under UV. 
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6.3.4 Effects of treatments on phagocytosis of neutrophils 
Representative flow cytometric dot-plots demonstrating MDMФ uptake of apoptotic 
neutrophils upon treatment with different treatments are presented in Fig. 6.11A. The 
populations of apoptotic neutrophils and MDMФ that had ingested apoptotic 
neutrophils were gated into quadrants that match the controls (unstained MDMФ and 
apoptotic neutrophils stained with Tracker
TM
 green alone): Tracker
TM
 green-stained 
apoptotic neutrophils (high fluorescence, low forward scatter, Q1); MDMФ that had 
phagocytosed neutrophils (high fluorescence, high forward scatter, Q2); unstained 
neutrophils (low fluorescence, low forward scatter, Q3) and MDMФ that had not 
ingested apoptotic neutrophils (low fluorescence, high forward scatter, Q4). 
Phagocytosis of fresh neutrophils was increased by HBO to 18.9% compared with 
normoxia (12.4%) and of aged neutrophils to 30.2% compared with normoxia (14.6%; 
Fig. 6.11A). 
The percentage of MDMФ that had ingested neutrophils labelled with TrackerTM green 
was assessed by flow cytometric analysis and the results are presented in Fig. 6.11B. As 
expected, phagocytosis of 22 h-aged neutrophils by MDMФ was significantly increased 
(two-way ANOVA, P < 0.005) compared with fresh neutrophils. Immediately after 
HBO and pressure treatments, MDMФ co-cultured with fresh and 22 h-aged neutrophils 
were characterized by a significantly increased uptake of neutrophils (two-way 
ANOVA, P < 0.00005) compared to normoxia (6.8 ± 0.8% fresh neutrophils and 12.9 ± 
0.9% 22 h-aged neutrophils; Fig. 6.11B). No differences in MDMФ phagocytosis of 
fresh and 22 h-aged neutrophils were observed after hyperoxia (10.9 ± 3.3% and 22.0 ± 
2.2%, respectively) and hypoxia (8.3 ± 1.0% and 10.4 ± 1.7, respectively) pre-
treatments compared with normoxia (6.8 ± 0.9% and 12.9 ± 0.9%, respectively, Fig. 
6.11B). 
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Phagocytosis of apoptotic cells by MDMФ was further confirmed by light microscopic 
examination of cytocentrifuged preparations of MDMФ after the phagocytosis assay 
had been performed. This analysis clearly showed the presence of MPO-positive cells 
inside MDMФ (Fig. 6.12A). Quantification of % phagocytosis confirmed the FACS 
data in that MDMФ were shown to be more able to uptake 22 h-aged neutrophils than 
fresh neutrophils following different treatments (two-way ANOVA, P = 0.009). In 
common with the flow cytometric results, MDMФ exhibited a higher capacity to 
phagocytose fresh and 22 h-aged neutrophils immediately after HBO and pressure 
treatments (two-way ANOVA, P < 0.00005) compared with normoxia (29.9 ± 1.3% and 
34.6 ± 2.4% for fresh and 22 h-aged neutrophils, respectively). Exposure to hypoxia did 
not produce a significant change in percentage phagocytosis of neutrophils (22.3 ± 2.3% 
and 29.2 ± 1.6% for fresh and 22 h-aged neutrophils, respectively) compared with 
normoxia (Figs 6.12A and B). 
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Fig. 6.11 Flow cytometry analysis of phagocytosis of neutrophils by MDMФ after pre-treatment of the 
neutrophils with normoxia, hypoxia, hyperoxia, pressure and HBO. Neutrophils (either fresh or 22 h 
aged) were labelled with Tracker
TM
 Green and co-cultured with MDMФ, after which they were exposed 
to a range of conditions for 90 min (section 2.1.1). Cells were washed and analysed using flow cytometry. 
Examples of flow cytometry dot blots demonstrating MDMФ that have or have not engulfed neutrophils 
for fresh and 22 h-aged neutrophils after exposure to HBO or normoxia (A). The results are presented as 
the percentage of MDMФ that had ingested neutrophils (B). Data are expressed as means ± SEM for three 
separate experiments (n = 3) with triplicate measurements. For each treatment bars with different lower 
case letters are significantly different (two-way ANOVA, P < 0.05).  
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Fig. 6.12 Light microscopic detection of phagocytosis of neutrophils by MDMФ after pre-treatment of the 
neutrophils with normoxia, hypoxia, hyperoxia, pressure and HBO. Fresh or 22 h-aged neutrophils 
neutrophils were co-cultured with MDMФ and exposed to a range of conditions for 90 min (section 
2.1.1). After exposure, cells were washed, fixed and stained for MPO, and then were analysed using light 
microscopy. Light microscopic analysis demonstrating MDMФ that had engulfed apoptotic neutrophils 
for both fresh and 22 h-aged neutrophils after exposure to HBO or normoxia. MDMФ that had ingested 
neutrophils contain a yellow-brown reaction product (MPO-positive cells). MDMФ that had not ingested 
neutrophils were MPO-negative (A). Results are presented as the percentage of MDMФ that had ingested 
neutrophils. Data are expressed as means ± SEM for three separate experiments (n = 3) with triplicate 
measurements. For each treatment bars with different lower case letters are significantly different (two-
way ANOVA, P < 0.05; B).  
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6.3.5 Oxidants mediate neutrophil clearance by MDMФ: possible effects of HBO 
The H2O2 concentrations in the supernatants from PMA-stimulated fresh or 22 h-aged 
neutrophils cultured alone or after co-culture of these with MDMФ are shown in Fig. 
6.13A. H2O2 levels showed a significant increase in fresh neutrophils and 22 h-aged 
neutrophils post treatment with HBO, pressure and hyperoxia (two-way ANOVA, P < 
0.00005) compared with normoxia (22.0 ± 0.5 and 18.7 ± 0.1 nmol per 10
6
 cells for 
fresh and 22 h-aged neutrophils, respectively). In contrast, hypoxia pre-treatment had no 
effect on H2O2 levels in fresh and 22 h-aged neutrophils (26.3 ± 0.8 and 20.6 ± 2.3 nmol 
per 10
6
 cells, respectively; Fig. 6.13A) compared with normoxia. 
HBO and pressure pre-treatments gave a significant increase in H2O2 levels in MDMФ 
that had ingested fresh or 22 h-aged neutrophils (two-way ANOVA, P < 0.00005) 
compared with normoxia (27.5 ± 0.6 and 35.1 ± 2.8 nmol per 10
6
 cells in MDMФ that 
had ingested fresh and 22 h-aged neutrophils, respectively). No treatment effects were 
observed on H2O2 levels in co-cultures of MDMФ with fresh or 22 h-aged neutrophils 
after pre-treatment to hyperoxia (31.3 ± 0.7 and 41.5 ± 0.4 nmol per 10
6
 cells, 
respectively) and hypoxia (26.0 ± 1.3 and 38.0 ± 0.2 nmol per 10
6
 cells, respectively, 
Fig. 6.13B). 
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Fig. 6.13 H2O2 release by isolated neutrophils and MDMФ that had ingested neutrophils after exposure to 
normoxia, hypoxia, hyperoxia, pressure and HBO. Neutrophils were isolated from bovine blood exposed 
to a range of conditions for 90 min (section 2.1.1). After exposure, fresh or 22 h-aged neutrophils were 
assayed after stimulation with 100 ng ml
-1 
PMA (A). For co-culture experiments (B) fresh or 22 h-aged 
neutrophils were stimulated with PMA, incubated with MDMФ and exposed to a range of conditions for 
90 min. H2O2 levels in the medium were determined in both neutrophils and MDMФ that had ingested 
neutrophils using HRP/homovanillic acid (section 2.1.3). These are expressed as the amount of H2O2 
produced per 10
6
 cells. Data are means ± SEM for three separate experiments (n = 3) measured in 
triplicate. For each treatment bars with different lower case letters are significantly different (two-way 
ANOVA, P < 0.05). 
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6.3.6 Effects of HBO on TNF-α and IL-10 gene expression following phagocytosis 
of apoptotic neutrophils 
It has been proposed that clearance of apoptotic neutrophils results in a non-
inflammatory response (Fox et al., 2010). Therefore the functional consequences of 
phagocytosis of apoptotic neutrophils by MDMФ were investigated by measuring the 
cytokine gene expression (TNF-α and IL-10) of fresh neutrophils, 22 h-aged neutrophils 
and MDMФ that had ingested neutrophils following different treatments and 
stimulation with 100 ng ml
-1 
LPS using qPCR. For fresh and 22 h-aged neutrophils 
cultured alone, the data were normalised against fresh neutrophils under normoxia (Figs 
6.14A and B) while co-culture data were normalised against MDMФ cultured alone 
(Figs 6.14C and D). HBO, pressure and hyperoxia significantly up-regulated the gene 
expression of TNF-α in fresh and 22 h-aged neutrophils (two-way ANOVA, P < 
0.00005; Fig. 6.14A) compared to normoxia (1.0 ± 0.0 and 1.5 ± 0.2 fold changes for 
fresh and 22 h-aged neutrophils, respectively). Hypoxia pre-treatment had no effect on 
gene expression of TNF-α in fresh and 22 h-aged neutrophils (1.3 ± 0.4 and 2.1 ± 1.1 
fold changes, respectively). 
A significant interaction was found between different treatments and time (fresh and 22-
h aged neutrophils) for IL-10 expression (two-way ANOVA; P < 0.009). Because of the 
interaction, the data were further analysed using one-way ANOVA. The only significant 
increases in IL-10 gene expression were observed with fresh and 22 h-aged neutrophils 
after HBO treatment (one-way ANOVA, P < 0.05; Fig. 6.14B) compared with normoxia 
(1.0 and 0.29 ± 0.08 fold for fresh and 22 h-aged neutrophils, respectively ). 
A significant interaction was found between different treatments and time (fresh and 
22h-aged neutrophils) for IL-10 in MDMФ which had ingested fresh and 22 h-aged 
neutrophils (two-way ANOVA; P= 0.008). Following MDMФ stimulation with 100 ng 
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ml
-1
 LPS and co-culture with fresh neutrophils for 1 h at 37 C for quantification of 
phagocytosis, no change was found in TNF-α gene expression in MDMФ that had 
ingested fresh and aged neutrophils after different treatments (two-way ANOVA, P 
<0.05; Fig. 6.14C) compared with normoxia (1.73 ± 0.34 for fresh neutrophils and 0.99 
± 0.02 for 22 h-aged neutrophils fold induction compared with MDMФ). 
There was a significant increase in IL-10 gene expression in MDMФ that had ingested 
fresh and 22 h-aged neutrophils after pre-treatment with HBO, pressure and hyperoxia 
(two-way ANOVA, P = 0.0008; Fig. 6.14D) compared with normoxia (3.07 ± 1.17 for 
fresh neutrophils and 6.4 ± 1.2 for 22 h-aged neutrophils fold induction compared with 
MDMФ). Because of the interaction, the data were further analysed using one-way 
ANOVA. The only significant increases in IL-10 gene expression were observed with 
fresh neutrophils following hypoxia (one-way ANOVA, P = 0.047). No change was 
found in IL-10 expression in MDMФ that had ingested fresh neutrophils following 
HBO, pressure and hyperoxia (7.07 ± 2.41, 0.94 ± 0.21 and 4.3 ± 1.4 fold induction 
compared with MDMФ) compared with normoxia (3.07 ± 1.17 fold induction compared 
with MDMФ). A significant increase in IL-10 was found in MDMФ that had ingested 
22 h aged neutrophils following exposure to HBO, pressure and hyperoxia (one-way 
ANOVA, P = 0.0008). Exposure to hypoxia had no effect on IL-10 gene expression in 
MDMФ that had ingested 22 h-aged neutrophils (8 79 ± 2.41 fold induction compared 
with MDMФ; Fig. 6.14D) compared to normoxia (6.43 ± 1.23 fold induction compared 
with MDMФ). 
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Fig. 6.14 TNF-α and IL-10 expression by neutrophils and MDMФ that had ingested neutrophils after 
treatment with normoxia, hypoxia, hyperoxia, pressure and HBO. Neutrophils were isolated from bovine 
blood exposed to a range of conditions for 90 min (section 2.1.1). After exposure, cells were washed and 
either used immediately (fresh neutrophils) or after 22 h of aging. Cells were stimulated with 100 ng ml
-1 
LPS and assayed (A and B) or co-cultured with MDMФ (C and D). Neutrophils co-cultured with MDMФ 
were exposed to a range of conditions for 90 min (section 2.1.1). qPCR was used to determine RNA 
expression under different treatments, and expression was normalised against endogenous controls. Gene 
expression under different treatments is expressed as a fold change in expression versus fresh neutrophil 
under normoxia (A and B) or MDMФ cultured alone (C and D). Data are means ± SEM for three separate 
experiments (n = 3) measured in triplicate. For each treatment bars with different lower case letters are 
significantly different (two-way ANOVA, P < 0.05). 
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6.4 Discussion 
It was not clear from in vitro studies whether HBO could alter the ability of MDMФ to 
phagocytose the apoptotic neutrophils, as this process is seen as an important step in the 
resolution of inflammation and the progress of wound healing. The hypothesis behind 
the present study was that oxidative stress contributes to the apoptosis of neutrophils 
and that this perhaps augments macrophage clearance mechanisms. Flow cytometric 
analysis using FITC-annexin V/PI, assessment of morphological changes, and DNA 
fragmentation assays demonstrated that HBO and pressure induced apoptosis in both 
fresh and 22 h-aged neutrophils after exposure. Studies of this type should be conducted 
with care as cells can display morphological features of apoptosis without DNA 
fragmentation and it is also possible that DNA fragmentation assays give false positive 
results during necrosis (Yasuhara et al., 2003, Grasl-Kraupp et al., 1995). Therefore, it 
is important that at least two different methods are used in the quantification of 
apoptosis, to confirm the data and to ensure the different stages of apoptosis are 
investigated. In this chapter, cell viability was assessed using trypan blue and MTT 
reduction, although these assays give only a crude indication of cell states, and are not 
able to indicate early apoptosis of cells. Hence, dual staining with annexin V and PI was 
used to identify cells that were undergoing early or late apoptosis, or necrosis, and so to 
give the whole progression of cell death after different treatments. 
There was an increase in the proportion of neutrophils displaying morphological 
features characteristic of apoptosis including nuclear chromatin condensation (observed 
by light microscopy) and DNA fragmentation over 22 h of aging. Flow cytometric 
assays with fresh or 22 h-aged neutrophils demonstrated a high percentage of early 
apoptotic cells after HBO and pressure treatments. Despite differences in relative 
methods, all three assays showed a significant increase in the percentage of apoptotic 
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neutrophils after exposure to HBO with the greater apoptotic response detected in 22 h-
aged neutrophils. These data are in agreement with the observations described in 
Chapter 5 with neutrophil-like cells. Previous studies have demonstrated that HBO is 
able to induce apoptosis in vitro in cultures of Jurkat-T cells (Ganguly et al., 2002, 
Chen et al., 2007b), HL-60 cells (Ganguly et al., 2002), NCI-H929 cells (Chen et al., 
2007b) and murine thymocytes (Ganguly et al., 2002). 
The present work is the first to demonstrate the effects of HBO in inducing apoptosis in 
bovine neutrophils. Subsequently, several assays were conducted to investigate the 
mechanisms involved in HBO-induced apoptosis of neutrophils. One of the mechanisms 
proposed for the enhanced spontaneous neutrophil apoptosis in this study, is that 
neutrophil-induced apoptosis is a function of oxygen partial pressure. HBO has been 
shown to up-regulate NADPH oxidase activity and caspase-3/7 activity, which suggests 
that HBO-induced ROS production may enhance apoptosis, resulting in the formation 
of pro-apoptotic substances in the cells or in the medium (Matsunami et al., 2011). It is 
well known that mitochondrial-generated ROS are involved in the release of 
cytochrome c and other pro-apoptotic proteins from mitochondria, therefore HBO-
induced apoptosis could be via the mitochondrial pathway (Weber et al., 2009a). 
Neutrophils have at least semi-functional mitochondria. This idea of semi-functionality 
is mainly based on the observation that mitochondrial poisons such as cyanide do not 
influence cellular functions in neutrophils (Borregaard and Herlin, 1982). Moreover, 
electron microscopy studies have identified hardly any mitochondria in neutrophils 
(Fossati et al., 2003) with very low mitochondrial respiration in these cells (Peachman 
et al., 2001). However, the mitochondria has been recently visualised as a tubular 
network by specific fluorescent dyes (Maianski et al., 2002, Fossati et al., 2003). Also, 
in neutrophils undergoing spontaneous or induced apoptosis, the mitochondria form 
clusters to where pro-apoptotic Bax protein is localized to produce permeabilization of 
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the outer mitochondrial membrane with subsequent release of additional pro-apoptotic 
proteins (Maianski et al., 2002, Pryde et al., 2000). Thus the exogenous H2O2 released 
by the activity of xanthine oxidase or glucose oxidase, induces apoptosis in neutrophils 
(Rollet-Labelle et al., 1998). Also, endogenous production of ROS has been shown to 
be involved in the activation of apoptosis by Fas and TNF-α (Kasahara et al., 1997, 
Scheel-Toellner et al., 2004, Van Den Berg et al., 2001). This agrees with the results 
presented here; HBO and pressure enhanced H2O2 production in both fresh and 22 h-
aged neutrophils post exposure, which in turn could have enhanced the neutrophil 
apoptosis. 
Other mechanisms could explain the results of the FITC-annexin V/PI assay. Annexin V 
binds to PS that has been externalised on the surface of cells undergoing apoptosis. 
Exposure to pressure could have caused deformation which leads to conformational 
changes that might enhance PS translocation to the outer leaflet of the cell membrane in 
order be recognised by annexin V. In the case of pressure alone, the present results 
showed an increase in cell apoptosis and a decrease in cell viability in fresh neutrophils 
and 22 h-aged neutrophils after exposure. Neutrophils aged for 22 h showed a 
significant increase in apoptosis and a decrease in viability after exposure to HBO. In 
contrast, the study by Weber et al. (2009b) demonstrated that 24 h after exposure to 
HBO (30 min at 2.8 ATA), there was no increase in apoptosis in mononuclear cells. A 
possible explanation of the differences observed between this study and the current 
study may be due to differences in exposure time and cell type used, as the behaviour of 
neutrophils in terms of the effect of oxygen tension on apoptosis is rather different to 
that observed in other cells (Nathan, 2003). 
Pre-treatment with hypoxia did not affect neutrophil apoptosis (fresh or 22 h-aged) and 
maintained cellular viability. These observations are in line with the previous studies 
using neutrophil-like cells as described in Chapter 5. 
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An important functional characteristic of macrophages is their ability to ingest apoptotic 
cells. Interestingly, the present data clearly indicate that HBO enhanced MDMФ 
ingestion of apoptotic neutrophils. MDMФ exhibited a higher capacity to ingest fresh 
neutrophils after HBO exposure, which confirmed the apoptotic effects of HBO that 
results in a high percentage of early apoptotic neutrophils that are targeted for 
phagocytosis. The morphological study showed the same pattern, although the 
differences in the percentages of phagocytotic cells observed in the flow cytometry 
assay and the morphological study was large. Several factors may have contributed to 
this difference, in particular that the data presented are from separate experiments with 
cells derived from different animals, and the assays were not performed in a side-by-
side comparison. In addition, no studies to date have investigated the effects of HBO on 
neutrophil clearance. Shiratsuchi and Basson (2004) found that increasing extracellular 
pressure to 20 mm Hg above ambient pressure stimulated phagocytosis of serum-
opsonized latex beads by PMA-stimulated THP-1 macrophages. These effects seemed 
to be due to inhibition of FAK-Y397 autophosphorylation and consequent inhibition of 
ERK activation. Similarly, the same authors demonstrated that exposure to pressure 20 
mm Hg above ambient pressure for 2 h also increased the phagocytosis of latex beads 
by monocytes that were isolated from human blood or MDMФ prepared by culturing 
with autologous unheated serum. These effects were mediated by p38 MAPKs which 
are activated by cellular stress and microbial phagocytosis in macrophages (Bertram et 
al., 1997). In the present study, cells were treated with HBO or pressure alone at 2.2 
ATA for 90 min. The flow cytometric analysis and light microscopy study have 
confirmed that HBO treatment affects MDMФ phagocytosis. The pressure utilized 
during HBO may have contributed to the phagocytosis percentage increase because 
hyperoxia treatment did not show the same effects as HBO treatment. 
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In addition, it is possible that oxidants may be responsible for an increase in 
phagocytosis of apoptotic cells, due to ROS generation during HBO treatment. Oxidants 
have been implicated in apoptosis associated with ageing neutrophils (Oishi and 
Machida, 1997, Kasahara et al., 1997). Therefore, treatments that stimulate oxidant 
release appear to accelerate this process (Kettritz et al., 1997, Harper et al., 2000). The 
present study suggests that functional NADPH oxidase may have a role in PS exposure 
in activated neutrophils as well as in their clearance by MDMФ. In the present study, a 
significant increase in H2O2 was observed after HBO, pressure and hyperoxia exposure 
in fresh and 22 h-aged neutrophils. Furthermore, the increase was correlated with 
enhanced neutrophil apoptosis, the process necessary for clearance of neutrophils. These 
results are in agreement with the work reported in Chapters 4 and 5, that indicated an 
increase of ROS and apoptosis in neutrophil-like cells post a 90-min HBO exposure. 
Recent studies have identified the ability of H2O2 to induce apoptosis in neutrophils 
(Rollet-Labelle et al., 1998, Lundqvist-Gustafsson and Bengtsson, 1999). Phosphatidyl 
serine exposure on apoptotic neutrophils can occur as a result of H2O2 production, 
enabling their uptake and clearance by macrophages (Hampton et al., 2002). Arroyo et 
al (2002) found that NADPH oxidase-induced oxidative stress in neutrophil-like cells 
initiated apoptosis and subsequent recognition and phagocytosis of these cells via 
pathways dependent on oxidation and externalization of PS. Therefore, the H2O2 
generated by both fresh neutrophils and 22 h-aged neutrophils following exposure to 
HBO and pressure has two functions, firstly to serve as a substrate for MPO to generate 
other microbiocidal agents, and secondly to trigger pathways that are needed for the 
clearance of neutrophils. These observations were confirmed by a marked increase in 
H2O2 levels in MDMФ that had ingested fresh and 22 h-aged neutrophils following 
HBO treatment. These findings are consistent with the previous suggestion of Fadeel et 
al. (1998) that PS externalisation in neutrophils may occur through two pathways for: a 
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caspase-dependent pathway activated during apoptosis and a ROS-dependent pathway 
that is involved in the clearance of activated cells. Patients with chronic granulomatous 
disease (CGD), whose neutrophils have a defective NADPH oxidase, are characterized 
by an accumulation of neutrophils at the wound site due to impaired neutrophil 
apoptosis and clearance (Amulic et al., 2012). This study suggests that a functional 
NADPH oxidase has a role in neutrophils and macrophages as part of the process of 
apoptotic cell clearance. 
The present study showed that exposure to hypoxia had no effect on MDMФ 
phagocytosis of fresh and 22 h-aged neutrophils observed by flow cytometry using 
Tracker Green and light microscopic examination. Although previous studies did not 
specifically examine the effects of hypoxia on MDMФ phagocytosis of apoptotic cells, 
such studies have clearly identified that neutrophil apoptosis was markedly inhibited 
under hypoxic conditions (Mecklenburgh et al., 2002, Walmsley et al., 2005). This 
effect involves a role of HIF-1α that regulates the most aspects of responses under 
hypoxic conditions (Walmsley et al., 2005). 
However, due to the complex regulatory effects of HBO on phagocytosis and the 
limited information from previous research on HBO, further investigation is needed to 
determine the phagocytosis signalling pathway, as well as to define the effects of HBO 
on MDMФ before co-culture with neutrophils in order to distinguish these effects from 
those after phagocytosis of apoptotic cells. 
Chronic wounds have been shown to be related to defects in the resolution of 
inflammation (Serhan et al., 2007). There are two main mechanisms involved in the 
resolution of inflammation: cell apoptosis and their subsequent clearance by 
macrophages (Gilroy et al., 2004). Therefore, the hypothesis in the present study was 
that HBO treatment enhances the clearance of apoptotic neutrophils in a non-
inflammatory process, which may involve effects on pro- and anti-inflammatory 
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mediators such as TNF-α and IL-10. Before ingestion by MDMФ, TNF-α gene 
expression was significantly increased in fresh neutrophils and 22 h-aged neutrophils 
following exposure to HBO, pressure and hyperoxia treatments. The maximal IL-10 
mRNA gene expression was observed in fresh and 22 h-aged neutrophils only after 
HBO treatment. This difference in the pattern of gene expression in 22 h-aged 
neutrophils is associated with higher percentages of dead and late apoptotic cells. The 
release of the cellular contents by dying cells leads to the development of a pro-
inflammatory response (Haslett et al., 1994, Haslett, 1992). In addition, in vitro culture 
of neutrophils could enhance TNF-α and IL-β release (Van Dervort et al., 1994). 
However, it is interesting that neutrophils (fresh and 22 h-aged) showed an increase in 
IL-10 mRNA gene expression when exposed to HBO that suggests that HBO mediates 
anti-inflammatory effects. The immunosuppressive effects of HBO have been identified 
in various studies (Inamoto et al., 1991, Satio et al., 1991, Lahat et al., 1995, Benson et 
al., 2003). The present study also showed that HBO, pressure and hyperoxia-mediated 
phagocytosis of apoptotic cells is associated with an increase in IL-10 gene expression. 
Uptake of fresh 22 h-aged neutrophils by MDMФ resulted an increase in IL-10 gene 
expression following HBO, pressure and hyperoxia treatments compared with 
normoxia, while no change was found in TNF-α levels in MDMФ that had ingested 
fresh or neutrophils after different treatments. Previously published data has 
demonstrated the regulatory role of IL-10 in phagocytosis of apoptotic cells (Savill, 
2000, Fadok et al., 1998, Voll et al., 1997). It was shown that the phagocytosis of 
apoptotic cells by macrophages is associated with suppression of the inflammatory 
response by decreasing the induction of pro-inflammatory cytokines such as TNF-α and 
IL-6 (Voll et al., 1997; Fadok et al., 1998; Savill, 2000). Previous studies have 
demonstrated that HBO inhibits LPS, lipid A and phytohaemaglutinin A-induced TNF-
α and IL-1β production, and PHA-induced production and mRNA gene expression 
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(mRNA) of Il-1β by human blood-derived monocytes-macrophages (Benson et al., 
2003). Another study examined the effects of HBO on pro-inflammatory cytokines 
(TNF-α, IL-6 and IL-8) in whole blood from healthy individuals previously stimulated 
with LPS; exposure to HBO enhanced cytokine release (Fildissis et al., 2004). IL-10 has 
been shown to inhibit TNF-α production (Xu et al., 2006) and up-regulate phagocytosis 
(Ogden et al., 2005). Phagocytosis of apoptotic neutrophils is dynamically regulated by 
the balance between pro- and anti-inflammatory cytokines, specifically TNF-α and IL-
10 (Fox et al., 2010). It is clear that exposure of cells to HBO enhanced apoptosis of 
neutrophils and this was associated with an increase in their clearance by MDMФ. In 
fact, uptake mediated by the PS exposure and recognition of apoptotic neutrophils has 
been associated with an anti-inflammatory response, where incubation of macrophages 
with lysed neutrophils induced the production of IL-8, TNF-α and IL-10 by 
macrophages (Fadok et al., 2001a). However, TNF-α production is highly controlled by 
a variety of complex mechanisms. TNF-α gene transcription involves a number of 
transcription factors such as red blooded (REB), LPS-induced TNF-α transcription 
factor (LITAF), activation transcription factor 2 (ATF-2), c-jun, early growth response 1 
(Egr-1) and NF-B (Skinner et al., 2008). For example, activation of NF-B by LPS 
induces the transcription of many pro-inflammatory cytokines (Baldwin, 1996). 
Therefore, suppression of NF-B has a key role in regulating inflammatory responses. 
Recent studies have identified NF-B as regulator of TNF gene activation (Hall et al., 
2005). The activation and translocation of NF-B to the nucleus results in transcription 
of various inflammatory genes including TNF-α (Meldrum, 1998). IL-10 inhibits the 
production of anti-inflammatory cytokines in human monocytes through the suppression 
of NF-B activation (Wang et al., 1995), and enhancement of the expression of the NF-
B inhibitor, IB (Lentsch et al., 1997). Our recent findings are that HBO induced 
apoptosis and suppression of NF-B gene expression and protein in neutrophil-like 
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cells. Furthermore, HBO treatment enhanced anti-inflammatory cytokine IL-10 
production. These observations suggest that HBO-enhanced clearance of apoptotic cells 
not only prevents the release of toxic intercellular contents, but also could stimulate the 
macrophages to produce anti-inflammatory or suppressive mediators, such as IL-10. 
Data obtained in the present study suggest the sequence of events shown in Fig. 6.15 
which suggest that HBO mediates activation of NADPH oxidase and consequently ROS 
production. Oxidative stress induced by HBO initiates apoptosis pathways and hence 
enhanced recognition of apoptotic neutrophils by MDMФ. 
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Fig 6.15 Diagram summarizing hypothetical effects of HBO on regulation of neutrophil clearance by 
macrophages. Exposure to HBO induces neutrophil apoptosis, followed by recognition and phagocytosis 
of intact apoptotic cells by macrophages. NADPH oxidase has a role in the process of macrophage 
elimination of activated neutrophils. HBO induces NADPH oxidase activation and ROS production 
which leads to initiation of the caspase cascade to induce neutrophil apoptosis via the intrinsic and 
extrinsic pathways, which in turn causes PS oxidation and its translocation from inner to outer leaflet of 
plasma membrane, acting as a main signal for macrophages to phagocytose these apoptotic cells. This 
process is also associated with anti-inflammatory effects on macrophages by decreasing the expression of 
pro-inflammatory cytokines and increasing anti-inflammatory cytokine production. 
 
6.4.1 Conclusion 
The findings presented here provide evidence that HBO enhances neutrophil engulfment 
by MDMФ. It is likely that the HBO effects are mediated by the generation of ROS and 
induction of neutrophil apoptosis that in turn accelerate their uptake by MDMФ. 
Furthermore, the data demonstrate another aspect in that HBO treatment is able to 
enhance the removal of apoptotic cells by MDMФ in a non-inflammatory process 
through decreased gene expression of TNF-α and increased gene expression of IL-10. 
Overall, this study provides new insights into the role of HBO in the regulation of the 
phagocytic removal of apoptotic cells, which may prove useful in developing a 
therapeutic approach to the resolution of inflammation. 
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CHAPTER SEVEN 
EFFECT OF LONG-TERM 
REPETITIVE HBO EXPOSURE ON 
PATIENTS WITH CHRONIC WOUNDS: 
AN IN VIVO STUDY 
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Abstract 
Although its clinical benefits are clear, HBO has also been reported to enhance ROS 
production and cause oxidative stress in several tissues. Recent studies have shown that 
HBO-induced oxidative stress is directly related to both its exposure to pressure and 
duration. However, these studies were performed with a single HBO treatment, whereas 
its clinical use depends on long-term, repetitive exposure. The purpose of this study was 
to determine the effect of long-term repetitive HBO in patients with chronic wounds. 
Four patients with chronic wounds were involved in this study and exposed to repeated 
HBO sessions (up to 40 sessions at 2.4 ATA for 90 min). Blood samples were taken 
immediately after 20, 30 and 40 sessions. Plasma antioxidant enzyme activities (CAT, 
GPx and SOD) and total ascorbate were measured as indirect markers of oxidative 
stress. Levels of pro- and anti-inflammatory cytokines were also measured to 
investigate the inflammatory response following repeated HBO exposures. 
Additionally, neutrophils were isolated from blood to investigate the expression of the 
anti-apoptotic genes, NF-B and Bcl-2. The findings demonstrated that long term-
exposure to HBO significantly decreased the antioxidant activity (CAT and SOD after 
30 HBO sessions; one-way repeated measures ANOVA, P = 0.005 and 0.02, 
respectively) and pro-inflammatory cytokines (TNF-α and IL-6 after 20 and 30 HBO 
sessions; one-way repeated measures ANOVA, P < 0.05) in plasma, with down 
regulation of NF-B and Bcl-2 in both unstimulated and stimulated cells after 20 and 30 
HBO sessions (two-way repeated measures ANOVA, P < 0.001). In conclusion, it is 
clear that repetitive treatment with HBO causes oxidative stress. Despite possible 
injurious effects, it is accepted that HBO-mediated ROS are responsible for the HBO 
immunosuppressive effects. 
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7.1 Introduction 
HBO therapy is used in the treatment of various clinical conditions, such as carbon 
monoxide poisoning, decompression sickness, osteomyelitis, and enhanced healing of 
selected problem wounds (Torbati et al., 1992). However, HBO has the potential risk of 
oxygen toxicity because 100% oxygen is breathed during the session (Thom et al., 
2002). The side effects of HBO are associated with prolonged exposure to levels greater 
than those generally used in clinical conditions (Harabin et al., 1990, Torbati et al., 
1992). It is assumed that hyperoxic injury is caused by the metabolic production of ROS 
at an increased rate that is dependent on oxygen tension, and which is in excess of the 
capacity of cell antioxidant defence mechanisms (Sies, 1997). In vitro studies have 
identified that O2
•-
, H2O2, and lipid peroxidation can be increased in homogenates, 
slices, and subcellular organelles of tissues such as lung and brain when the oxygen 
tension is increased (Freeman and Crapo, 1981, Jamieson, 1991). The clinically-
approved maximum pressure and duration of exposure is 3 ATA and 120 min and the 
common clinical protocol for standard HBO therapy is 1.8-2.8 ATA for 60-90 min 
(Kleen and Messmer, 1999). It has been reported that HBO toxic effects correlate with 
high pressures and long exposure durations (Harabin et al., 1990, Kleen and Messmer, 
1999, Wada et al., 2001). Furthermore, oxidative stress induced by HBO seems to be 
less of a concern at the 2.4 ATA pressure level often used clinically (Bitterman et al., 
1993). With repeated long-term exposure, HBO below 2 ATA can actually decrease 
oxidative stress (Yatsuzuka, 1991, Ozden et al., 2004) by inhibiting lipid peroxidation 
(Kudchodkar et al., 2000), and increasing the activity of the antioxidant enzymes, 
superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT), which 
are critical to the cell’s defences against oxidative stress-induced by ROS (Ozden et al., 
2004, Nie et al., 2006).  
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Hyperbaric oxygen is well known to exert a significant influence on immune function in 
general and cytokine production in particular (Al-Waili et al., 2006). It has been shown 
to inhibit the levels of pro-inflammatory cytokines (Hansbrough et al., 1980, Inamoto et 
al., 1991, Lahat et al., 1995, Satio et al., 1991), increase release of the anti-
inflammatory cytokine IL-10 (Yatsuzuka, 1991) and induce HSP-90 expression (Ozden 
et al., 2004). Hyperbaric oxygen also reduced both inflammation and pain in an animal 
model (Kudchodkar et al., 2000), but the molecular mechanisms mediating these 
immunomodulatory actions are still unclear. This evidence suggests that HBO may have 
some regulatory function on immune responses. HBO effects are generally attributed to 
its separate components, namely increased oxygen concentration and increased 
pressure. The anti-inflammatory effects of HBO seem to be pressure-dependent. For 
example, in one animal study, hyperbaric pressure without the addition of oxygen was 
shown to decrease TNF-α level (Nie et al., 2006). In another study in humans, HBO 
(100% O2 at 2 ATA) and hyperbaric pressure (10.5% O2 at 2 ATA) both resulted in a 
decrease in IFN-γ level in plasma, while exposure to 100% O2 at 1 ATA demonstrated 
the opposite effect (Akin et al., 2002, Luongo et al., 1998, Granowitz et al., 2002). 
Based on these findings, repeated exposures to HBO might help improve the resolution 
of inflammation in chronic wounds. HBO inhibits proliferation of the HL-60 
granulocytic cell line (Mcintyre et al., 1997), suppresses β-integrin-dependent 
adherence in both human and rat neutrophils (Thom, 1993, Thom et al., 1997) and 
causes a decrease in circulating CD4+ T cells (Bitterman et al., 1993, Bitterman et al., 
1994). HBO has been shown to induce cell apoptosis via oxidative stress and ROS 
production, these effects being time-dependent (Ganguly et al., 2002), and contributes 
to both in terms of increased pressure and hyperoxia. Repeated exposure to HBO (2.4 
ATA for 90 min, once daily for seven days) has been shown to induce further ROS 
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production and apoptosis via mitochondria in streptozotocin-induced diabetic rats 
(Matsunami et al., 2009). 
This study aimed to test whether long-term repetitive exposure to HBO would modify 
the antioxidant enzymes including CAT, GPx and SOD as indirect markers to evaluate 
oxidative stress following HBO exposure in patients with chronic wounds, and whether 
this is more potent than the influence induced by a single exposure to HBO in vitro (see 
Chapter 5). In addition, the immune response following a long-term repetitive exposure 
to HBO was also investigated, including whether it was modified during HBO 
treatments. This study may help to elucidate the mechanisms involved during HBO 
treatment in patients with chronic wounds. 
7.2 Materials and methods 
7.2.1 Ethical Considerations 
All studies reported in this chapter were approved by the Devon and Torbay Research 
Ethics Committee (REC reference number: 08/H0202/149, Exeter, UK). All patients 
were recruited from the Plymouth Hyperbaric Medical Centre (Diving Disease Research 
Centre, DDRC, Tamar Science Park, Plymouth PL8 8BU, UK) and given a minimum of 
24 h to consider participation before giving their consent to the DDRC. 
7.2.2 Experimental design 
Four patients with venous leg ulcers (male, n = 3 and female, n = 1; mean age of 65 ± 
5.9 years) were enrolled and were accepted to undergo HBO treatment between March 
2011 and November 2011. Patients who met the selection criteria (at least one chronic 
ulcer, wound present for six weeks or more, over 18 years of age and suitable for HBO 
therapy) were included in the study. All the patients were maintained on their medical 
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treatments such as insulin and antibiotics (e.g. flucloxacillin, fucidin, cefradine and co-
amoxiclav) throughout the course of the HBO treatment. 
Patients were exposed to HBO treatment (1 session per day) according to a routine 
therapy protocol. The multiplace chamber was pressurized with compressed air to 2.4 
ATA while the patients breathed 100% O2 through a mask for one period of 90 min, 
with 2 × 5 min intervals during which the patient breathed air. The patients were 
monitored after repeated exposure to HBO (20, 30 and 40 HBO sessions). A blood 
sample (20 ml) was taken from each patient before and after the 20, 30 and 40 HBO 
treatments using a 19 gauge needle to avoid mechanical stress, which can activate 
neutrophils. The blood was then immediately put in dipotassium-EDTA Vacutainer® 
tubes and kept at room temperature until analysis. Plasma samples were obtained by 
centrifuging the blood at 400 × g for 20-25 min at 4 °C. The supernatant was divided 
into 200 µl aliquots, and stored at -80 °C until analysis for antioxidant enzyme activities 
(as detailed below) and pro- and anti-inflammatory cytokines using a Luminex
®
 assay 
(section 2.1.8). 
Neutrophils were isolated from blood samples (section 2.1.9) for gene expression 
quantification using qPCR. Cell suspensions (1 ×10
6 
cells ml
-1
) were washed with PBS, 
and treated with 10 ng ml
-1 
TNF-α and incubated for 3 h at 37 °C at 5% CO2 (balance 
air). RNA was extracted and expression of NF-B and Bcl-2 genes was analysed using 
qPCR (section 2.1.7.5; Fig. 7.1). Based on the response to HBO treatment and the 
rate/quality of wound healing, just two patients continued through to the 40
th
 HBO 
session, which decreased the power of the study. 
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Fig. 7.1 Experimental design. Four patients (n = 4) with venous leg ulcers were enrolled in this study. 
Patients were exposed to HBO treatment (1 session per day) according to a routine therapy protocol in the 
multiplace chamber. Blood samples were taken from each patient after repeated exposure to HBO (20, 30 
and 40 HBO treatments). Plasma samples were obtained by centrifuging the blood at 400 × g for 20-25 
min at 4 °C and assessed for antioxidant enzyme activity, total ascorbate and pro and anti-inflammatory 
cytokines. Neutrophils were also isolated from blood for gene expression experiments. 
 
7.2 3 Biochemical analysis 
7.2.3.1 Catalase (CAT) assay 
Catalase activity may be determined in two successive steps. Firstly, catalase catalyses 
the dismutation of a known concentration of H2O2 to produce water and oxygen (O2), 
and secondly, Amplex Red reagent reacts with any unreacted H2O2 (catalysed by HRP) 
to produce the highly-fluorescent oxidation product, resorufin (Mueller et al., 1997). 
Following plasma sample preparation, 50 µl aliquots of the sample were added to each 
well of a 96-well plate, and then 25 µl of 40 µM H2O2 was added. The plates were then 
incubated for 30 min at 37 
○
C. After incubation, 50 µl of reaction buffer containing 100 
µM Amplex Red reagent and 0.4 U ml
-1
 of HRP (Sigma-Aldrich, Poole, UK) was added 
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to each well. The resulting fluorescence was measured using a CytoFluor II 
fluorescence microplate reader (PerSeptive Biosystems, Framingham, USA) with 
excitation 540 nm and emission 590 nm. The Amplex Red stock solution was prepared 
at 10 mM in DMSO and aliquots stored at -20 ºC. Catalase activity was calculated from 
a standard curve prepared using purified catalase (0-2000 U ml
-1
, Sigma, Poole, UK; 
Fig. 7.2). 
 
Fig.7.2 Standard curve of catalase assay. Catalase concentrations (0 - 2000 U ml
-1
) were prepared in assay 
buffer and the data points are the mean of triplicates ± SEM. A linear fit curve with R
2 
= 0.993 over a 
more limited range of catalase activities was used to calculate catalase activity (insert). 
 
7.2.3.2 Glutathione peroxidase (GPx) assay 
This assay measures GPx indirectly using a coupled reaction catalysed by glutathione 
reductase (GR). Oxidized glutathione (GSSG) is produced upon reduction of H2O2 
catalysed by GPx activity, and then recycled back to its reduced state (GSH) by 
NADPH (catalysed by GR). The oxidation of NADPH to NADP
+
 is accompanied by a 
 221 
 
decrease in absorbance at 340 nm, the rate of decrease being directly proportional to the 
GPx activity in the sample (Mannervik, 1985). 
Plasma from patients with venous leg ulcers was prepared as described in section 7.2.2 
The assay mixture was prepared by mixing 9.2 ml of buffer (5 mM potassium HEPES, 
pH 7.5, containing 1 mM dipotassium EDTA) with 1 mM NADPH, followed by the 
addition of 100 µl of 100 U ml 
-1 
glutathione reductase (GR; Sigma G3664), 50 µl of 
200 mM GSH, and 95 µl of 10 mM potassium cyanide. The assay mixture (290 µl) was 
added to each well of a 96 well plate, followed by 15 µl of plasma before mixing. The 
reaction was started by adding 5 µl of 0.042 % (w/w) H2O2 solution to each well. The 
rate of change of absorbance at 340 nm was measured for at least 10 min in a VersaMax 
plate reader (Molecular Devices, Sunnyvale, CA, USA). GPx activity was calculated in 
pmol ml
-1 
min
-1
. 
7.2.3.3 Superoxide dismutase (SOD) assay 
Superoxide dismutase activity can be measured indirectly through the reduction of 
cytochrome c by superoxide. The superoxide can be generated via the activity of 
xanthine oxidase (XO). The rate of reduction of cytochrome c (detected as the rate of 
increase of absorbance at 550 nm) is inhibited by SOD, thereby giving a measure of 
SOD activity (Mccord and Fridovich, 1969). 
The assay mix consisted of three reagents (xanthine, xanthine oxidase and cytochrome 
c) dissolved in potassium buffer (pH 7.8) stored at room temperature during use and at 4 
○
C between uses. Xanthine (0.5 mM) was prepared fresh each day and stored at room 
temperature during use. Xanthine oxidase (5 µl of Sigma X4500, diluted with 495 µl of 
potassium phosphate buffer, final concentration, 0.32 U ml
-1
) was prepared fresh each 
day and stored on ice during use. Cytochrome c (12.5 mg in 0.5 ml) was prepared in 
phosphate buffer (pH 7.8) and stored on ice during use and at -20 
○
C between uses. The 
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assay mixture was prepared from 8.85 ml potassium phosphate buffer, 1 ml xanthine 
and 50 µl cytochrome c. Superoxide dismutase was prepared fresh each day by diluting 
10 µl of a commercial (Sigma S8409, from bovine erythrocytes) with 90 µl buffer (final 
concentration, 960 U ml
-1
) and stored on ice during use. Assay mix (10 ml) was 
prepared just before use. This was sufficient for at least 32 wells. Plasma from patients 
with venous leg ulcers before and after HBO treatment was purified by centrifugation 
(400 × g for 5 min). Aliquots (50 µl) of plasma were added to the wells of a 96-well 
plate. Some wells were also used as controls either by replacing the sample with SOD 
or with buffer. Xanthine oxidase solution (100 µl) was added immediately before use to 
the assay mix, the wells were loaded as appropriate and readings started within 1 min of 
this addition. Assay mixture (250 µl) was pipetted into each well and mixed carefully. 
The plate was immediately transferred to the VersaMax plate reader (Molecular 
Devices, Sunnyvale, CA, USA), and the increase in absorbance monitored at 550 nm 
using a kinetic program for at least 5 min. All data are expressed as units ml
-1
. 
7.2.3.4 Determination of total ascorbic acid by high-performance liquid 
chromatography (HPLC) 
The well-known  method for  measuring ascorbic acid is HPLC with ultraviolet (UV) or 
electrochemical detection (Levine et al., 1999). For total ascorbic acid a sensitive HPLC 
electrochemical detector was used, which is based on a chemical reaction involving 
either oxidation or reduction of ascorbic acid, to produce an electron flow measurable as 
current, which may be correlated to the type and quantity of the ascorbic acid (Washko 
et al., 1989).  
Plasma or ascorbate standard (up to 200 µl) was mixed with 10% metaphosphoric acid 
(MPA; Sigma-Aldrich, Poole, UK) containing 2.0 mM EDTA to acidify the serum and 
stabilize the ascorbate. The tubes were capped and mixed well on a vortex mixer. The 
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mixture was centrifuged for 10 min at 20,000 × g at 4 °C. The supernatant (90 µl) was 
transferred to another tube and 10 µl of 350 mm of Tris (2-carboxyethyl) phosphine 
hydrochloride (TCEP) in 5% MPA containing 1 mM EDTA was added; the tubes were 
then capped and mixed well on a vortex mixer. The mixture was incubated for 20 min at 
room temperature to reduce oxidised dehydroascorbate back to ascorbate. The mixture 
was injected into a C-18 reversed-phase column and eluted with a mobile phase of 0.1 
M of sodium acetate containing 0.54 mM EDTA and 1.5 mM octylamine. Quantitation 
was by measurement of peak area and is based on a standard curve generated using 
different concentrations of known standards of ascorbate (5-50 µM; Fig.7.3). 
The chromatography system consisted of an LDC/Milton Roy ConstaMetric HPLC 
pump connected to a BAS LC-4L electrochemical detector (Bioanalytical Systems Inc., 
West Lafayette, IN, USA). The column was a Hichrom reversed-phase C18 column, 
189 × 4.8 mm, particle size 4 µm, operated at a flow rate 1-2 ml min
-1
. 
 
Fig. 7.3 Standard curve of ascorbate assay. Ascorbate concentrations (5-50 µM) were prepared in dH2O 
and the data points are the mean of triplicates ± SEM. 
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7.2.4 Statistical analysis 
Data were analysed using Statgraphics Centurion XVI software (Stat Point 
Technologies, Inc.). Data are expressed as means ± SEM (n = 4) for 0, 20 and 30 HBO 
sessions and were analysed using repeated measures ANOVA. A P value of < 0.05 is 
considered significant throughout. 
 
7.3 Results 
7.3.1 Effect of prolonged repeated HBO treatment on plasma enzymatic antioxidant 
defences 
After completion of HBO sessions (20 to 40 sessions) a significant decrease was 
observed in wound area in patients with chronic wounds (paired t-test, P = 0.032) 
compared to before treatment (control; Fig. 7. 4A). The activities of SOD, CAT and 
GPx were measured in the plasma of patients with chronic wounds before and after 
repeated HBO sessions. Before HBO treatment the activity values in the plasma were 
49.2 ± 3.6 U ml
-1
 for CAT, 2.9 ± 0.2 pmol min
-1 
ml
-1 
for GPx and 27.0 ± 2.4 U ml
-1
 for 
SOD. Exposure of the patients with chronic wounds to repeated HBO treatments 
resulted in a decrease in antioxidant enzyme activities. Following the 20 HBO sessions 
no significant decrease was observed in CAT, GPx and SOD activities (36.9 ± 4.0 U ml
-
1
, 2.7 ± 0.4 pmol min
-1 
ml
-1
 and 23.7 ± 1.3
 
U ml
-1 
respectively, Figs 7.5A, B, and C). A 
significant decrease in CAT (one-way repeated measures ANOVA, P = 0.005) and SOD 
(one-way repeated measures ANOVA, P = 0.02) was observed following 30 HBO 
sessions compared to before HBO treatment, whereas there was no significant decrease 
in GPx activity (one-way repeated measures ANOVA, P > 0.05, Figs 7.5A, B and C). 
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After 40 HBO sessions only two patients remained in the study. The antioxidant 
enzyme activities were decreased to 20.6 and 20.9 U. ml
-1
 for CAT, 1.8 and 1.7 pmol 
min
-1
 
 
ml
-1
 for GPx and 20.8 and 16.3 U ml
-1
 for SOD, but due to limited sample size (n 
= 2), it is uncertain whether this decline in antioxidant enzyme activity was significant 
(Figs 7.5 D, E and F). 
 
 
Fig.7.4 Wound area in the patients with chronic wounds after exposure to the repeated HBO sessions. (A) 
Wound area was measured in patients with chronic wounds before and at the end of long-term repetitive 
HBO treatments. * indicate significant differences from before HBO treatment. (B) Representative photo 
of a wound is shown before the initiation of HBO treatment, and after 30 HBO sessions. 
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Fig. 7.5 Plasma antioxidant activities in patients with chronic wounds after exposure to repeated HBO 
sessions. Plasma samples were isolated from the blood of patients with chronic wounds before and after 
exposure to repeated HBO sessions. Catalase activity was assessed in the presence of Amplex Red and 
HRP (A). GPx activity was assessed in the presence of NADPH and GR (B) and SOD activity was 
assessed in the presence of cytochrome c and XO (sections 7.2.3.1, 2 and 3). Data are expressed as means 
± SEM, for four patients, n = 4 with triplicate measurements. Bars with the different lower case letters are 
significantly different (one-way repeated measures ANOVA, P < 0.05). Scatter plot of catalase, GPX and 
SOD activities for all patients before HBO, after repeated 20 and 30 HBO sessions (n = 4) and after 40 
HBO sessions (n = 2; D, E and F). 
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7.3.2 Effect of prolonged repeated HBO treatment on non-enzymatic antioxidant 
defences 
The levels of the non-enzymatic antioxidant ascorbic acid were measured before and 
after HBO treatment in the plasma of patients with chronic wounds. There were no 
significant changes in total ascorbate (ascorbate + dehydroascorbate) at the end of the 
20 HBO sessions (12.5 ± 0.6 nmol ml
-1
) and the 30
th
 HBO session (11.7 ± 1.1 nmol  ml
-
1
) compared to before treatment (12.9 ±0.9 nmol ml
-1
; Fig. 7.6A). Since only two 
patients with chronic wounds continued until the 40 HBO sessions, it was not possible 
to analyse these data due to a limited sample size (n = 2, 10.1 and 8.6 nmol ml
-1
, Fig. 
7.6 B). 
 
Fig 7.6 Plasma ascorbate levels in the patients with chronic wounds after exposure to repeated HBO 
sessions. Plasma samples were isolated from blood of patients with chronic wounds before and after 
exposure to repeated HBO sessions. Ascorbate was measured using HPLC and calculated against a 
standard curve (see section 7.2.4.4). Data are expressed as the means ± SEM, for four patients, n = 4 with 
triplicate measurements. Bars with the same lower case letters are not significantly different (one-way 
repeated measures ANOVA, P > 0.05). Scatter plot of ascorbate levels for all patients before HBO, after 
20 and 30 HBO sessions (n = 4) as well as after 40 HBO sessions (n = 2; B). 
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7.3.3 Effect of prolonged repeated HBO treatment on pro- and anti-inflammatory 
cytokines in plasma 
 
The plasma levels of TNF-α, IL-1β, IL-6 and IL-10 were measured in patients with 
chronic wounds using the multiplex Luminex
®
 assay technique. Before HBO 
treatments, the values for TNF-α, Il-1β, IL-6, and IL-10 were 57.3 ± 6.6, 30.9 ± 4.9, 
45.6 ± 3.9 and 7.2 ± 1.2 pg ml 
-1
,
 
respectively (Figs 7.7A, B, C and D). Following the 20 
and 30 HBO sessions, TNF-α and IL-6 levels were significantly decreased in the plasma 
of chronic wound patients compared to before treatment (one-way repeated measures 
ANOVA, P = 0.002). IL-1β production was not significantly changed following 20 and 
30 HBO sessions (22.5 ± 3.6 and 20.3 ± 3.3, respectively) while no change was 
observed in IL-10 plasma levels after 20 and 30 HBO treatments (4.90 ± 0.3 and 8.4 ± 
0.3pg ml
-1
, respectively, Figs 7.7A, B, C and D). 
Exposure to repeated 40 HBO sessions decreased the TNF-α to 29.8 and 25.6 pg ml-1, 
IL1β to 6.5 and 9.5 pg ml-1 and IL-6 levels to 18.6 and 18.9 pg ml-1, whereas IL-10 
levels were increased to 17.7 ± 6.0 and 29.7 pg ml
-1
. Again, it was not possible to 
analyse these data due to a limited sample size (n = 2; Figs 7.7 E, F, G and H). 
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Fig. 7.7 Plasma pro- and anti-inflammatory cytokine levels in the patients with chronic wounds after 
exposure to the repeated HBO sessions. Plasma samples were isolated from blood from patients with 
chronic wounds before and after exposure to repeated HBO sessions. TNF-α, IL-1β, IL-6, IL-10 levels 
were analysed by Luminex (section 2.1.8) and calculated against a standard curve. Data are expressed as 
the means ± SEM, for four patients, n = 4 with triplicate measurements. Bars with the different lower case 
letters are significantly different (one-way repeated measures ANOVA, P = 0.002 for TNF-α and IL-6 
following 20 and 30 HBO sessions, A, B, C and D). Scatter plot of cytokines for all patients before HBO, 
after repeated 20 and 30 HBO sessions (n = 4) as well as 40 HBO sessions (n = 2) (E, TNF-α) (F, IL-1β) 
(G, IL-6) and (H, IL-10). 
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7.3.4 Effect of prolonged repeated HBO treatment on NF-B and Bcl-2 gene 
expression in neutrophils 
Gene expression of both NF-B and Bcl-2 was analysed by qPCR (Figs 7.8A and 7.9A). 
The gene expression of NF-B was significantly decreased after 20 and 30 HBO 
sessions in untreated cells and TNF-α treated cells (two-way repeated measures 
ANOVA, P < 0.001 fold change compared to untreated cells before HBO treatment; 
Fig. 7.8A). The same pattern was observed with Bcl-2 expression following 20 and 30 
HBO sessions in untreated and TNF-α treated cells (two-way repeated measures 
ANOVA, P< 0.001 fold induction compared to untreated cells before HBO treatment). 
Exposure to 40 HBO sessions decreased the expression of NF-B gene in TNF-α treated 
cells (0.24 and 0.15 fold induction compared to untreated cells before HBO treatment, 
respectively) and in untreated cells (0.08 and 0.04 fold induction compared to untreated 
cells before HBO treatment respectively). The same was also observed for Bcl-2 in 
TNF-α treated cells (0.21 and 0.13 fold induction compared to untreated cells before 
HBO treatment respectively) and in untreated cells (0.05 and 0.03 fold induction 
compared to untreated cells before HBO treatment respectively). Due to sample size (n 
= 2), it was not possible to analyse these data. The qPCR results for NF-B and Bcl-2 
were confirmed by visualisation of the PCR product using 1% agarose gel 
electrophoresis (Figs 7.8B and 7.9B). 
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Fig. 7.8 NF-B gene expression in neutrophils from patients with chronic wounds after exposure to 
repeated HBO sessions. Neutrophils were isolated from blood from patients with chronic wounds before 
and after exposure to repeated HBO sessions, after which cells were washed and either treated with TNF-
α or left untreated. cDNA was synthesised from extracted RNA. qPCR was used to determine expression 
of NF-B (section 2.1.7.5). Gene expression was normalised against the untreated cells before HBO 
exposure. Data are expressed as the means ± SEM, for four patients, (n = 4) with triplicate measurements. 
For each HBO session, bars with the different lower case letters are significantly different (two-way 
repeated measures ANOVA, P < 0.05) (A). The PCR product for NF-B, before and after exposure to 
long-term repeated HBO sessions in both TNF-α treated and untreated cells in 1% agarose gel. Lanes: 
before HBO unstimulated cells (1), before HBO TNF-α stimulated cells (2), 20 HBO sessions 
unstimulated cells (3), 20 HBO sessions TNF-α stimulated cells (4) 30 HBO sessions unstimulated (5) 
and 30 HBO sessions TNF-α stimulated cells (6, B). 
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Fig. 7.9 Bcl-2 gene expression in neutrophils from patients with chronic wounds after exposure to 
repeated HBO sessions. Neutrophils were isolated from blood from patients with chronic wounds before 
and after exposure to repeated HBO sessions, after which cells were washed and treated with TNF-α or 
left untreated. cDNA was synthesised from extracted RNA. qPCR was used to determine expression of 
Bcl-2 (section 2.1.7.5). Gene expression was normalised against the untreated cells before HBO exposure. 
Data are expressed as the means ± SEM, for four patients, (n = 4) with triplicate measurements. For each 
HBO session, bars with the different lower case letters are significantly different (two-way repeated 
measures ANOVA, P < 0.05, A).The PCR product for Bcl-2, before and after exposure to long-term 
repeated HBO sessions in both TNF-α treated and untreated cells in 1% agarose gel. Lanes: before HBO 
unstimulated cells (1), before HBO TNF-α stimulated cells (2), 20 HBO sessions unstimulated cells (3), 
20 HBO sessions TNF-α stimulated cells (4) 30 HBO sessions unstimulated (5) and 30 HBO sessions 
TNF-α stimulated cells (6, B). 
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7.4 Discussion 
Although sample size in this preliminary study was small and hence the results need to 
be treated with caution, nevertheless, the present work demonstrated a decrease in 
antioxidant enzyme activities after repeated exposure to HBO in patients with chronic 
wounds. This effect became apparent in patients after 20 HBO sessions, with significant 
effects observed after 30 HBO sessions as indicated by decreased antioxidant enzyme 
activity, particularly CAT, and SOD activities. Antioxidant enzyme levels, particularly 
SOD, have been shown to be related to increased oxidative stress and may be 
considered as potential indirect markers of it (Cherubini et al., 2005). One explanation 
for the present results is that HBO induced an oxidative stress response in patients with 
chronic wounds, which could have led to decreased antioxidant enzyme activities, as a 
consequence of oxidative damage. An alternative explanation for the decrease in 
antioxidant enzyme activities is that HBO enhanced the resolution of inflammation in 
patients with chronic wounds which led to a reduction in oxidative stress and 
consequently also to reduced antioxidant enzyme activities. Hyperbaric oxygen has 
been demonstrated to exhibit anti-inflammatory effects by modifying growth factor and 
cytokine effects by regulating their levels or receptors (Zhao et al., 1998, Benson et al., 
2003). The present results require further exploration and replication to confirm. A 
series of 15 HBO treatments has been shown to increase levels of reactive oxygen 
metabolites, malondialdehyde and decrease the activities of SOD and CAT in patients 
with pathological conditions related to hypoxia (Benedetti et al., 2004). The results of 
the current study corroborate this earlier finding because they demonstrated a decrease 
in CAT and SOD activities after 20 and 30 HBO
 
sessions with significant effects only 
after the latter, which suggests that the antioxidant enzymes could have been inactivated 
by singlet oxygen and peroxyl radicals after prolonged oxidative stress (Narkowicz et 
al., 1993). HBO has been identified to cause an increase in the production of ROS 
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(Narkowicz et al., 1993) and consequently can lead to oxidative stress (Bearden et al., 
1999). This depends on the toxic nature of the hyperoxic component of HBO (Wispe 
and Roberts, 1987). In addition, a clear relation for elevated levels of oxidative stress 
with both increased exposure pressure and time was demonstrated in lung tissue (Ay et 
al., 2007). However, an increased level of antioxidant enzyme activities in rat lung and 
erythrocytes was not found after a 90-min exposure (Ay et al., 2007). These 
observations provide evidence for the safety of HBO administration within the 
clinically-approved limit. Since the antioxidant enzyme activities were measured 
immediately after HBO sessions, the decrease in antioxidant activities is of particular 
importance indicating an uncontrolled oxidative effect in cases of 30 HBO exposures or 
more. Interestingly, oxidative DNA damage has previously been detected after a single 
HBO exposure but not after further treatments under the same conditions (Speit and 
Bonzheim, 2003), demonstrating the induction of an adaptive response. However, these 
protective mechanisms were not detected in cases where HBO treatment was repeated 
more than twice (Speit et al 2002). It seems that the results of the present study may be 
due to the fact that HBO treatment may cause uncontrolled oxidative stress in patients 
with chronic wounds when continued for more than 20 sessions as shown by a decrease 
of antioxidant enzyme activities (CAT and SOD) at the 30 HBO session but not after 20 
sessions, in spite of the adaptive responses after a single session of HBO. Additionally, 
HBO might affect antioxidant enzyme transcription or have an indirect effect through 
superoxide production (Oury et al., 2002) as the beneficial effects of HBO seems to be 
through superoxide and H2O2 (Hink and Jansen, 2001). Another possible explanation 
for a decrease in antioxidant enzyme activities is that HBO enhanced the resolution of 
inflammation in patients with chronic wound through its effects on cytokine levels, 
which caused a reduction in oxidative stress and consequently antioxidant enzyme 
activities. HBO has been demonstrated to exhibit anti-inflammatory effects by 
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modifying growth factor and cytokine effects by regulating their levels or receptors 
(Zhao et al., 1998, Benson et al., 2003). Further work should be conducted to 
investigate how HBO affects antioxidant enzymes (e.g. directly by gene transcription or 
indirectly through ROS production for example superoxide production) with varying 
durations of HBO exposure. 
In a previous study, a single exposure to HBO decreased ascorbate levels and elevated 
lipid peroxidation in human volunteers (Bader et al., 2007). Contrary to expectations, 
the current study did not find any change in ascorbate levels following repeated HBO 
treatment. One possible reason for this is that the depletion of antioxidants by oxidative 
stress activates signal transduction pathways leading to antioxidant mobilization in the 
body through the plasma (Elsayed, 2001). It should be noted that patients with chronic 
wounds generally have low ascorbate levels (Burns et al., 2003) and that it is possible 
that this might be accentuated by ROS production following HBO leading to excessive 
oxidative stress that overwhelms the endogenous cellular antioxidant mechanisms. 
However, the present study does not indicate that this is the case. Nevertheless, 
supplementing with antioxidants, such as ascorbate, during HBO treatment could 
potentially enhance the therapeutic effect of HBO (Alleva et al., 2005). As well as being 
an antioxidant, ascorbate has been shown to stimulate the rate of procollagen secretion 
in a cell culture system (Murad et al., 1981, Blanck and Peterkofsky, 1975) via the 
formation of hydroxyproline that provides stability for the procollagen triple helix (Berg 
and Prockop, 1973), whereas ascorbate deficiency is associated with defective 
connective tissue (Peterkofsky, 1991), impaired wound healing, weaker scars and 
abnormal capillary formation (Burns et al., 2003). 
The levels of cytokines in plasma or serum are often low and these levels are influenced 
by factors such as the length of time between the drawing of the patient’s blood to the 
separation of plasma, the temperature of storage, and repeated thawing and freezing 
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(Fletcher et al., 2009). Therefore, the availability of sensitive multiplex technology, in 
this case the Luminex
®
 assay, was useful in that it allowed the determination of multiple 
cytokines simultaneously in plasma samples as well as in control samples. Previous 
studies have examined in vitro effects of HBO on cytokine production (Van Den Blink 
et al., 2002, Brenner et al., 1999). These studies involved the measurement of cytokines 
in stimulated whole blood, mononuclear cells and the supernatants of cell culture in 
vitro, which may not be predictive of what occurs in vivo. In addition, they involved 
single exposures to HBO; while in reality patients often receive 20 or more HBO 
treatments. HBO treatment decreased plasma TNF-α in a murine zymosan-induced 
shock model (Luongo et al., 1998). However, in vivo effects of repeated exposure to 
HBO on plasma cytokine levels of patients with chronic wounds are still unclear. The 
present results demonstrated that HBO significantly decreased plasma TNF-α and IL-6 
after 20 and 30
 
HBO sessions compared to before HBO treatment. Although there was a 
trend for the levels of the anti-inflammatory cytokine IL-10 to increase after the 
repeated HBO sessions, this increase was not significant. Overall, the results suggest an 
immunosuppressive effect of HBO and that it has broad ranging effects on the adaptive 
immune response. HBO could be exerting its immunosuppressive effects by inducing 
apoptosis in cytokine-producing cells. For example, exposure to HBO can enhance 
apoptosis in murine thymocytes, lymphocytes, and granulocytic cell lines (Ganguly et 
al., 2002) and result in a decrease in circulating CD4
+
 cells in rats (Bitterman et al., 
1994) and humans (Bitterman et al., 1993). Neutrophil apoptosis may also contribute to 
the immunosuppressive effects of HBO treatment (Weber et al., 2009a). Therefore, it is 
suspected that in chronic wounds, the effects of HBO may involve the induction of 
apoptosis in neutrophils. Interestingly, repeated exposure to HBO treatment decreased 
Bcl-2 expression after the 20 and 30 sessions. Bcl-2 is part of a signal transduction 
pathway that counterbalances oxidative stress effects and protects the cells from ROS-
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mediated apoptosis (Hockenbery et al., 1993). A possible explanation for the present 
results is that ROS act to down-regulate endogenous Bcl-2 within cells, thus in different 
cell types, increases in ROS correlate with decrease in Bcl-2 and vice versa (Hildeman 
et al., 2003). Since levels of Bcl-2 within cells are critical to antiapoptotic activity, 
down regulation of Bcl-2 could be a mechanisms to sensitize cells to apoptosis. Bcl-2 
itself does not possess antioxidant activity, but it may act indirectly to increase 
antioxidants (e.g. glutathione or superoxide dismutase) within cells (Voehringer and 
Meyn, 2000, Lee et al., 2001). Thus, decreased expression of Bcl-2 may allow cells to 
be affected by ROS, possibly by allowing a decrease in endogenous antioxidant 
enzymes. The current results relating to CAT and SOD levels after repeated exposure to 
HBO support this hypothesis as repeated exposure to HBO lead to a decrease in 
antioxidant enzyme activities and Bcl-2 expression. Down regulation of the Bcl-2 
family is mediated by signal transduction involving transcription agents such as NF-B 
(Lee et al., 1999). The present results demonstrated a down regulation of NF-B after 
repeated exposure to HBO treatment which may result in down regulation of Bcl-2. 
It is widely accepted that HBO mediates its beneficial effect via ROS (Hink and Jansen, 
2001). The HBO effects on pro-inflammatory cytokine production could also have a 
stress-related and hyperoxia-dependent component which may be at least partly 
responsible for these effects. Additionally, the decrease in cytokine production by 
repeated exposure to HBO appears to involve transduction signals such as NF-B, a 
prominent signal transduction factor in the inflammatory processes, for example in 
TNF-α production. Therefore, NF-B is involved in immunodulatory signals of 
increased pressure or oxygen. In support of this notion, repeated exposure to HBO 
caused a significant decrease in NF-B expression after 20 and 30 HBO treatments in 
neutrophils from patients with chronic wounds as well as in neutrophil-like cells, while 
a single exposure to HBO (2.4 ATA, 90 min) led to a decrease in both NF-B gene 
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expression and protein levels (see Chapter 5). Thus, signal transduction through NF-B 
may be involved in the effects of long term exposure to HBO. Apoptotic cell death can 
be prevented by the expression of nuclear NF-B (Beg and Baltimore, 1996, Wang et 
al., 1996), which is responsible for controlling expression of genes involved in 
inflammation. This suggests that NF-B may also be a part of the signal transduction 
process that is involved in the cell survival mechanism (Barinaga, 1996). Previous 
studies have demonstrated an association between ROS production and NF-B 
activation (Sen and Packer, 1996, Shea et al., 1996). A single exposure to HBO (2.8 
ATA, 1 h) induced NF-B activation in isolated human peripheral-blood mononuclear 
cells (Madden et al., 2011), in mouse lymphocytes (Shea et al., 1996) and leukocytes 
(Dennog et al., 1996) in response to increased ROS generation. NF-B activity was also 
enhanced following DNA damage (Beg and Baltimore, 1996, Wang et al., 1996). 
Several factors can explain the difference between the results presented here with these 
studies. For example, the HBO exposure conditions used in this study may differ from 
those that patients might be exposed to in other studies. Another factor may be the type 
of cells used. For example, monocytes and lymphocytes were used in these studies as 
the cell viability was not affected by hyperoxia. However, in neutrophils the mechanism 
of HBO is different in that a single in vitro exposure to HBO was shown to induce 
apoptosis with increased ROS production in both neutrophil-like cells and neutrophils 
from bovine blood. In addition, in previous studies mentioned above, the NF-B 
activity was measured and not the NF-B mRNA gene expression as in the present 
study. Increased levels of mRNA do not necessarily result in similarly increased levels 
of NF-B activity; it is an estimate of the functional difference that occurs at the protein 
level. In a previous study, nuclear translocation and DNA-binding activity of NF-B 
failed to produce any significant difference in NF-B-dependent gene expression in 
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human monocytes exposed to a pulsed ultra-wideband electromagnetic field (Natarajan 
et al., 2006). Furthermore, other signals such as mechanical pressure which can affect 
G-protein-coupled receptors (GPCRs) that act as mechanoreceptors have been identified 
on different cells, including neutrophils (Zou et al., 2004) and may possibly affect NF-
B activation. This suggests that HBO-mediated down regulation of NF-B could be 
partly due to a pressure effect. 
However, it should be borne in mind that the presence or absence of cytokines in 
biological fluids such as plasma reflects a complex balance of enhancing and inhibitory 
signals acting on cells. Such signals regulate their production and catabolism, as well as 
their binding to target cells, and also the modulation of their receptors on the cell 
surface (Cavaillon et al., 1992). Plasma cytokines might be regarded as a spill over from 
the tissue, and their levels do not necessarily parallel their activity. In patients with 
sepsis, measurements of pro- and anti-inflammatory cytokine levels in plasma only 
indirectly reflected tissue secretion, and combining them with other measurements such 
as NF-B activity provided a useful record of the overall pattern of immunological 
events in these patients (Arnalich et al., 2000). Also, plasma cytokine levels poorly 
reflect the mRNA expression of pro- and anti-inflammatory cytokines in neonatal pigs 
(Brix-Christensen et al. (2003). Further in vivo studies may allow better investigation of 
the mechanisms of prolonged HBO treatment on cytokines and gene expression. 
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7.4.1 Conclusion 
In conclusion, repetitive HBO sessions led to a condition of oxidative stress in patients 
with chronic wounds that appeared to affect the antioxidant defence system. A possible 
explanation for the decrease in antioxidant enzyme activities is that paradoxically HBO 
exposure may result in short-term oxidative stress that induces immunosuppressive 
effects (a decrease in the pro-inflammatory cytokines, TNF-α and IL-6) which 
ultimately lead to a decrease in oxidative stress (reflected in the lowered plasma 
antioxidant enzyme activities). However, the decrease in plasma antioxidant enzymes 
could also be explained as direct oxidative damage as a consequence of the HBO 
treatment, and so further studies should focus on whether the changes in enzyme 
activity result from chemical modifications caused by reactive oxygen species or from 
changes in expression of the proteins. 
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CHAPTER EIGHT 
GENERAL DISCUSSION 
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8.1 General discussion 
HBO is a medical treatment in which patients are placed in a chamber pressurized to 
more than one ATA breathing 100% pure oxygen. HBO as a treatment has been 
established for a number of clinical and surgical conditions; for example it has been 
used for a range of inflammatory conditions. However, the exact mechanism of its 
action is still the subject of some discussion. 
HBO has been successfully prescribed as a treatment option for chronic wounds for at 
least 40 years (Kulonen and Niinikoski, 1968). Chronic wounds are common and 
persistent problems, with significant effects on quality of life with an additional 
economic cost (Kranke et al., 2004). The application of HBO has been shown to aid the 
healing of problematic wounds and it has been demonstrated to reduce the risk of 
amputations (Thackham et al., 2008). Wound healing is a highly regulated and 
interactive process involving three main phases, inflammation, proliferation and 
remodelling. There is a degree of overlap of these phases over time. There is a growing 
consensus that chronic wounds remain stuck in the inflammatory phase, with an 
overabundance and persistence of neutrophils (Agren et al., 2000, Yager et al., 1996). 
In fact, in chronic wounds the inflammatory response is characterized by continued 
neutrophil infiltration (Nwomeh et al., 1998b, Yager and Nwomeh, 1999). Despite their 
beneficial role in wound healing as part of the host’s defence against infection, 
neutrophils may have detrimental effects on wound healing by destroying growth 
factors and degrading ECM components via the production of proteolytic enzymes 
(Yager and Nwomeh, 1999, Agren et al., 2000). Neutrophil apoptosis is important in the 
successful resolution of inflammation, leading to down regulation of pro-inflammatory 
functions and their safe clearance by macrophages. Local hypoxia predisposes wounds 
to infection due to limited neutrophil-mediated killing of bacteria by ROS. Exposure to 
HBO restores this defence against infection and improves the rate of healing. Although 
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these effects enhance the host defence, the overall effects of HBO appear to be 
immunosuppressive (Brenner et al., 1999). The mechanisms by which these effects are 
produced remain largely unrecognised. Therefore, research is essential in providing 
sufficient scientific evidence for the therapeutic application of HBO and to elucidate the 
mechanisms involved in order to improve treatment protocols and the subsequent 
benefits to patients. 
It is widely accepted that breathing oxygen at pressures greater than 1 ATA will 
increase production of ROS (Thom, 2011). This is critical for the therapeutic action of 
HBO. While oxidative stress caused by ROS may mediate damage to surrounding tissue 
and cells, ROS also have a role in signal transduction cascades, and can generate 
positive or negative effects depending on their concentrations and their intracellular 
localisation. Therefore, the present study focused on the effect of HBO on the 
inflammatory response of neutrophils and how significant modification of their action 
could affect the resolution of inflammation in patients after treatment. 
Firstly, the effect of a single exposure to HBO was investigated on the antimicrobial 
activity of neutrophil-like cells and their apoptosis, obtained by differentiation of HL-60 
cells using ATRA. The study also investigated with neutrophil-like cell apoptosis and 
their subsequent clearance by MDMФ, measured after a single exposure to HBO, and 
investigated whether this is associated with HBO-induced ROS production. Changes in 
pro- and anti-inflammatory cytokine production by neutrophil-like cells were also 
investigated. An in vivo study was conducted to investigate the effect of prolonged 
exposure to HBO on patients with chronic wounds. 
The research presented here has provided evidence of anti-inflammatory effects of HBO 
and their role in the resolution of the inflammatory response in the pathogenesis of 
chronic wounds. The most important evidence was the significant increase in neutrophil 
apoptosis and their clearance by macrophages following a single exposure to HBO (2.4 
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ATA, 90 min). These effects appear to be partly due to HBO-mediated ROS production. 
The study further supported the previous research and confirmed the 
immunosuppressive effects of single exposure to HBO through a decrease in pro-
inflammatory cytokines and promotion of anti-inflammatory cytokines in neutrophil-
like cells. In addition, this work has highlighted some interesting features of HBO, such 
as the effects of pressure which have not been fully explained (Fig. 8.1). 
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Fig. 8.1 Proposed mechanisms by which HBO affects neutrophil function and apoptosis based on the 
findings of the present study. Exposure to HBO increases oxygen delivery and enhances the respiratory 
burst activity and ROS production by neutrophils, which in turn improves antimicrobial activity. This, 
combined with improved neutrophil apoptosis and neutrophil clearance via phagocytosis by macrophages, 
reduces pro-inflammatory cytokine levels and increases levels of the anti-inflammatory cytokine, IL-10. 
This results in resolution of the inflammation. Red arrows highlight the findings of the present study. 
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The inflammatory response and subsequent wound healing are principally dependent on 
cellular immune elements (neutrophils and macrophages) leading to a recognizable 
physiological response. As well as encountering invading microorganisms, these cells 
also produce signalling molecules that actively participate in wound healing. Research 
to date regarding clinical treatments remains limited in terms of understanding the 
cellular events of tissue injury and inflammation. Although it is becoming clear that 
neutrophil apoptosis is critical for resolving inflammation, phagocytic activity of 
neutrophils is still required for proper macrophage function and wound healing. What is 
not yet clear is the degree to which the clinician’s attempts to minimize the neutrophil-
mediated tissue damage through accelerating apoptosis might interfere with neutrophil 
functions in wound healing. Elucidating this balance is a key target in understanding the 
resolution of inflammation and the wound healing progress. Clinical therapies may 
focus on modifying the cellular response at the tissue and immune cell levels, possibly 
to decrease the detrimental effects of inflammation and enhance wound healing 
(Butterfield et al., 2006). Recently, ROS-mediated neutrophil apoptosis has been 
suggested as an essential step for the generation of neutrophil extracellular mediators 
that bind and kill invading microorganisms (Fuchs et al., 2007). 
Since therapeutic HBO treatment demonstrates the beneficial effects of resolving 
inflammation and chronic wound healing, the mechanisms involved suggest a strong 
relationship between HBO treatment and ROS. In vitro and in vivo studies suggest 
contradictory evidence on this subject (Hink and Jansen, 2001, Benson et al., 2003, 
Thom et al., 2008, Thom, 2009). However, previous research has identified the key 
HBO effect as being ROS formation. For a long time, ROS generation by HBO was 
considered to be a detrimental factor inducing unexpected damage to tissue and cells. 
However, more recent evidence has identified that ROS production is balanced with 
antioxidant defence systems, and that this balance is essential for the redox signalling 
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system. Therefore, ROS at moderate levels are able to regulate cell functions 
(Trachootham et al., 2008). 
The present study investigated the effects of a single HBO treatment on antimicrobial 
activity and apoptosis of neutrophils. HL-60 cells differentiated using ATRA were used 
as a well-defined neutrophil-like cell model that can be readily maintained in standard 
conditions. Initial experiments showed that incubation of HL-60 cells with 1 µM ATRA 
for 5 days initiated their differentiation into neutrophil-like cells, whilst incubation with 
PMA as the stimulus demonstrated PMA’s ability to enhance the respiratory burst 
activity in these neutrophil-like cells. Therefore, a comparative experiment was carried 
out whereby neutrophil-like cells were exposed to a single 90 min treatment of either 
HBO (2.4 ATA), pressure, hyperoxia or hypoxia. The biochemical assays confirmed 
that pre-treatment with HBO enhanced the respiratory burst activity of neutrophil-like 
cells. Exposure to HBO increased O2
•-
 and H2O2 production compared to normoxia-
treated cells. 
ROS such as O2
•-
 and H2O2 serve as signalling molecules in different pathways 
regulating production of various growth factors and cytokines (Allen and Balin, 1989, 
Calabrese et al., 2007, Maulik, 2002). HBO treatment enhanced the phagocytic activity 
of neutrophil-like cells and increased MPO activity and evidence of degranulation 
(exocytosis). HBO-induced oxidative stress also regulates the production of NO 
production, which is known to react with O2
•-
 to generate ONOO
-
 and OH
•
. The present 
study showed that high levels of NOx were observed following HBO as well as 
hyperoxia treatments. A possible mechanism by which of HBO exerts its effects is via 
the impaired neutrophil adherence through the inhibition of β2 integrin. A key target of 
HBO effects on neutrophil adhesion might be the cytoskeleton. The present findings are 
consistent with the idea that HBO may induce changes in the cytoskeleton that are 
manifested by increased actin depolymerisation that normally follows stimulus-induced 
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F-actin assembly. Actin depolymerisation plays a key role in a number of neutrophil 
functions including respiratory burst, phagocytosis and chemotaxis (Crawford and 
Eggleton, 1991, Cano et al., 1991). This suggests that actin might be an important, 
functional target for HBO. Rac1, a member of the Rho family of GTPases, which 
contribute to the organization of the actin cytoskeleton and of the associated sites of cell 
adhesion to the extracellular matrix (Yager et al., 1996), regulates exocytosis through 
the formation of F-actin, which is necessary for granule translocation to the sites of 
exocytosis, whilst depolymerisation of actin should occur concurrently with 
cytoplasmic F-actin formation to control actin remodelling during neutrophil activation. 
Treatment with HBO causes an increase in NO production in cells as a consequence of 
enhanced NOS function (Thom, 1993). NO not only acts as a free radical, but also has a 
role in VEGF regulation and subsequently angiogenesis. Nitrite (NO2
-
), the major 
oxidation product of NO, can react with hypochlorous acid that is generated by MPO to 
yield nitryl chloride and nitrogen dioxide (NO2). Under physiological conditions, NO2
-
 
can react with protein and result in an S-nitrosylation reaction that appears to be 
responsible for the impairment of β2 integrin function observed in HBO-treated 
neutrophils (Thom et al., 2008). This is also in accordance with earlier observations 
which have shown, for example, that HBO-mediated elevation of S-nitrosylated proteins 
was inhibited in neutrophils pre-treated with N
G
-nitro-L-arginine methyl ester (L-
NAME) or in neutrophils from MPO knock-out mice (Thom et al., 2008). Therefore, 
HBO-induced reactive species formation by iNOS and MPO activity are responsible for 
excessive S-nitrosylation of β-actin. This commonly occurs in neutrophils due to the 
high abundance of MPO. 
Oxygen levels have been found to regulate Ca
2+ 
signals via mechanisms involving ROS 
(Ermak and Davies, 2002). Ca
2+ 
release and storage may be directly regulated by the 
cytoskeleton, particularly actin depolymerisation. Ca
2+
 levels are reduced when cells are 
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exposed to dominant-negative constructs of Rac proteins and restored when exposed to 
constitutively active forms of Rac (Hong-Geller et al., 2001). Therefore, Rac-mediated 
signalling in neutrophils may exploit Ca
2+
 signalling as a mode of primary granule 
translocation and exocytosis (Mitchell et al., 2008). 
Regarding the results in the present study, enhancement of antimicrobial activity of 
neutrophil-like cells by HBO seems to limit the resolution of inflammation in chronic 
wounds. However, antimicrobial activity in neutrophils is associated with apoptosis 
(Nagaoka et al., 2012). Neutrophil apoptosis is clearly essential for wound healing, 
since chronic wounds are characterized by the persistence of inflammatory and hypoxic 
conditions in which neutrophil longevity is increased (Khanna et al., 2010). Meanwhile, 
HBO treatment led to a decrease in the viability of neutrophil-like cells, an increase in 
apoptosis as assessed using caspase 3/7 activity and morphological changes associated 
with apoptosis. The increase in apoptosis of the neutrophil-like cells seems to be a 
consequence of increased ROS production by the cell itself that activates death receptor 
signalling thereby promoting neutrophil apoptosis via caspase cascade activation. In 
addition, there is the possibility of a role for mitochondria both in ROS production and 
in the initiation of the intrinsic apoptotic pathway. The HBO-induced oxidative stress is 
linked with a mitochondrial pathway of apoptosis (Weber et al., 2009a). 
Although neutrophils possess mitochondria that are deficient in certain life-maintaining 
functions, a growing body of research has reported that mitochondria are involved in 
neutrophil apoptosis. Release of cytochrome c appears to play a major role, since it is 
released from mitochondria upon an apoptotic insult and initiates the extrinsic pathway 
of apoptosis, promoting oligomerization of Apaf-1 and consequently caspase-9 
activation (Liu et al., 1996a, Adams and Cory, 2002). Neutrophils are thought to 
express a low amount cytochrome c which perhaps leads to the accumulation of 
electrons in the respiratory chain and subsequent ROS formation, when other 
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respiratory complexes, which do not need cytochrome c, are still active. The low 
content of cytochrome c seen in neutrophils leads to conditions that promote caspase-9 
activation (Maianski et al., 2004a). Pro- and anti-apoptotic members of the Bcl-2 family 
of proteins control the release of cytochrome c, Apaf-1 and caspase-9 (Hengartner, 2000, 
Nicholson et al., 1995). While Bcl-2 and Bcl-x1 exert anti-apoptotic effects, the pro-
apoptotic member of the Bcl-2 family, Bax, can directly cause the release of 
cytochrome c and cause apoptotic effects. HBO treatment caused a down regulation of 
the gene expression of the anti-apoptotic factor Bcl-2 in untreated and TNF-α treated 
neutrophil-like cells. These results suggest the possibility of HBO-induced apoptosis via 
the mitochondrial pathway. Due to the fact that HBO treatment combines the dual 
elements of hyperoxia and high pressure, it is possible that the apoptosis increase 
observed could be due to either of these factors. Down regulation of the Bcl-2 gene was 
exhibited in untreated and TNF-α treated cells following exposure to hyperoxia. The 
molecular control of neutrophil apoptosis is still unclear; studies have suggested that 
apoptosis is triggered in the absence of survival factors such as HIF and NF-B. For 
instance, TNF-induced apoptosis inactivated the NF-B pathway via the inactivation of 
a typical protein kinase C that regulated the IKK enzymatic activity (Diaz-Meco et al., 
1999) and factors that activate NF-B blocked the apoptosis. LPS blocked TNF-induced 
apoptosis in myeloid cells through activation of NF-B (Manna and Aggarwal, 1999). 
The findings in the present study also suggest a role for NF-B as an anti-apoptotic 
agent. HBO, pressure and hyperoxia treatment decreased the expression of NF-B and 
protein levels in the nuclear fraction in neutrophil-like cells that were treated with TNF-
α. HBO may affect several genes that may play a role in inhibiting apoptosis and whose 
expression is regulated by NF-B; these include cellular inhibitors of apoptosis such as 
cIAP-1, cIAP-2 and TRAF2 (Stehlik et al., 1998, Chu et al., 1997). The Bcl-2 
homologue Bfl-1/A1 is another gene whose transcription is regulated by NF-B and 
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which inhibits apoptosis (Wang et al., 1999, Zong et al., 1999). Bcl-2 activates NF-B 
through the degradation of the inhibitor IBα (De Moissac et al., 1998; Fig. 8.2). This is 
consistent with the present results, which showed a decrease of expression of Bcl-2 after 
HBO treatment in TNF-α-treated neutrophil-like cells (see Chapter 5). Furthermore, a 
possible role for HIF-1α may be in NF-B regulation. HIF-1α is a direct target gene of 
NF-B and itself contributes to the activation of the NF-B pathway. This important 
interaction was confirmed in a previous study (Van Uden et al., 2008) which suggested 
that several members of the NF-B family can bind to the HIF-1α promoter under basal 
conditions as well as under exposure to TNF-α. 
 
Fig. 8.2 Proposed molecular mechanisms underlying constitutive activation of NF-B and Bcl-2. Bcl-2 
activates NF-B through a mechanism that involves the N-terminal phosphorylation and degradation of 
IBa (inhibitor of kappa B) by proteasomes. This permits NF-B to translocate to the nucleus and 
activate downstream expression necessary to suppress apoptosis, stimulate IKK activity and cause 
augmentation of NF-B activation. Bcl-2 expression protects against ROS–induced apoptosis and is 
associated with regulation of redox sensitive signal pathways such as changes in gene expression or the 
inflammatory process (Wang et al., 1999, Zong et al., 1999). 
 
 
To confirm that the HBO-induced neutrophil apoptosis occurred in a non-inflammatory 
way, pro-inflammatory (TNF-α and IL-1) and anti-inflammatory (IL-10) cytokine 
levels were measured. HBO inhibited pro-inflammatory cytokine production and 
enhanced anti-inflammatory effects which could be due to HBO-induced apoptosis. 
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Given that the resolution of inflammation at the wound site requires removal and 
clearance of apoptotic neutrophils from the inflamed site, it is reasonable to suppose 
that failure to achieve this could result in chronic, persistent inflammation. In Chapter 5, 
the investigation of apoptotic neutrophil-like cells demonstrated an integral response to 
HBO-mediated ROS production, but the design of this particular experiment meant that 
it was not possible to find out whether these apoptotic cells would remain at the wound 
site or be removed in a safe manner. Consequently, experiments using co-culture of 
apoptotic neutrophils and macrophages with HBO treatment may be useful in following 
up the present work by investigating the clearance of apoptotic neutrophils at wound 
sites. Initially, isolated bovine neutrophils and monocytes were used, which may be 
more directly applicable to an in vivo situation rather than the cell line model. MDMФ 
differentiated from bovine monocytes using autologous serum were used as an in vitro 
macrophage model. Initially, apart from morphological changes during apoptosis, 
changes on the apoptotic cell surface also occurred. These changes are important in 
stimulating the efficient removal of apoptotic cells by phagocytes. HBO and pressure 
treatments enhanced the apoptosis of fresh and 22 h-aged neutrophils and their 
clearance by MDMФ. Oxidation of PS may stimulate its externalisation, the possible 
mechanism being that oxidised PS inhibits aminophospholipid translocase, the enzyme 
that is responsible for the maintenance of plasma membrane phospholipid asymmetry 
(Tyurina et al., 2004). HBO and pressure treatments enhanced H2O2 production in both 
fresh and 22 h-aged neutrophils as well as in co-culture experiments. Hence, the 
activation of the NADPH oxidase burst of ROS after HBO treatment might be coupled 
with the externalisation of PS. Oxidants have been implicated previously in apoptosis 
associated with aging neutrophils (Oishi and Machida, 1997, Kasahara et al., 1997). The 
present study suggests that HBO induced PS oxidation through activation of the 
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NADPH oxidase that generates ROS, and hence catalyses oxidation of different cellular 
constituents, including phospholipids, due to triggering of the apoptotic program. 
Alterations in the cytoskeleton (polymerisation, depolymerisation) interacting with cell 
apoptosis signals might enhance the activation of caspases or disrupt mitochondria and 
cause the release of cytochrome c (Thomas et al., 2006). During phagocytosis of 
apoptotic cells, major changes in the cytoskeleton of the cell occurs, leading to the 
formation of filopodia surrounding an apoptotic cell that is to be engulfed. Alteration in 
actin depolymerisation plays an important role in this process and the signalling 
mediators in pathways resulting in cytoskeleton rearrangement all involve Rac-1. 
Engulfment is stimulated by activation of Rac-1 and Cdc42, both members of the Rho 
family of GTPases, and they affect cytoskeletal organization (Somersan and Bhardwaj, 
2001). Cytoskeletal rearrangement enables the phagocyte to enclose the apoptotic cell 
into a phagosome where degradation occurs. It has been suggested that HBO has effects 
on the cytoskeleton and actin polymerisation. HBO exposure causes a marked increase 
in Rac activity (Thom et al., 2008). The results support the hypothesis that actin 
depolymerisation in apoptotic and phagocytic cells acts as a target of a signalling 
cascade during exposure to HBO (Fig. 8.3). This is an important topic for further 
research. 
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Fig. 8.3 Hypothesised mechanisms of HBO effects on the actin cytoskeleton during neutrophil apoptosis 
and their clearance by macrophages. Neutrophils undergoing apoptosis following HBO treatment show 
pronounced membrane blebbing, and alterations in phospholipid asymmetry leading to phosphatidylserine 
(PS) exposure. Binding and engulfment of apoptotic cells are achieved through one of a number of 
membrane receptors, which may include SR- B, CD14, SR-A and CD36/VnR (vitronectin receptor αvβᴣ), 
together with thrombospondin (TSP) in macrophages (Fadok et al., 1992, Zwaal and Schroit, 1997). 
HBO-induced apoptosis results in changes in the actin cytoskeleton in apoptotic cells leading to the 
following biochemical changes: actin-myosin II contraction mediates morphological hallmarks of 
apoptosis including membrane blebbing and cell rounding. Activation of the caspase cascade pathway 
enhances actin cleavages and triggers their N-myristoylation with actin being translocated to the 
mitochondria. Internalization of the dying cell involves reorganization of elements of the cytoskeleton 
through adaptor/signalling molecules in macrophages (Swanson and Baer, 1995). These signalling events 
might also change the profile of cytokine and/or chemokine secretion by the macrophages (Hughes et al., 
1997). Internalized apoptotic material might be extensively degraded and directed to a salvage pathway 
(Brazil et al., 1997). 
 
 
Phagocytosis by macrophages actively suppresses inflammation; this is often referred to 
as a ‘silent event’, reducing pro-inflammatory TNF-α production and increasing anti-
inflammatory TGF-β1 production, but only following the ingestion of apoptotic, not 
secondary necrotic, cells (Savill and Fadok, 2000). Therefore it was of interest to study 
whether HBO-induced neutrophil apoptosis and clearance coincided with the 
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suppression of the inflammatory response. HBO appeared to elicit an anti-inflammatory 
effect and decreased the expression of TNF-α, and significantly increased IL-10. 
In spite of the fact that HBO exposure is applied for chronic wound treatment in a 
repeated manner, it also leads to oxidative stress. Other studies have shown that HBO 
treatment leads to increased ROS formation that causes cellular damage to lipids, 
proteins and DNA (Narkowicz et al., 1993, Jamieson et al., 1986). The present study 
was based on in vitro experiments to investigate the effects of HBO; therefore 
knowledge of biochemical indexes and anti-inflammatory effects of HBO treatment for 
patients with chronic wounds could lead to developments in treatment protocols. Thirty 
in vivo HBO exposures led to a reduction in the antioxidant enzymes SOD and CAT in 
the plasma, with changes in the levels of the pro-inflammatory cytokines TNF-α, IL-1β 
and IL-6 and the anti-inflammatory cytokine IL-10, and subsequent changes in the 
levels of the anti-apoptotic factors NF-B and Bcl-2. Several experiments in the present 
study were limited in their power to detect statistically significant differences between 
treatments because only four patients were available and there are potentially large 
variations between different patients. Increasing the scope of some of these studies by 
performing further replicates might allow detection of statistically significant 
differences, thereby increasing the robustness of the results. 
In the present study, neutrophils were treated with 8.8% O2 at a pressure of 2.4 ATA, to 
give a final PO2 equal to that observed under normoxic conditions, but at a pressure 
more than double atmospheric pressure. Neutrophils treated with the pressure control 
(pressure alone) demonstrated increases in H2O2 and O2
•-
 production, and apoptosis 
compared to normoxic conditions. The mechanical effects of pressure could be 
responsible for most of the changes seen after this treatment. Mechanical deformation of 
PMNs results in an increase in cytoplasmic free Ca
2+
 and up regulation of cell surface 
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adhesion molecules CD11b/CD18 (Anderson et al., 2001). This could explain the 
observed pressure effects, and suggests that priming of neutrophils with a 
chemoattractant such as FMLP would make the cells more sensitive to activation by 
mechanical stress (Doerschuk et al., 1993). Neutrophil functions such as H2O2, OH
•
 and 
HOCl production are directly related to the level of PO2 (Davis et al., 1988). 
Additionally, the formation of microbubbles during decompression may have an effect 
on the cell surface molecules (Madden and Laden, 2007). However, in the present study 
a sealed chamber was used. This did not allow the measurement of microbubble 
formation in the cell culture medium during decompression. Therefore the measurement 
of microbubbles, for example by ultrasound (Bollinger et al., 2009) using a multiplace 
HBO chamber would be a possible way of investigating whether or not microbubble 
formation is plays a role in this situation. 
The response to fluid shear involves specific mediators on the cell membrane. In 
neutrophils, G protein-coupled receptors (GPCRs) mediate the response to fluid shear 
stress. Formyl peptide receptor (FPR) is the most predominant mechanoreceptor in 
neutrophils (Makino et al., 2006). This receptor is also involved in the initiation of 
apoptosis in fibroblasts; stimulation of FPR triggers a signalling cascade leading to 
cytochrome c release from mitochondria and the initiation of apoptosis. This could 
explain pressure-mediated neutrophil apoptosis (Revankar et al., 2004). However, in 
vivo, neutrophil function involves processes that could alter the pressure on the cell 
membrane, which in turn initiates changes in cell status such as L-selectin binding or G-
protein ligation leading to activation of the leukocyte and initiating actin 
polymerization, respiratory burst and granulation (Zarbock and Ley, 2008). 
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8.2 Limitations of the present work 
Although the various experiments have been conducted as part of this research, there are 
limitations, some of which may be addressed in the future. 
Most chronic wounds are mainly characterised by hypoxia, infection and the presence 
of inflammatory cytokines. Due to fact that it is difficult to control the experimental 
conditions, the study was unable to proceed with other independent experiments to 
investigate the effects of HBO on neutrophils and macrophages under pathological 
conditions. 
The in vivo results in the present study were limited in their power to detect statistically 
significant differences between treatments because only four patients were available for 
the study. Increasing the sample size of these studies by involving more patients with 
chronic wounds, would allow for the detection of statistically significant differences. 
As an appropriate incubator was not available, a small HBO chamber and custom-
prepared sealed boxes were used to perform the experiments at room temperature, and 
the present study was unable to demonstrate the exact effects of oxygen or pressure on 
the cells at actual body temperature (37 °C) under optimum conditions as would be 
found in vivo. 
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8.3 Future work 
Hyperbaric oxygen (HBO) works to aid the healing of chronic wounds via various 
mechanisms including the killing of anaerobic bacteria, promotion of neovascularisation 
and the relief of relative tissue hypoxia in affected tissues. However, there are thought 
to be many other mechanisms by which HBO aids the healing of chronic wounds. 
Taking into account the limitations of current work and possible further research, the 
following selected experiments could be undertaken in future. 
In the present study, the apoptotic effects of HBO were partly dependent on ROS 
production that suggested a contribution by the mitochondrial pathway. Therefore 
measurement of apoptotic substances released from mitochondria (for example, 
cytochrome c) by Western blotting could be helpful in the analysis of the mechanisms 
of apoptosis induction by HBO. 
The mediators of the effects of HBO on neutrophils should be examined. These 
potential mediators are HIF-1 and NF-B. HIF-1 is a DNA-binding complex which 
consists of a HIF-1α and a HIF-1β subunit, and is responsible for the regulation of 
cellular responses to hypoxia. Whilst oxygen has no effect on HIF-1β expression, HIF-
1α demonstrates high translational regulation by oxygen. In cells exposed to oxygen, 
HIF-1α is quickly ubiquitinated and degraded by the proteasome system, whereas 
hypoxia induces HIF-1α by decreasing its ubiquitin-proteasome-mediated degradation 
(Huang et al., 1998). Whilst a few studies have examined the effect of HBO on HIF-1α 
expression (Li et al., 2005, Peng et al., 2008), none have examined its effect on HIF-1α 
transcription. From these studies, HBO may have different effects on HIF-1α in 
different cell types, or the effect may depend on the state of the cells before HBO 
treatment and also the HBO exposure protocol. NF-B has been investigated in this 
study. Therefore it is important to examine the effect of HBO on HIF-1α using Western 
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blotting and electromobility shift assays (EMSA), combining these with measurements 
of NF-B which show the effect of HBO on transcription signals and its importance in 
regulation of pathways. 
Excessive neutrophil recruitment is associated with impaired wound healing. Limited 
research to date has focussed on neutrophil influx to the wound site. Therefore 
development of an inflammatory animal model to assess the dynamics of neutrophil 
influx into the wound site and its association with neutrophil viability in circulation is 
important to identify the mechanisms that aid normal wound healing. A histological 
study using immunostaining with specific antibodies or biochemical detection of MPO 
activity as well as fluorescence-based studies using a flow cytometry or fluorescence 
microscopy protocols could be applied. 
Adhesion molecules and their importance in inflammatory conditions have been widely 
investigated, but the effect of HBO on their expression and their contribution to chronic 
wound healing is not fully understood. Therefore an ELISA-based examination of the 
effects of HBO on some adhesion molecules such as ICAM-1, VCAM-1 and selectin, 
which play a key role in neutrophil recruitment to the wound site via the endothelium, 
could be of help in understanding the effects of HBO on neutrophil infiltration into the 
wound site. 
IL-8 is potent in attracting and activating neutrophils. Production of IL-8 induces 
migration of neutrophils to the affected site where they inactivate pathogens by 
phagocytosis and enhance production of O2
•- and H2O2 via respiratory burst activity. 
Investigation of the effects of HBO treatment on IL-8 release from neutrophils using 
ELISA protocols will provide further information about HBO effects on neutrophil 
infiltration into wound sites. 
There is mounting evidence to suggest that the actin cytoskeleton acts as a sensor and 
mediator of HBO effects. The remodelling of the actin cytoskeleton appears consistent 
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with apoptosis signalling. Therefore it would be desirable to conduct experiments 
involving analysis of actin deformation following HBO treatment by using techniques 
such as flow cytometry (Yap and Kamm, 2005), fluorescence microscopy or Western 
blotting to identify the changes in the distribution of the actin cytoskeleton. 
The in vitro experiments used in the study involved only the examination of the short-
term effects of HBO due to the limited life span of neutrophil-like cells, and there was a 
limited sample size for the in vivo studies. In order to study the effects of a course of 
HBO treatments, cells would need to be studied daily over the course of 20-30 
treatments, which represents an actual patient treatment protocol. Isolated neutrophils 
from the wound site, obtained via lavage, may be a better alternative to determine the 
functions of neutrophils at the wound site, although the number of neutrophils obtained 
by this procedure is limited. 
The coordinated activity of phagocytic cells in the inflammatory phase, as well as 
endothelial cells and fibroblasts is essential for wound healing. These cells are known to 
contribute substantially to the wound healing environment, including the resistance to 
infection and the sustaining of the inflammatory phase and also release of various 
growth factors. Interactions between the different cell types could be crucial for the 
effects of HBO. For example, platelets are known to interact with neutrophils and 
endothelial cells during the process of neutrophil recruitment. Therefore, it is important 
to investigate the effect of HBO on these cells alone or in co-culture in vivo. 
HBO has been demonstrated to increase intracellular Ca
2+
 concentration. A further 
study to investigate the effects of HBO treatments on Ca
2+
 levels will aid understanding 
of Ca
2+
 signalling in cells and whether it is associated with ROS production. 
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8.4 Conclusions 
The present study demonstrated several mechanisms by which HBO could resolve 
inflammation in chronic wounds, through alteration of neutrophil functions. The results 
and analyses have indicated that a single exposure to HBO in vitro enhances 
antimicrobial functions and apoptosis of the neutrophil-like cells, thus providing an 
important contribution to knowledge concerning the effects of HBO in chronic wounds. 
A single HBO treatment exhibited immunosuppressive effects through decreased pro-
inflammatory cytokine production in neutrophil-like cells. In addition, a single 
therapeutic HBO treatment increased neutrophil clearance by monocyte-derived 
macrophages. More importantly, HBO is able to enhance clearance of apoptotic 
neutrophils in a non-inflammatory process suggesting the possibility for treatment of 
other inflammatory conditions with HBO. The contributions of hyperoxia and pressure 
conditions to HBO effects were identified, and further investigations to confirm the in 
vitro and in vivo findings are required. The work presented included research on some 
aspects of the in vivo effect of prolonged, repeated HBO treatment in patients with 
chronic wounds, and further work with a suitable sample size could provide evidence to 
support the more effective use of hyperoxia and pressure during HBO treatments. 
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